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Abstract 
We have developed a method to externally control blood clotting using gold 
nanoparticles. Gold nanorods (NRs) have unique size and shape-dependent optical 
properties that can be used for externally controlled release of biomolecules by laser 
excitation. Femtosecond pulsed laser irradiation at the NR longitudinal surface plasmon 
resonance peak (LSPR) can excite the NRs and induce melting, and thus cause release of 
drug or biomolecular payload on the NR. Because the peak wavelength of the LSPR 
changes with NR aspect ratio, NRs with different aspect ratios can be independently 
excited at different wavelengths to release different payloads in a mutually exclusive 
fashion. This approach can be used to create a biological switch for blood clotting by 
releasing a single stranded (ssDNA) thrombin binding aptamer (TBA) upon laser 
irradiation. It is possible to control blood clotting by releasing TBA that binds and 
inhibits thrombin, and an antidote consisting of a complementary ssDNA sequence that 
binds to TBA and restores thrombin activity. Both the TBA and the antidote are loaded 
onto NRs with different aspect ratios. This enables us to use laser excitation at one 
wavelength to deliver the TBA and inhibit thrombin and consequently blood clotting. 
We then use a different wavelength to deliver the antidote and reverse the effect of the 
TBA. We use covalent attachment techniques (thiol-gold binding) for loading the ssDNA 
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on the NRs and study the interface between the NRs and the biomolecules. We also take 
advantage of serum protein coronas for loading, which enable enhanced loading 
capacities. This localized, selective and externally controlled release of biomolecules 
represents an advance that could impact a number of biological applications, where the 
current practice is systemically administering drugs though the whole bloodstream and 
relying on physiological clearance to restore the system. 
 
Thesis supervisor: Kimberly Hamad-Schifferli 




                                                                                                   5
Acknowledgements 
First of all, I would like to thank Prof. Kimberly Hamad-Schifferli, for her advise during 
the years I spent in her research group at MIT. Doing research with her has been a great 
learning experience, due to her kind character and her ability to discuss and share ideas, 
without those, this research project would have not been feasible. The time she has 
shared with me has a priceless value, as it has helped me grow both as a researcher and 
personally. I am as well thankful for the opportunities she has given me to present our 
work in conferences, both in the US and in Europe. These experiences are very 
important for my initiation in a research career. 
I am grateful for having been able to work also in Prof. Lee Gehrke’s lab. I am thankful 
for his lab support and also for the help I received from his research group, especially 
Chunwan, Ann, Irene and José. 
I would also like to thank Prof. Mercedes Balcells and Prof. Salvador Borrós, who 
enabled me to contact Prof. Hamad-Schifferli on the first place. Prof. Mercedes Balcells, 
as a co-director of the MIT-Spain Program, welcomed me on my arrival in Boston; she 
has been a helpful guide during my stay at MIT. 
I am very thankful for all the people I have worked with in the lab. Especially Anna 
Cifuentes and Paula Ciaurriz, for the hours we spent together in the lab (“¡felices 
                                                                                                   6
domingos de laboratorio!”); Dr. Salmaan H. Baxamusa who has taught me the basics of 
working in research. The rest of Hamad-Schifferli’s group: Dr. James Kah, Dr. Stefania 
Federici, Dr. Niraj Sinha, Dr. Sunho Park, Edurne Tellechea and Prof. Paolo Bergese, 
for fruitful discussions and help throughout these years. I would also like to thank Dr. 
Zhichuan Xu, for taking amazing TEM pictures, and for his nice character. Also, the 
undergraduate students who have helped me in the lab: Helen D’Couto, Dorma C. 
Flemister, Nate Miska and Ashley Fletcher. 
I thank our collaborators at MIT. First, Prof. Andrei Tokmakoff and his students: Sam, 
Aritra, Luigi, Paul, Carlos, Krupa and Kevin, for the use of their lasers. Prof. Kristala 
Jones-Prather, Prof. Krystyn Van Vliet, Prof. Moungi Bawendi, Prof. Alexandra A. 
Techet, for the use of their equipment. Also, the Center for Materials Science and 
Engineering (CMSE) and the Biophysical Instrumentation Facility (BIF), for the use of 
their equipment. 
I would also like to thank Denise MacPhail and Joan Hutchins for assistance, and Obra 
Social La Caixa, for my postgraduate fellowship. 
I would finally like to thank my parents, family and friends, who have greatly 
contributed to making this experience even more enjoyable, my roomates: Maria, Sagi, 
Nuria, Martu, Majo and Gemma, for fruitful philosophical discussions. I thank Bayridge 
residence and its staff, Irene and Sara. I thank my friends in “headquarters”, Spain@MIT 
group and the IQS crew, especially Enrique, Marcel, Jose, and Jorge. Gràcies! 
                                                                                                   7
 
                                                                                                   8
  
                                                                                                   9
Table of contents 
1. Introduction: On the control of blood clotting ............................... 25	  
1.1. Motivation ........................................................................................... 25	  
1.2. Objectives and strategies .................................................................... 28	  
1.3. Background ......................................................................................... 31	  
1.3.1. Gold nanoparticles ........................................................................................... 31	  
1.3.1.1. Surface chemistry .................................................................................................. 33	  
1.3.1.2. Optical properties .................................................................................................. 35	  
Nanoparticle assembly ................................................................................................... 38	  
Photothermal heating of gold nanorods ......................................................................... 39	  
Selective photothermal heating of gold nanorods with different SPR ............................ 42	  
1.3.2. Thrombin and the coagulation cascade ........................................................... 45	  
1.3.2.1. Thrombin binding aptamer ................................................................................... 48	  
1.4. Thesis outline ...................................................................................... 53	  
1.5. Bibliography ........................................................................................ 54	  
2. Materials and Methods ................................................................... 67	  
2.1. Synthesis of gold nanoparticles ........................................................... 67	  
2.1.1. Gold nanorods ................................................................................................. 67	  
2.1.2 Gold nanocapsules and Gold nanobones ........................................................... 68	  
2.1.3. Gold nanospheres ............................................................................................ 71	  
                                                                                                   10
2.2. Loading of DNA on NPs by thiol chemistry ....................................... 76	  
2.2.1. Ligand exchange of gold nanoparticles ............................................................ 76	  
2.2.2. Salt stability of the gold nanoparticles ............................................................ 81	  
2.2.3. DNA conjugation of gold nanoparticles ........................................................... 82	  
2.2.4. Surface modifications on the DNA-conjugated NRs ........................................ 87	  
2.2.4.1. HSA block ............................................................................................................. 87	  
2.2.4.2. PEG backfill .......................................................................................................... 88	  
2.3. HS Corona conjugation on NP surfaces .............................................. 90	  
Carbon nanotube solubilization and characterization ............................................... 90	  
2.4. Laser Irradiation of NR ...................................................................... 92	  
2.5. Blood clotting tests ............................................................................. 93	  
2.7. Bibliography ........................................................................................ 94	  
3. Characterization of the covalently bound aptamer-NP conjugates 99	  
3.1. Introduction ........................................................................................ 99	  
3.2. Thermodynamic study of the binding of the aptamer-thrombin on the 
surface of a NP ......................................................................................... 101	  
3.2.1.  Analysis methods ......................................................................................... 104	  
3.2.1.1. Langmuir isotherm .............................................................................................. 104	  
3.2.1.2.  Van’t Hoff equation ............................................................................................ 106	  
3.2.2. Theoretical .................................................................................................... 108	  
3.2.3. Results and discussion ................................................................................... 113	  
                                                                                                   11
3.2.3.1. Synthesis and characterization of TBA decorated NRs ....................................... 113	  
3.2.3.2. Probing thrombin directed self-assembly ............................................................. 116	  
3.2.3.3. Nanomachinery of TBA on NRs .......................................................................... 121	  
3.2.4. Conclusions .................................................................................................... 133	  
3.3. Kinetics of biomolecule-induced nanoparticle assembly ..................... 136	  
3.3.1. Theoretical .................................................................................................... 141	  
3.3.2. Results and discussion ................................................................................... 141	  
3.3.2.1. Different surface chemistries ................................................................................ 143	  
3.3.2.2. Different concentrations of biomolecule added .................................................... 148	  
3.3.4. Conclusions .................................................................................................... 152	  
3.4. Reversible nanomachinery at the nanoparticle-biomolecule interface 154	  
3.4.1. Theoretical .................................................................................................... 155	  
3.4.2. Results and discussion ................................................................................... 158	  
3.4.3. Conclusions .................................................................................................... 160	  
3.5. Quantifying DNA hybridization at the nanoparticle interface ........... 161	  
3.5.1. Theoretical .................................................................................................... 162	  
3.5.2. Results and discussion ................................................................................... 165	  
3.5.3. Conclusions .................................................................................................... 170	  
3.6. Conclusions ........................................................................................ 172	  
3.7. Bibliography ....................................................................................... 174	  
4. Release of covalently bound aptamers from NPs .......................... 183	  
                                                                                                   12
4.1. Introduction ....................................................................................... 183	  
4.2. Melting the NR-CTAB and NB-CTAB ............................................. 186	  
4.2.1. Melting NRs and NBs at their SPR .............................................................. 187	  
4.2.2. Control experiments with single NRs and NBs ............................................. 188	  
4.2.3. Selective melting of a mixture of NRs and NBs ............................................ 190	  
4.3. Release of thiolated ssDNA from NRs ............................................... 193	  
4.3.1. Increasing the loading of thiolated TBA with intramolecular G-quadruplexes
 ................................................................................................................................ 193	  
4.3.2. Aptamers and antidotes effect in blood clotting ............................................ 194	  
4.3.3. Melting and release of TBA from NRs .......................................................... 196	  
4.3.4. Effect of NPs in blood clotting time .............................................................. 199	  
4.4. Release of dsDNA from NRs ............................................................. 201	  
4.5. Conclusions ........................................................................................ 204	  
4.6. Bibliography ....................................................................................... 205	  
5. Increasing loading capacity: NR coronas ....................................... 209	  
5.1. Introduction ....................................................................................... 209	  
5.2. Characterization methods for NR-coronas ......................................... 211	  
5.3. Optimizing the protein corona ........................................................... 216	  
5.3.1. Different binding strategies and proteins ...................................................... 216	  
5.3.2. 5/5/5 Optimal Conditions ............................................................................. 223	  
                                                                                                   13
5.3.2.1. Effect of phosphate buffer ................................................................................... 223	  
5.3.2.2. Effect of CTAB concentration ............................................................................. 225	  
5.3.2.3. Effect of HS concentration ................................................................................... 226	  
5.3.3  Effect of particle material on loading ............................................................ 227	  
5.4. Kinetics of formation of the protein coronas ...................................... 229	  
5.5. Leakage from the NR-coronas ............................................................ 230	  
5.6. Conclusions ........................................................................................ 238	  
5.7. Bibliography ....................................................................................... 239	  
6. Switching on and off blood clotting with light .............................. 243	  
6.1. Introduction ....................................................................................... 243	  
6.2. Effect of TBA and antidote in thrombin clotting tests ...................... 247	  
6.3. Preparation and characterization of NR-coronas ............................... 249	  
6.4. Single laser irradiations for the release of TBA and antidote ............ 253	  
6.5. Selective release of TBA and antidote for the control of blood clotting
 .................................................................................................................. 257	  
6.4. Conclusions ........................................................................................ 262	  
6.5. Bibliography ....................................................................................... 263	  
7. Conclusions and future directions .................................................. 267	  
7.1. Summary of the work ......................................................................... 267	  
7.1.1. Limitations and further studies ..................................................................... 271	  
                                                                                                   14
7.1.2. Advantages .................................................................................................... 274	  
7.2. Future prospects and applications ..................................................... 276	  
7.2.1. Control of blood clotting using gold nanorods in vivo ................................... 276	  
7.2.2. Triggered release for combinational therapy ................................................. 277	  
7.2.3. Switchable enhancement of in vitro translation with light ............................ 278	  
7.2.4. Nanobiomachinery and protein-NR / DNA-NR origamis .............................. 279	  
7.3. Bibliography ....................................................................................... 281	  
                                                                                                   15 
List of figures 
Figure 1-1: Scheme ........................................................................................................... 29	  
Figure 1-2: Published articles on nanotechnology since 1990. Searched “nanoparticle” in 
google scholar ................................................................................................................... 32	  
Figure 1-3: Surface Plasmon Absorption of Spherical Nanoparticles[17] .......................... 36	  
Figure 1-4: Overview of the selective release[69]. Reprinted with permission from Wijaya 
A, Schaffer SB, Pallares IG, Hamad-Schifferli K. Selective Release of Multiple DNA 
Oligonucleotides from Gold Nanorods. ACS Nano 2008;3:80. Copyright 2008 American 
Chemical Society. ............................................................................................................. 42	  
Figure 1-5: Absorbance and TEM image of the NRs and NB after irradiation[69]. 
Reprinted with permission from Wijaya A, Schaffer SB, Pallares IG, Hamad-Schifferli K. 
Selective Release of Multiple DNA Oligonucleotides from Gold Nanorods. ACS Nano 
2008;3:80. Copyright 2008 American Chemical Society. .................................................. 44	  
Figure 1-6: Fluorecense of the DNA released after the irradiation[69] Reprinted with 
permission from Wijaya A, Schaffer SB, Pallares IG, Hamad-Schifferli K. Selective 
Release of Multiple DNA Oligonucleotides from Gold Nanorods. ACS Nano 2008;3:80. 
Copyright 2008 American Chemical Society. ................................................................... 45	  
Figure 1-7: Coagulation cascade ....................................................................................... 46	  
Figure 1-8: TBA-thrombin cycle ...................................................................................... 52	  
                                                                                                   16 
Figure 2-1: TEM image and absorbance graph of synthesized NR .................................. 68	  
Figure 2-2: Extinction plot, TEM and histogram of the synthesized NC ......................... 70	  
Figure 2-3: Extinction plot and TEM of the synthesized NBs ......................................... 71	  
Figure 2-4: TEM Histogram (left), DLS (middle) and extinction (right) of the synthesized 
NS .................................................................................................................................... 72	  
Figure 2-5: TEM images of the NS .................................................................................. 73	  
Figure 2-6: Method for NR ligand exchange[17]. Adapted with permission from Wijaya A, 
Schaffer SB, Pallares IG, Hamad-Schifferli K. Selective Release of Multiple DNA 
Oligonucleotides from Gold Nanorods. ACS Nano 2008;3:80. Copyright 2008 American 
Chemical Society. ............................................................................................................. 77	  
Figure 2-7: Gel electrophoresis of the NRs-CTAB; NRs-MUDA and NRs-MHDA .......... 80	  
Figure 2-8: Gel electrophoresis of PEG-NRs .................................................................... 81	  
Figure 2-9: NR-CTAB; NR-MHA and NR-DNA ............................................................. 84	  
Figure 2-10: Secondary structure of the thrombin binding aptamer (TBA) .................... 87	  
Figure 2-11: Gel of PEG-backfilled NRs .......................................................................... 88	  
Figure 3-1: Thermodynamic cycle describing the assembly of NR-TBA in the presence of 
thrombin. Adapted with permission from de Puig H, Federici S, Baxamusa SH, Bergese 
P, Hamad-Schifferli K. Quantifying the Nanomachinery of the Nanoparticle-Biomolecule 
Interface. Small 2011;7. Copyright 2011 WILEY-VCH Verlag GmbH & Co. KGaA, 
Weinheim. ....................................................................................................................... 109	  
                                                                                                   17 
Figure 3-2: Samples probed. Adapted with permission from de Puig H, Federici S, 
Baxamusa SH, Bergese P, Hamad-Schifferli K. Quantifying the Nanomachinery of the 
Nanoparticle-Biomolecule Interface. Small 2011;7. Copyright 2011 WILEY-VCH Verlag 
GmbH & Co. KGaA, Weinheim. .................................................................................... 116	  
Figure 3-3: Change in absorption spectra of NR-T15-TBA high coverage as a function of 
time upon incubation with 121 nM of thrombin (arrow indicates increasing time). 
Adapted with permission from de Puig H, Federici S, Baxamusa SH, Bergese P, Hamad-
Schifferli K. Quantifying the Nanomachinery of the Nanoparticle-Biomolecule Interface. 
Small 2011;7. Copyright 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. ... 117	  
Figure 3-4: A400/A800 as a function of time for NR-T15-TBA high coverage for different 
thrombin concentrations. Adapted with permission from de Puig H, Federici S, 
Baxamusa SH, Bergese P, Hamad-Schifferli K. Quantifying the Nanomachinery of the 
Nanoparticle-Biomolecule Interface. Small 2011;7. Copyright 2011 WILEY-VCH Verlag 
GmbH & Co. KGaA, Weinheim. .................................................................................... 118	  
Figure 3-5: Aggregation isotherm for NR-T15-TBA high coverage. Adapted with 
permission from de Puig H, Federici S, Baxamusa SH, Bergese P, Hamad-Schifferli K. 
Quantifying the Nanomachinery of the Nanoparticle-Biomolecule Interface. Small 2011;7. 
Copyright 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. ......................... 118	  
Figure 3-6: A400/A800 as a function of time upon incubation with thrombin (t = 0 min) 
and complementary DNA sequence (gray area, 60 min). Adapted with permission from de 
Puig H, Federici S, Baxamusa SH, Bergese P, Hamad-Schifferli K. Quantifying the 
                                                                                                   18 
Nanomachinery of the Nanoparticle-Biomolecule Interface. Small 2011;7. Copyright 2011 
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. .................................................. 119	  
Figure 3-7: A400/A800 of already formed NR-T15-TBA -thrombin aggregates as a 
function of changing the temperature from 25ºC to 80ºC and back down to 25ºC (arrows 
indicate direction). Adapted with permission from de Puig H, Federici S, Baxamusa SH, 
Bergese P, Hamad-Schifferli K. Quantifying the Nanomachinery of the Nanoparticle-
Biomolecule Interface. Small 2011;7. Copyright 2011 WILEY-VCH Verlag GmbH & Co. 
KGaA, Weinheim. ........................................................................................................... 120	  
Figure 3-8: Modified Langmuir aggregation isotherms for a) NR-T15-TBA high coverage, 
b) NR-T15-TBA low coverage, c) NR-T15-TBA mPEG backfill 0.5:1 mPEG:TBA, d) fits 
for plots a-c , e) NR-TBA without poly T spacer (the dashed line is the average value), f) 
NR-T15-TBA HSA block (the dashed line is the average value), g) NR- T15-TBA high 
coverage mPEG backfill 5:1 mPEG:TBA. Reprinted with permission from de Puig H, 
Federici S, Baxamusa SH, Bergese P, Hamad-Schifferli K. Quantifying the 
Nanomachinery of the Nanoparticle-Biomolecule Interface. Small 2011;7. Copyright 2011 
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. .................................................. 124	  
Figure 3-9: a) θ vs. -Wσ for NR-T15-TBA high coverage (square), NR-T15-TBA low 
coverage (triangle), and NR-T15-TBA -PEG backfill 0.5:1 (circle), b) ThT vs. - Wσ for 
NR-T15-TBA high coverage (square), NR-T15-TBA low coverage (triangle), and NR- T15-
TBA -mPEG backfill. Adapted with permission from de Puig H, Federici S, Baxamusa 
SH, Bergese P, Hamad-Schifferli K. Quantifying the Nanomachinery of the Nanoparticle-
                                                                                                   19 
Biomolecule Interface. Small 2011;7. Copyright 2011 WILEY-VCH Verlag GmbH & Co. 
KGaA, Weinheim. ........................................................................................................... 126	  
Figure 3-10: Melting profile of the NR-thrombin conjugates and fitted model ............... 132	  
Figure 3-11. Nanorod assembly kinetics scheme .............................................................. 137	  
Figure 3-12: Formation of the unit blocks of aggregation scheme ................................... 138	  
Figure 3-13: Subsequent monomer addition scheme ........................................................ 139	  
Figure 3-14: Overall kinetic scheme of NR assembly ...................................................... 139	  
Figure 3-15: Evolution of the extinction of the NRs with time ....................................... 142	  
Figure 3-16: Assembly of the NRs at 121nm thrombin ................................................... 142	  
Figure 3-17: Kinetic fits with different surface chemistries ............................................. 144	  
Figure 3-18: Comparison of the fits between different surface chemistries ...................... 145	  
Figure 3-19: T15-TBA high coverage kinetics at different thrombin concentrations ....... 149	  
Figure 3-20: T15-TBA low coverage kinetics at different thrombin concentrations ......... 150	  
Figure 3-21: PEG Backfill kinetics at differetn thrombin concentrations ....................... 151	  
Figure 3.22: Thrombin-TBA nanomachine ..................................................................... 155	  
Figure 3.23: Thermodynamic cycle of NRs disassembly .................................................. 157	  
Figure 3-24: Reverisble assembly of NRs after the addition of thrombin and anti-TBA 159	  
Figure 3-25: Disassembly of NRs after antidote addition ................................................ 160	  
Figure 3-26: DNA hybridization on the NRs surface ...................................................... 163	  
Figure 3-27: FRET curve at 25ºC and 80ºC ................................................................... 164	  
Figure 3-28: DNA hybridization on high coverage NCs .................................................. 166	  
                                                                                                   20 
Figure 3-29: DNA hybridization on high coverage NRs .................................................. 166	  
Figure 3-30: DNA hybridization on TBA NRs ................................................................ 167	  
Figure 3-31: DNA hybridization on mid-Coverage NRs .................................................. 167	  
Figure 3-32: DNA hybridization on Low-coverage NRs .................................................. 168	  
Figure 3-33: Sigmoidal fit for the DNA hybridization (r2=0.998) ................................... 169	  
Figure 4-1. Absorbance spectra of NRs (red) and NBs (blue). ....................................... 184	  
Figure 4-2. Scheme of the selective release of thiolated ssDNA ...................................... 185	  
Figure 4-3. CTAB-NRs and CTAB-NBs ......................................................................... 186	  
Figure 4-4. Melting CTAB-NRs at 800nm ...................................................................... 187	  
Figure 4-5. Melting CTAB-NBs at 1100nm .................................................................... 188	  
Figure 4-6. Minimal melting of the CTAB-NRs at 1100nm ............................................ 189	  
Figure 4-7. No melting of the CTAB-NBs at 800nm ...................................................... 189	  
Figure 4-8. Selective melting of CTAB-NR-NB at 800nm .............................................. 191	  
Figure 4-9. Selective melting of CTAB-NR-NB at 1100nm ............................................ 192	  
Figure 4-10. Loading of thiolated TBA with and without PolyT spacer ........................ 194	  
Figure 4-11. Effect of TBA in blood and effect of antidote on TBA ............................... 195	  
Figure 4-12. ABS spectra of 5nM TBA-NRs at increasing irradiation times .................. 196	  
Figure 4-13. TBA release as a function of irradiation time ............................................. 197	  
Figure 4-14. ABS spectra of TBA-NRs irradiated for 30 min ......................................... 198	  
Figure 4-15. TBA release as a function of irradiation time ............................................. 198	  
Figure 4-16. Functionality of the released TBA .............................................................. 199	  
                                                                                                   21 
Figure 4-17. Effect of thiolated TBA-NRs in blood ........................................................ 200	  
Figure 4-18. Scheme of CW irradiation ........................................................................... 201	  
Figure 4-19. Absorbance of CW irradiated NRs ............................................................. 202	  
Figure 4-20. Released TBA and thiolated T15-antidote after 800nm CW laser irradiation
 ........................................................................................................................................ 203	  
Figure 5-1. Scheme of combined and sequential assembly .............................................. 211	  
Figure 5-2. Absorbance spectra of the protein coronas ................................................... 213	  
Figure 5-3. TEM images of NR, NB, CNT and CoNR, CoNB, CoCNT ......................... 214	  
Figure 5-4. DLS measurements (top) and Zeta potentials (bottom) of NR, NB, CNT and 
CoNR, CoNB, CoCNT .................................................................................................... 215	  
Figure 5-5. Variation of the corona components ............................................................. 217	  
Figure 5-6. Absorbance of NR-coronas ............................................................................ 217	  
Figure 5-7. Absorbance of SeNR ..................................................................................... 219	  
Figure 5-8. Loading from coronas as measured by supernatant loss ............................... 220	  
Figure 5-9. Loading of NR-coronas measured by heat displacement ............................... 221	  
Figure 5-10. DLS of coronas formed with HS, ES and HSA ........................................... 222	  
Figure 5-11. Loading of CoNRs, as a function of [PB] .................................................... 224	  
Figure 5-12. Stability of NR-coronas in different buffer strengths and buffers. .............. 224	  
Figure 5-13. Loading of the NRs as a function of CTAB concentrations ........................ 226	  
Figure 5-14. Loading of the NRs as a function of HS concentrations ............................. 227	  
Figure 5-15. Loading of the NRs, NBs and CNTs ........................................................... 228	  
                                                                                                   22 
Figure 5-16. Formation of the protein coronas ................................................................ 229	  
Figure 5-17. Leakage from NP-coronas, by tuning corona formation .............................. 232	  
Figure 5-18. Changing the PB after formation of coronas .............................................. 233	  
Figure 5-19. Formation of the protein coronas ................................................................ 236	  
Figure 6-1. Scheme of the selective release approach ...................................................... 245	  
Figure 6-2. Calibration of TBA (top) and antidote:TBA, with [TBA]=500nM(bottom) 248	  
Figure 6-3. Absorbance spectra of NR, NB, NR-HS-TBA and NB-HS-anti .................... 250	  
Figure 6-4. Loading of NR-HS-TBA and NB-HS-anti ..................................................... 251	  
Figure 6-5. DLS and Zeta potential of NB-CTAB, NB-HS-anti, NRs-CTAB and NR-HS-
anti .................................................................................................................................. 252	  
Figure 6-6. 1100nm irradiation of NB-HS-anti. Melting and release (inset) .................... 253	  
Figure 6-7. 800nm irradiation of NR-HS-TBA. Melting and release (inset) .................... 254	  
Figure 6-8. Comparison of HS-TBA-Bock release, thiolated TBA-NRs and calibrations 255	  
Figure 6-9. Comparison of HS-TBA-Bock release and thiolated TBA-NRs .................... 256	  
Figure 6-10. Comparison of HS-TBA-Bock release and thiolated TBA-NRs .................. 257	  
Figure 6-11. Comparison of HS-TBA-Bock release and thiolated TBA-NRs .................. 258	  
Figure 6-12. Comparison of HS-TBA-Bock release and thiolated TBA-NRs .................. 259	  
Figure 6-13. 1100nm irradiation of the NR-HS-TBA and NB-HS-antidote. Left: 
Absorbance. Right: fluorescence of the released species .................................................. 260	  
Figure 6-14. Measurement of the effect of particles in blood. ......................................... 261	  
                                                                                                   23 
List of tables 
Table 1-1: Specificities of aptamers to heparin-binding molecules[73] .............................. 50	  
Table 1-2: Kinetic parameters of some aptamers[73] ....................................................... 50	  
Table 2-1: Parameters for the synthesis of NS of different sizes ...................................... 72	  
Table 3-1: Kinetic binding constants for different surface chemistries ............................ 143	  
Table 3-2: Assembly kinetic constants of different surface chemistries ........................... 146	  
Table 3-3: Kinetic binding constants for High Coverage NR-T15-TBA ........................... 148	  
Table 3-4: Calculated kinetic binding constants for high coverage T15-TBA .................. 149	  
Table 3-5: Kinetic binding constants for Low coverage NR-T15-TBA ............................. 150	  
Table 3-6: Calculated binding constants for T15-TBA with Low coverage ...................... 151	  
Table 3-7: Kinetic binding constants for PEG backfilled NR-T15-TBA .......................... 151	  
Table 3-8: Calculated kinetic binding constants for PEG-backfilled NR-T15-TBA ......... 152	  
Table 3-9: Compared values of DNA hybridization on different surfaces ....................... 168	  
	   	  
                                                                                                   24 
	   	  
Helena de Puig Guixé 
Mechanical Engineering MS Thesis 
MIT 
 
1. Introduction                                                                                                   25 
1. Introduction: On the control of blood clotting 
1.1. Motivation 
The coagulation of blood is necessary to avoid bleeding and is achieved by the blood 
clotting cascade, which is an enzymatic cascade that ensures a rapid and localized 
response to injury. However, there are a number of thrombophylic disorders, such as deep 
venous thrombosis (DVT), stokes, heart attacks, peripheral vascular diseases, and many 
others where precise control of blood clotting by the use of anticoagulants is required. 
The most widespread anticoagulants are (1) heparin –which acts rapidly by its presence 
in the blood-, (2) warfarin –which is acts after some delay- and (3) aspirin.  
The discovery of heparin by McLean and Howell on 1916[1, 2] is one of the most 
important advances in medicine. Heparin is a mucopolysaccharide that is extracted from 
bovine and porcine gut mucosa[3]. Even nowadays, injectable heparin is the most 
commonly used anticoagulant due to its rapid effectiveness, availability and low cost. It 
prevents blood coagulation by inhibiting thromboplastin –by depressing factors V, IX, XI 
and XII- and by enhancing fibrinolysis –and inhibiting the polymerization of fibrinogen-
[4].  
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Warfarin was discovered in the 1920s, when cattle in northern US and Canada started 
dying of internal bleeding, due to sweet clover disease. Later, in 1948, warfarin was used 
as rat poison, with rodents dying of internal haemorrhage. In 1950s, warfarin started 
being used as an anticoagulant, with the name ‘Coumadin’, and is currently the most 
widespread oral anticoagulant[2]. However, its effect in preventing blood clotting is not 
immediate, and it requires a controlled dosage and the use of heparin before it can be 
administered. Warfarin prevents blood clotting by lowering the amount of active vitamin 
K available for the activation of clotting factors II, VII, IX and X[5].  
Aspirin was discovered by Hoffmann in 1898, and was initially used as an antipyretic and 
anti-inflammatory drug. Aspirin also has antithrombotic effects, and it prevents the 
coagulation of blood by preventing platelet aggregation, increasing blood clot lysis, and 
lowering the formation of thrombin by decreasing tissue factor expression[6]. 
All these anticoagulants have side effects, the most common of them being a high risk of 
bleeding, if dosage is not correctly monitored[1, 5]. Moreover, anticoagulants are 
administered to the entire bloodstream, and most of them do not have a specific antidote, 
so their effect can only be reduced by clearance. Therefore, when surgery is required, it 
needs to be postponed for several days, until the anticoagulants are cleared from the 
body, during which time blood clots could be produced and transported in the 
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bloodstream, with the possibility of eventually causing strokes-. Moreover, in the early 
2000’s several deaths were caused by contaminated batches of heparin that were 
distributed in the US [7-10]. Other adverse reactions of anticoagulants include 
thrombocytopenia, acute heparin reaction, heparin associated osteoporosis, heparin and 
warfarin-related skin reactions, abnormal liver functioning, and eosinophilia, among 
others [4, 11].   
Therefore the possibility of manipulating blood clotting in a way that is specific –by 
using an anticoagulant that can inhibit only one protein in the blood clotting cascade-, 
reversible –by using an antidote that can stop the activity of the anticoagulant-, localized 
–by enabling the control of blood clotting in a confined area- and externally controlled, 
would represent a great improvement over the current practice of administering 
anticoagulants over the whole bloodstream and relying in physiological clearance to 
restore the system’s activity.   
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1.2. Objectives and strategies 
With the use of gold nanoparticles, it is possible to achieve a localized and external 
release of biomolecules. The conjugation of gold nanoparticles with biomolecules has 
enabled important advances in diagnostic and therapeutic nanomedicine. The 
biocompatibility and unique optical properties of gold nanoparticles has enabled their use 
in sensing, imaging, drug release and assembly applications.   
The interaction of light with noble metal nanoparticles results in collective oscillations of 
the electrons in the metal known as surface plasmon resonance (SPR). The SPR is 
dependent on the size and shape of the particles, and can be tuned throughout the visible 
and IR regions. Gold nanoparticles have a SPR peak, and therefore can be melted by 
ultrafast laser irradiation at the SPR to release a drug or biomolecule on their surface. 
Thus, gold nanoparticles of different sizes and shapes have been used for photothermal 
therapy and delivery. 
We have developed a method to externally control blood clotting by exploiting 
the optical properties of gold nanoparticles. Nanoparticles are attractive for 
interfacing to biological systems and have been used to manipulate biological processes 
and reactions in a way that is specific, reversible and spatially localized. Here we use gold 
nanoparticles conjugated with a biomolecule (ssDNA aptamer, TBA) that can specifically 
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inhibit human thrombin, and an antidote (ssDNA complementary sequence) that restores 
its activity. We use gold nanorods (NRs), as they can be synthesized to absorb light in 
the infrared region, where biological tissue has minimal absorption. The SPR is tunable 
by changing the NR aspect ratio (AR); therefore, NRs with different ARs can be 
independently excited at different wavelengths to release different payloads[12]. By using 
this approach, we use laser excitation at one wavelength to release the aptamer and 
trigger the inhibition of thrombin, and then use a different wavelength to deliver the 
antidote and specifically reverse the effects of the aptamer (Fig. 1-1). Thus, the pair of 
NRs acts an on/off switch for blood clotting.  
 
Figure 1-1: Scheme 
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We study the binding of the TBA by thiol chemistry and by taking advantage of protein 
coronas that naturally form around nanoparticles in biological fluids for enhanced 
loading[13]. We also quantify the interactions of thrombin with gold nanoparticles at the 
interface, the formation of protein coronas, and the passive release of ssDNA from protein 
coronas weakly bound to nanoparticles.  
  
Helena de Puig Guixé 
Mechanical Engineering MS Thesis 
MIT 
 
1. Introduction                                                                                                   31 
1.3. Background 
1.3.1. Gold nanoparticles 
It was in the Middle Ages when artisans started using gold nanoparticles to give color to 
stained glasses in the cathedrals. This fact was not recognized until 1857, in M. Faraday’s 
Bakerian Lecture on the “Experimental Relations of Gold (and other Metals) to Light” 
[14], when he observed that the red color of colloidal gold comes from the presence of 
aggregates of gold atoms. Nevertheless, it was not until the twentieth century when 
colloidal chemistry received a huge growth due to the works of Oswald, Mie [15], 
Svedberg and Zsigmondy[16]. 
One fact that was already noticed more than a 100 years ago is how the amount of 
surface atoms increases with decreasing the particle size. If we imagine a cube of 1cm 
edge, the percentage of surface atoms would be around 10-5%. Moreover, in a cube of 
10nm edge, this percentage would increase to 10%; and in a cube of 1nm edge, each atom 
would be a surface atom [17]. This is one of the reasons why one can expect very 
different physical and chemical properties in a nanoparticle than those expected in bulk 
materials.  
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Nanotechnology comprises all the methods and techniques to study, design and fabricate 
devices that work in the nanometer scale (1-100nm). Its interest has increased in the last 
decade, where more than 35 countries have developed programs in nanotechnology since 
2000[18], and the number of published articles regarding nanotechnology has rapidly 
increased during the last years (Fig. 1-2). The interest on nanotechnology is based on the 
fact that all biological systems have their first level of organization at the nanoscale [19]; 
therefore, nanotechnology can lead to important improvements in biology, biotechnology, 
medicine and healthcare.  
 
Figure 1-2: Published articles on nanotechnology since 1990. Searched “nanoparticle” in google scholar 
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The nanoscale interactions of organic and inorganic matter lead to the construction of 
cells and more complex organisms –the brain and the human body-. Therefore, 
nanotechnology plays a key role in understanding these processes and in the progress of 
biological sciences and biotechnology. A significant amount of research has been devoted 
to studying the interactions of many types of nanoparticles, including quantum dots [20], 
polymeric nanoparticles[21], carbon nanotubes[22] or gold nanoparticles[23-28], with 
biological systems. 
Gold nanoparticles are especially interesting for interacting with biological systems due to 
their surface chemistry and optical properties. They can be synthesized with different 
sizes and shapes, such as spherical[23], stars[29], shells[30-32], bones[33] or rods[34, 35] –
among others-, resulting in diverse physical and chemical properties.  
Gold nanorods (NRs) are particularly attractive due to the fact that tuning their size 
tunes their optical properties. They can be synthesized to absorb light in the infrared 
region, where biological tissue does not absorb. Moreover, their surface properties make 
them amenable for biological applications.  
1.3.1.1. Surface chemistry 
The surface chemistry of gold nanoparticles varies depending on their size and shape. 
Moreover, as the size of the nanoparticles increases they need to be stabilized by ligand 
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in order to be stable in solution, particularly in the case of gold nanorods. This coating 
on the particles plays a key role in the nanoscale interactions of the nanoparticles with 
biological materials. 
Usually, gold nanoparticles are synthesized in a surfactant solution that keeps them 
stable [35, 36]. Thiol-gold chemistry has been widely used when working with gold 
nanoparticles[37-39]. After the synthesis of the nanoparticles, it will usually be necessary 
to perform a ligand exchange[38, 40] for biofunctionalization and to lower the 
cytotoxicity, of the synthesizing surfactant in the case of NRs. After the ligand exchange, 
a DNA conjugation, PEG backfill[41] or other modification to the particles’ surface can 
be achieved. Therefore, the ligand on the particle surface is the most important 
parameter when studying its interactions with biological molecules.  
Other approaches for nanoparticle functionalization include the use of protein coronas. Its 
greatest advantage is that it enables for an enhanced loading[13] on the particles, and a 
potential reduction on biocompatibility, as the proteins that mask the particle surface are 
already present in blood. 
An important parameter to study when working with gold nanoparticles is their toxicity, 
which not only depends on the ligand on the particle’s surface, but also on their size and 
shape. In the case of gold nanoparticles, several studies of their toxicity have been 
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conducted [42-44]. These studies show that the toxicity of nanoparticles both in vivo and 
in vitro is low.   
1.3.1.2. Optical properties 
The optical properties of a material are due to the motion its surface electrons can 
execute. The electrons in metals are highly delocalized, therefore, when we reduce the size 
of a metal until it is comparable to the electron mean free path, one can observe an 
intense absorption in the visible-near-UV, which results from coherent oscillation of the 
free electrons from one surface of the particle to the other and is called surface plasmon 
resonance (SPR). Such strong absorption induces strong coupling of the nanoparticles to 
the electromagnetic radiation of light. 
In figure 1-3, we can observe a scheme illustrating the excitation of the dipole surface 
plasmon oscillation. The electric field of an incoming light wave induces polarization of 
the free conduction electrons in respect to the core of the spherical gold nanoparticle. 
There is a net charge difference at the nanoparticle’s boundaries. In this way, the SPR is 
the dipolar oscillation of the electrons with period T. This condition can be observed in 
absorption and scattering spectroscopy and depends on the shape, size and dielectric 
constants of the metal and the surrounding material. The SPR is the physical 
characteristic most responsible for the optical properties of gold nanoparticles[45].  Mie 
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was the first to solve Maxwell’s equations of an electromagnetic field interacting with a 
spherical gold particle under the appropriate boundary conditions. 
 
Figure 1-3: Surface Plasmon Absorption of Spherical Nanoparticles[17] 
 
In the case of gold nanorods, their unique optical properties rely on their lack of 
symmetry.  The aspect ratio (length divided by width) of gold nanorods can be tuned by 
the synthesis conditions, and it determines the wavelength of the Surface Plasmon 
Resonance. Therefore, gold nanorods with different aspect ratios will have different SPRs. 
Gans extended Mie’s theory to account for ellipsoids –which are similar to the shape of 
gold nanorods[46]-. The extinction coefficient of randomly oriented NRs (εNR) according 
to Gans is: 
𝜀!" = 2𝜋[𝑁𝑅]𝑉!"𝜀!! !3𝜆 𝜀!𝑃!!𝜀! + 1 − 𝑃!𝑃! 𝜀! + 𝜀!!!  
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Where εm is the relative dielectric constant of the medium immediately surrounding the 
particle, εi is the wavelength-dependent relative complex dielectric constant of gold 
(Imaginary: ε2; Real: ε1). The wavelength of the interacting light is symbolized by λ, VNR 
is the volume of one nanorod and Pi is the depolarization factors for the three axes A,B 
and C for the rod, where A > B =C. They are dependent on the aspect ratio (AR) of the 
NR, following the equation: 
𝑃! = 1 − 𝑒!𝑒! 12𝑒 𝑙𝑛 1 + 𝑒1 − 𝑒 − 1  
𝑃! = 𝑃! = 1 − 𝑃!2  
Where e is a function of the AR of the NR: 
𝑒 = 1 − 1𝐴𝑅! 
The previous equations predict that as the AR of the particles approaches to 1 (spherical 
particles), there is a peak in the extinction coefficient at around 530nm. As the AR 
increases, this peak splits in two. The redder peak is due to the plasmon resonance of the 
longitudinal direction of the NR; while the bluer peak is due to the plasmon resonance of 
the transverse direction of the NR. The extinction coefficient increases as the AR 
increases.  
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Nanoparticle assembly 
The assembly of gold nanoparticles to form larger structures leads to a change in their 
optical properties [47-49], which can be observed as a shift in their SPR peaks. El-Sayed 
group[50] simulated the changes in the absorption spectra of gold NR after their 
attachment to form dimers and trimers. They observed that if the NRs attach side by 
side, their SPR longitudinal absorption peak shifts to the blue region of the spectra, and 
if the NR attach head to tail, their spectra shifts to the red region of the spectra, 
resulting from plasmon coupling of neighboring particles interacting in the assembly. 
Authors agree that the optical properties of gold nanoparticle assemblies depend mainly 
on the size of the aggregate[49], and that they cannot be explained using small aggregate 
models[47]. 
In the last years, the use of nanoparticles as building blocks to form functional devices 
has gained increasing attention for a number of applications, such as sensing, in vivo 
targeting and imaging, of single molecule detection by surface enhanced Raman 
spectroscopy [51, 52]. NRs are especially interesting as they absorb light both in the 
infrared and in the visible regions.  Some authors have reported the design and formation 
of NR assemblies of controlled size and shape[53-57] in one, two and three dimensions. 
Also, biorecognition systems[58] such as antibody-antigen pairs (biotin-streptavidin)[59], 
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DNA hybridization[48, 53], or aptamer-protein[55, 60] recognition has gained much 
attention in the last years.  
Photothermal heating of gold nanorods 
Photothermal heating is the phenomenon based on the conversion of the optical energy 
that certain materials selectively absorb to heat. Gold nanorods can be used as strong 
absorbers due to their high absorption coefficient in the SPR peak. Moreover, the fact 
that their absorption peak can be tuned –and therefore the wavelength of the incoming 
light- by the synthesis conditions, makes them attractive for photothermal therapy[30].  
By using photothermal therapy, it is possible selectively kill targeted cells, or enable 
externally controlled drug delivery. In order to do so, the absorption peak of the gold 
nanorods has to be inside the “tissue window”, between 600 and 1300nm, where the 
penetration of light in tissue is maximal. This ensures that the gold nanorods with SPRs 
inside the tissue window will absorb light preferentially.  
Photothermal heating can be accomplished by a variety of sources, such as continuous 
wave (CW) laser, nanosecond-pulsed laser or femtosecond-pulsed lasers[62]. The local 
temperature of the NRs will be higher as the laser pulse width decreases, taking into 
account the same energy per pulse.  
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During the femtosecond laser irradiation of the gold nanorods at their SPR there is a 
collective motion of the electrons in the metal nanoparticle that resonantly couples with 
the oscillating electric field of the incident light. The energy of the photons absorbed is 
converted to heat via a multi-step process. First, (1) the photons excite the electron 
cloud during the pulse duration. (2) The electrons transfer the energy to phonons in the 
lattice; the particle’s temperature increases as a result of the electron-phonon scattering. 
(3)This heat is dissipated to the surrounding media though phonon-phonon interactions. 
The dissipation of heat is dependent on the nanoparticle size, ligand and surrounding 
media.[63] 
Photon-Electron 
Once the gold nanoparticle is irradiated with light at their SPR, the energy from the 
photons is transferred to the electron cloud. Exciting the coherent motion of the free 
electrons by use of femtosecond laser pulses leads to a rapid dephasing of the electronic 
coherent oscillation due to strong electron-electron repulsion. This leads to the formation 
of a pulse of hot electrons of tens of thousands of degrees (approaching 1000K) on the 
femtosecond time scale (~4fs).  
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Electron-phonon 
When the electron cloud is raised to a high temperature, there is an imbalance in the 
energy level of the electrons and the crystal lattice. This imbalance is relaxed by 
collisions of the hot electrons with the lattice ions; it results in heating the gold 
nanocrystal lattice homogenously via electron-phonon interactions, which happens in the 
picosecond time-scale (≈1.5-4ps)[64, 65]. The energy transfer to the lattice induces 
vibrations of the lattice ions from their mean position that leads to thermal expansion of 
the nanoparticle.  
Phonon-phonon 
As the lattice starts to vibrate, there is an imbalance between the phonons in the 
nanoparticle lattice and the surrounding fluid. This energy imbalance is relaxed through 
phonon-phonon interactions, and conduction will be the dominant mode of heat transfer. 
Therefore, classical diffusion equations characterize nanoparticle cooling. The energy 
transfer in phonon-phonon interactions happens in the picoseconds time scale 
(≈100ps)[62, 64].  
Ultrafast photothermal heating of the gold nanorods at their SPR induces the melting of 
the particles. For NRs, this results in a shape transformation to spheres. The timescale of 
the melting process of gold nanorods has been measured by El-Sayed group to be ~35ps 
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[66]. Also, the energy needed to melt gold nanorods with fs laser pulses is around 
0.01J/cm2 [62, 67]. Moreover, the photothermal heating and melting of the gold nanorods 
cause the dissociation of the thiol-gold bonds on the surface of the gold nanorods[68].  
Selective photothermal heating of gold nanorods with different SPR 
Previous work from Hamad-Schifferli group shows that it is possible to selectively release 
different ssDNA sequences from NRs with different AR (Fig 1-4)[69]. Such experiments 
were performed by mixing DNA conjugated NRs with SPR maximum at 800nm 
wavelength and DNA-conjugated gold nanobones (NBs) with SPR maximum at 1100nm, 
and irradiating them at 1100nm and 800nm with fs lasers at different fluences.  
 
Figure 1-4: Overview of the selective release[69]. Reprinted with permission from Wijaya A, 
Schaffer SB, Pallares IG, Hamad-Schifferli K. Selective Release of Multiple DNA Oligonucleotides from Gold 
Nanorods. ACS Nano 2008;3:80. Copyright 2008 American Chemical Society. 
 
 
Helena de Puig Guixé 
Mechanical Engineering MS Thesis 
MIT 
 
1. Introduction                                                                                                   43 
The results showed that when the mixture was irradiated at 1100nm, only the ssDNA 
attached on the NBs was released; and when the mixture was irradiated at 800nm, only 
the DNA attached on the NRs was released. 
They could observe the decrease in the SPR of the nanoparticles as they were irradiated 
with different fluences (Fig 1-5). In the top image, the particles were irradiated with a 
800nm fs laser, and one can observe, both in the absorbance spectrum and in the TEM 
image, that only the NRs melted. On the bottom image, the mixture was irradiated at 
1100nm wavelength, with a femtosecond pulsed (fs) laser. It can be observed both in the 
TEM image and in the absorbance spectrum that only the NBs melted.  
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Figure 1-5: Absorbance and TEM image of the NRs and NB after irradiation[69]. Reprinted with 
permission from Wijaya A, Schaffer SB, Pallares IG, Hamad-Schifferli K. Selective Release of Multiple DNA 
Oligonucleotides from Gold Nanorods. ACS Nano 2008;3:80. Copyright 2008 American Chemical Society. 
 
 
Selective DNA release from the gold nanoparticles was also demonstrated (Fig. 1-6). In 
the image on the left, the mixture was irradiated at 800nm, releasing the DNA attached 
to the NRs and not the DNA attached on the NB. Moreover, this DNA was still 
functional as shown in the melting curve of the DNA (Image 10, left on the top). In the 
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image on the right, one can see the results after the laser irradiation of the mixture at 
1100nm.  
 
Figure 1-6: Fluorecense of the DNA released after the irradiation[69] Reprinted with permission 
from Wijaya A, Schaffer SB, Pallares IG, Hamad-Schifferli K. Selective Release of Multiple DNA 
Oligonucleotides from Gold Nanorods. ACS Nano 2008;3:80. Copyright 2008 American Chemical Society. 
 
 
In this thesis we will use this approach and selectively release ssDNA aptamers and 
antidotes from NRs and NBs, by irradiating them at different wavelengths. 
1.3.2. Thrombin and the coagulation cascade  
The blood clotting cascade is an enzymatic cascade. Enzymatic cascades are efficient at 
reaching a rapid response, and can often do so with both temporal and spatial precision. 
In a cascade, an initial signal starts a series of steps, each of them catalyzed by an 
enzyme. The signal is amplified at each step[70].  Therefore, small amounts of the initial 
factors are enough to start the cascade, and ensure a rapid response to trauma. 
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Blood clotting is initialized by the intrinsic and the extrinsic pathways (Fig 1-7). The 
intrinsic pathway starts with the activation of factor XII by contact with abnormal 
surfaces produced after an injury. The extrinsic pathway is started by trauma, which 
activates factor VII and releases tissue factor from blood vessels. The extrinsic and 
intrinsic pathways meet on the common final step where the conversion of fibrinogen into 
fibrin by thrombin, leads to the formation of a blood clot. The two pathways interact 
with each other and both are needed for proper clotting. For instance, in patients 
suffering from Hemophilia A, the factor VIII has a severe loss of activity or is missing. 
Factor VIII stimulates the formation of factor Xa, by factor IXa. Therefore, the 
activation of the intrinsic pathway is severely damaged in hemophilia. 
 
 
Figure 1-7: Coagulation cascade 
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Vitamin K is also essential for the synthesis of prothrombin and other clotting factors. 
Therefore, vitamin K antagonists such as dicoumarol or warfarin are used as 
anticoagulants in patients prone to clot formation.   
The termination of clotting is achieved due to the short life that activated factors have, 
as they are diluted by blood flow, and degraded by proteases. For example, the factors 
Va and VIIIa are degraded by protein C, a protease that is switched on by the action of 
thrombin. Thus, thrombin has a dual function: it catalyzes the formation of fibrin and it 
initiates the deactivation of the clotting cascade. 
Moreover, there are specific inhibitors of clotting factors that are important in the 
clotting termination. The most important one is antithrombin III, a plasma protein that 
inactivates thrombin. Antithrombin III also blocks other serine proteases in the clotting 
cascade: factors XIIa, XIa, IXa, and Xa. The inhibitory action of antithrombin III is 
enhanced by heparin, which acts as an anticoagulant by increasing the rate of formation 
of irreversible complexes between antithrombin III and the serine protease clotting 
factors.  
Therefore, in some surgical procedures, such as heart surgery, it is extremely important 
to control the blood clotting cascade. Moreover, thrombosis is a serious cause of illness 
and death. The drugs typically given to patients suffering these illnesses are heparin and 
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warfarin. These drugs are anticoagulants and prevent the formation of blood clots; 
therefore, it is extremely important to control the doses, as an overdose could lead to 
bleeding. Warfarin takes a few days to affect the coagulation cascade, has different 
reactions in different patients and it is very difficult to dose[71]. In the case of heparin, 
some patients develop antibodies against it, and there have been cases of adulterated 
heparin that have causes the death of many people[10].  Common factors of both drugs 
are that their activity is stopped by clearance of the drug and therefore cannot be 
effectively controlled. Furthermore, they have an effect in the whole bloodstream and 
they do not affect specifically one protein in the coagulation cascade.  
As thrombin is a key regulatory enzyme in the coagulation cascade[72], a drug that could 
directly control its activity would be an important step while solving the aforementioned 
issues. Thrombin is a seriene protease, produced from prothrombin by the action of factor 
Xa, and converts fibrinogen to fibrin, which is the building block of the fibrin matrix of 
blood clots. Among other effects, it activates platelets by initiating a change in their 
shape.  
1.3.2.1. Thrombin binding aptamer 
Aptamers are sequences of RNA or DNA that serve as powerful binders to small 
molecules for many applications -they can interact with proteins, polypeptides, viruses or 
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even cells-.  Nowadays, they can be generated against most target proteins with binding 
affinities as high as Kd ~ nM, and in most cases they are also able to inhibit the activity 
of the target protein.  
Aptamers are isolated by systematic evolution of ligands by exponential enrichment 
(SELEX). Initially, a DNA library containing random sequences is –in the case of RNA, 
transcribed to an RNA pool, and- applied to selection procedures, such as affinity 
chromatography. The ligand against which the selection is being performed is attached 
covalently to the column resin. DNA or RNA molecules that do not bind to the ligand 
are washed off the column, and those that are specifically binding are eluted with the 
ligand. These sequences are reverse-transcribed -in the case of RNA- and amplified using 
polymerase chain reaction (PCR) resulting in a selected DNA pool which is submitted to 
consecutive rounds of selection[73]. 
Aptamers bind their targets with affinities comparable to those observed for antibodies, 
with Kd values that range from the low picomolar to the mid-nanomolar range[73]. For 
instance, thrombin binding aptamer (TBA) binds to thrombin with a Kd of 0.5nmol/l[74]; 
the aptamer to P-selectin can bind its target with an affinity of 29pmol/l[75] and the 
aptamer developed to target amyloid beta 4 has an affinity of 29nmol/l[76].  
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Generally, aptamers are specific binders. In fact, aptamers to heparin binding members of 
the coagulation cascade are very specific for their targets versus the other members of the 
coagulation cascade, as illustrated in table 1-1[73]:  














0.14 286 NA 91 3060 
bFGF 
(m21a) 
426 0.35 450 140 >10μmol/l 
KGF 
(14F3’T) 
NA 10 0.0008 50 >10μmol/l 
Table 1-1: Specificities of aptamers to heparin-binding molecules[73] 
 
The kinetics of a few aptamer-target pairs have also been studied, usually by calculating 
the koff by forming the complexes with radiolabeled aptamers, and monitoring the decay 
of aptamer-protein complexes after the addition of an excess of unlabeled aptamers. kon 
can be calculated using the approximation kon=koff/Kd : 




t½ (min) T (ºC) 
NX-213 NEGF 1.4x10-3 1.0x107 0.14 8.2 37 
m21a bFGF 1.96x10-3 5.6x106 0.35 5.9 37 
Table 1-2:Kinetic parameters of some aptamers[73] 
 
Helena de Puig Guixé 
Mechanical Engineering MS Thesis 
MIT 
 
1. Introduction                                                                                                   51 
One of the first therapeutic aptamers isolated by SELEX was against human thrombin 
[74, 77, 78]. The 15mer TBA DNA aptamer (TBA): 5’ GGTTGGTGTGGTTGG 3’, 
prolongs clotting time from 25s to 169s in purified fibrinogen, and from 25s to 43s in 
human plasma. Moreover, it inhibits platelet aggregation and prolongs thrombin-induced 
platelet activation [79, 80]. This DNA aptamer has a G-quadruplex secondary structure 
while binding to thrombin [81, 82], which is stabilized by K+, and other ions in solution 
[83-87]; and can be even induced in the presence of thrombin[88]. TBA can bind to 
thrombin at either exosite I or II. As a consequence, two TBAs can bind to one thrombin 
[55, 81, 89]. As mentioned earlier, thrombin-TBA interaction is highly specific, with a Kd 
in the picomolar range. Other aptamers that bind and inhibit human thrombin have been 
discovered[77], however, in this work we will focus on the TBA-thrombin binding. 
Thrombin-TBA interaction is reversible. Because TBA needs to be in a G-quadruplex 
structure in order to bind to thrombin, it is possible to unbind it by unfolding the G-
quadruplex structure of TBA. Some authors have reported the use of poryphrins[90]. But 
the complementary DNA sequence of the aptamer may be used as well to dissociate the 
TBA-thrombin complexes. Therefore, it is possible to picture a biomachine that can cycle 
through states of binding and unbinding from thrombin after the addition of ssDNA[91]. 
On a first stage, TBA would fold in its G-quadruplex structure and bind to thrombin, 
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and after the addition of the ssDNA complement, TBA would bind to its complement 
and release thrombin. 
 
Figure 1-8: TBA-thrombin cycle 
 
One can interface such a biomachine to a surface, for example gold nanorods (NRs), by 
conjugating the surface of the NRs with TBA via a thiol bond. In this case, because TBA 
can bind to both exosite I and II of thrombin, the binding of thrombin to TBA-NRs 
results in NRs self-assembly, that can be monitored by optical absorption. Once the 
complementary ssDNA sequence to TBA is added, the assembly process is reversed. This 
procedure is useful for obtaining the binding energies of the TBA with thrombin, when 
the TBA is bound to gold nanoparticles, and will provide insight on the binding energies 
that are involved in the process. 
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1.4. Thesis outline 
In this thesis we will first explain the Methods used in all of the following projects. Then, 
we will introduce the first approach we used for the biomolecular control of blood 
clotting. This involved binding the TBA covalently to gold nanoparticles and testing the 
release of TBA and its effects on blood clotting. We performed characterization on the 
interactions of thrombin and antidote with covalently bound TBA on the NPs (Chapter 
3). Chapter 4 focuses on the release of the covalently bound TBA from gold 
nanoparticles. In Chapter 4, we also observe the limitations that binding TBA covalently 
to the NPs have, such as the loss of activity of the released TBA, and the low binding of 
TBA to the NPs. In order to increase the loading on the particles and the activity of the 
released drug, we will test the use of protein coronas (Chapter 5), that enables increased 
loading on the NPs, and therefore, higher released concentrations of the aptamer. We will 
characterize the protein coronas, study their formation and the leakage rates that arise 
from their non-covalent binding nature. In Chapter 6, we will test the selective release 
idea with protein coronas and observe that blood clotting time can be selectively and 
externally controlled by taking advantage of the capacities of protein coronas.  
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2. Materials and Methods 
2.1. Synthesis of gold nanoparticles 
The optical properties of gold nanoparticles (NP) strongly depend on their morphology. 
Therefore, in recent years, there has been intense research on the synthesis methods to 
produce gold nanoparticles of precise sizes and shapes. The optical properties of spherical 
gold nanoparticles slightly vary depending on their diameter. However, if the particles are 
anisotropic, a slight change in one of their dimensions leads to a huge difference in the 
absorption spectrum of the particles. This Chapter will cover some synthesis procedures 
of gold nanorods (NRs), long gold nanocapsules (NCs), gold nanobones (NBs) and 
different sizes of gold nanospheres (NS). 
2.1.1. Gold nanorods 
Gold nanorods (NRs) are synthesized using a single surfactant non-seed-mediated growth 
method[1] in 200mL batches. In a typical synthesis, 2.4mL of 50mM gold chloride 
trihydrate (HAuCl4) are added to 189.6ml of 150mM cetyltrimethylammonium bromide 
(CTAB) solution mixed with 3ml of 100mM sodium chloride (NaCl), and the solution 
turns orange; 2.4ml of 10mM silver nitrate (AgNO3) are added to the solution, followed 
by gentle mixing; 2.4 ml of 100mM ascorbic acid (AA) are added, followed by inversion 
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until the solution turns colorless. Finally, 0.128 ml of 3.125mM sodium borohydride 
(NaBH4) is added. The solution sits on the bench undisturbed overnight, during which 
time it turns reddish brown, indicating the presence of NRs. TEM analysis shows that 
the NRs have a length of 34.7 ±5.3nm a width of 9.6 ±1.2nm (Fig. 2-1, left) and an 
aspect ratio of 3.6±0.7. The absorbance of the NRs shows one absorbance peak at 770 
nm, and another peak at 511nm (Fig 2-1, right). The absorbance ratio for these particles 
is around 3.7. 
 
 
Figure 2-1: TEM image and absorbance graph of synthesized NR 
 
2.1.2 Gold nanocapsules and Gold nanobones 
Long gold nanocapsules (NC) and gold nanobones (NB) are synthesized by a binary-
surfactant seed-mediated growth method. The co-surfactants are CTAB and 
benyldimethylhexadecylammonium chloride (BDAC). This synthesis method is typically 
divided in two steps: preparation of the gold seeds and the growth of the NC.  
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The seed preparation step consists in a rapid reduction of the gold ion in the presence of 
CTAB. In a typical protocol, 7.5ml of a 0.2M CTAB solution are mixed with 0.25ml of 
0.001MHAuCl4 in a beaker. While the solution is vigorously stirred, 0.6ml of ice-cold 
0.01M NaBH4 is added and the solution turns brownish yellow. Vigorous stirring 
continues for 2 minutes. 
During the growth step of nanorods, there is a slow deposition of gold atoms onto the 
added seeds in anisotropic way, which results in elongation of the seeds to form gold 
nanocapsules. In a typical protocol, 25ml of 0.001M HAuCl4 is added into a mixture of 
10ml of 0.2M CTAB and 15ml of 0.3M BDAC in a glass bottle, and the solution turns 
orange. 1ml of 0.004M AgNO3 is added to the solution, followed by gentle mixing until 
the solution turns colorless. 0.05ml of the seed solution is added to the growth solution. 
The solution sits undisturbed overnight and turns reddish-purple, and NCs are formed. In 
order to turn these long nanocapsules into nanobones, it is necessary to add 1ml of 
100mM AA to 54ml of synthesized NC solution, in order to finally reduce the gold salt 
that has not reacted overnight. The reason for preferable binding of the gold on the sides 
of the NCs is due to molecular rearrangements of the BDAC and CTAB overnight, after 
the synthesis of the long capsules has finished. It is believed that the CTAB and 
BDAC[2] rearrangement after the formation of the NCs creates a preferable binding of 
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the gold ions on the sides of the NCs. This AA will reduce the gold that is still in 
solution preferably on the sides of the NC, due to the presence of CTAB and BDAC.  
TEM imaging shows that the NCs have a length of 80-90nm a width of 10-12nm (Fig 2-2, 
middle) and an aspect ratio of 7-10. The absorbance of the NCs shows one absorbance 
peak at 1050-1100 nm (Fig. 2-2, left), and another peak at around 530nm. The 
absorbance ratio for these particles is 2.  
 
Figure 2-2: Extinction plot, TEM and histogram of the synthesized NC 
 
Gold nanobones were synthesized by adding AA to the prepared NCs, to further increase 
their dimensions. AA was added to reduce remaining Au+ present in the synthesis 
solution that bound preferentially to the sides of the NCs, forming dogbone-shaped 
particles TEM imaging shows that the NBs measured 59.4 ± 13.7 nm × 12.5 ± 2.4 nm, with 
an AR of 4.8 (image 2-3, right). The absorbance of the NCs shows one absorbance peak at 
1050-1150 nm (Fig. 2-3, left), and another peak at around 530nm.  
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Figure 2-3: Extinction plot and TEM of the synthesized NBs 
 
2.1.3. Gold nanospheres 
Gold nanospheres of different diameters are synthesized using a single surfactant seed-
mediated growth method[3], using CTAB as the surfactant in order to obtain similar 
surface properties to the NRs. In order to synthesize them, first 3.5±0.7nm gold seeds 
were prepared by adding 0.6mL of ice-cold, freshly prepared 0.1M NaBH4 solution to a 
20ml solution containing 0.25mM trisodium citrate and 0.25mM HAuCl4, while the 
solution was stirring. After the addition of the NaBH4, the solution turns pink/orange 
immediately, indicating the particles formation. This seed solution is used within 2-5 
hours after its formation. 
Next, a solution containing 80mM CTAB and 2.5mM HAuCl4 (growth solution) was 
prepared. The different NS synthesis will be obtained by adding different volumes of 
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growth solution and seed solution, as indicated in table 2-1. For example, in order to 
synthesize 9.44nm NS, 0.5ml of 0.1M freshly prepared AA are added to 9ml of the growth 
solution while the solution is stirring. Stirring continues until the solution turns clear. 
Next, 10ml of the seed solution are added, and stirring continues for 10min.   




6.71±1.48nm 7.5 0.5 25 
9.44±1.26nm 9 0.5 10 
12.4±2.35nm 9 0.5 3 
Table 2-1: Parameters for the synthesis of NS of different sizes 
 
Dynamic light scattering (DLS) and TEM imaging were used to measure the diameter of 
the NS (Fig. 2-4).    
 
Figure 2-4: TEM Histogram (left), DLS (middle) and extinction (right) of the synthesized NS  
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In figure 2-5, one can see three different TEM images for each of the syntheses. From left 
to right, the NS are: 6.71nm, 9.44nm and 12.4nm. The scale bar is 100nm. NS are well-
separated, spherical, and monodisperse, indicating high-quality samples. 
 
Figure 2-5: TEM images of the NS 
 
The synthesis of metal nanoparticles from their salt solutions can be divided into three 
distinct processes: cation reduction, nucleation, and growth. However, the formation 
mechanism of NRs in aqueous surfactant media is still not completely clear. Most 
authors[4-13] agree on the idea CTAB absorbs on the NRs forming a bilayer, with the 
trimethylammonium headgroups of the first monolayer facing the gold surface[14], 
Murphy and co-workers[9] proposed that once the seed grows to a critical size, the CTAB 
headgroup preferentially binds to the crystallographic faces of gold existing along the 
sides of the rods, as compared to the faces at the tips. Therefore, the growth of gold 
nanorods would be governed by preferential absorption of CTAB to different crystal faces 
Helena de Puig Guixé 
Mechanical Engineering MS Thesis 
MIT 
 
2. Materials and Methods                                                                                                             
   
74 
during the growth. The different growth rates in different facets are what enable the long 
shape of NRs.  
Some studies show that the length of the hydrocarbon tail of the CTAB molecule in the 
synthesis of NRs is critical to control the length and the yield of the formed NRs, when 
longer chain lengths produce longer nanorods in higher yields and shorter chains produce 
shorter nanorods in lower yields. Therefore, we can think that more stable bilayers 
promote the formation of longer NR[15]. The role of the CTAB counterion was also 
considered[6, 7], concluding that only brominated long chain surfactants lead to 
significant yields of rod shaped particles. These studies study the role of an in situ 
formed complex of CTAB and silver bromide that would be responsible for the 
anisotropic growth of the NRs.  
The role of Ag+ ions in the growth of NR has, as well, been extensively studied. Most 
authors agree that the Ag+ reacts with CTAB and forms silver bromide that absorbe 
onto preferential NR’s facets and thus decreases their growth in these directions [2, 6-8, 
10]. Nikoobakht and El-Sayed explained that the Ag–Br pairs decrease the charge density 
of bromide ions and thus decrease the repulsion of neighboring CTAB headgroups. This 
repulsion results in CTAB elongation and thus NR formation. Other authors explain that 
although Ag in the CTAB solution cannot be reduced to bulk silver atoms by ascorbic 
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acid in acidic pH. Ag can be reduced to Ag0 onto a metal substrate in the form of a 
metal monolayer at a potential much less than bulk reduction, known as underpotential 
deposition (UPD). Therefore, they propose that the silver deposition on the long side of 
the NRs is faster than on the ends due to UDP effects, and thus the seeds grow into NRs. 
Thus, by controlling the concentration of silver nitrate in the growth solution it is 
possible to control the optical properties of the synthesized NRs. In figure 2-6 [10], we 
can see that by increasing the silver concentration, the longitudinal plasmon band 
redshifts and its intensity increases-the silver concentration increases from sample 1 to 5-. 
By observing the size distribution of the particles, we can observe that the aspect ratio of 
the particles increases as well.  
The ability of ascorbic acid (AA) to reduce Au3+ halides to metals has been known for 
decades and has been utilized in both qualitative and quantitative determination of 
gold[16]. During the synthesis of NRs, the AA would reduce the Au3+ to Au+. After the 
AA reduction, the NaBH4 would reduce the Au+ to Au0, and start the seed formation. 
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2.2. Loading of DNA on NPs by thiol chemistry 
For different types of NPs, slightly different protocols should be used. In this thesis, we 
will explain the procedures for NRs, and explain, in some cases, the specific differences 
with other types of NP.  
After the synthesis of the NRs, it is necessary to wash the excess reagents and 
concentrate the sample. In order to do so, the NRs are washed and concentrated by 
centrifugation (60 min at 7000 relative centrifugal force (RCF) for a 200 mL sample) to 
reduce their volume. After this wash, the supernatant is discarded and the pellets are 
resuspended in 1mM CTAB and centrifuged at 4000 RPF for 90 min. After the particles 
have precipitated during this second wash, the pellets are resuspended in 10mM CTAB 
and centrifuged, again at 7000 RPF for 90min. Finally, all the pellets can be mixed and 
the concentrated NRs can be stored in 10mM CTAB. 
2.2.1. Ligand exchange of gold nanoparticles 
After the synthesis and wash of nanoparticles they are stabilized by a double layer of 
CTAB, which is problematic for stability, bioconjugation, nonspecific absorption of DNA 
and cytotoxicity. Therefore, in order to tune the biological properties of the gold 
nanorods-DNA conjugates, the ligand exchange must reduce nonspecific absorption and 
enable ligand customization. Desirable ligands are those that can be covalently attached 
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to the NR via a thiol (SH), and a chain that is biocompatible (PEG) or an endgroup that 
permits water solubility (COO-). The round trip phase transfer ligand-exchange[17] 
enables the customization of the ligand and a uniform charge distribution on the NR 
surface. Because the ligand exchange involves extraction from an aqueous phase to an 
organic phase, and then back to an aqueous phase, the probability that any CTAB 
remains on the surface of the NR is minimal, in contrast with other ligand exchange 
attempts, that are done in a single phase, and therefore, some residual CTAB remains on 
the surface. 
 
Figure 2-6: Method for NR ligand exchange[17]. Adapted with permission from Wijaya A, Schaffer 
SB, Pallares IG, Hamad-Schifferli K. Selective Release of Multiple DNA Oligonucleotides from Gold 
Nanorods. ACS Nano 2008;3:80. Copyright 2008 American Chemical Society. 
 
 
Helena de Puig Guixé 
Mechanical Engineering MS Thesis 
MIT 
 
2. Materials and Methods                                                                                                             
   
78 
Figure 2-6 shows a schematic representation of ligand exchange on gold nanorods. First, 
the concentrated NR stabilized with CTAB in water are put in contact with either 
dodecanethiol (DDT) or 1-hexanethiol (HexSH). In order to extract the NRs into the 
organic ligand, it is necessary the addition of acetone and swirling the solution for a few 
seconds. After 30 min, the aqueous phase becomes clear, which indicates that no NRs 
remain soluble in water. To remove the excess DDT or Hex-SH, the NRs are diluted in 
toluene and collected by centrifugation.  
Next, organic-to aqueous phase transfer is performed. The collected NRs are resuspended 
in 9 mL of 0.01 M MCA (three different mercaptocarboxilic acids have been used: 
mercaptohexanoic acid (MHA), mercaptoundecanoic acid (MUDA) and 
mercaptohexadecanoic acid (MHDA)) in toluene at 95 °C and vigorously stirred until 
visible aggregation is observed (within 15 min), and then the MCA coated NRs (MCA-
NR) are allowed to settle and cool to room temperature. The precipitation of NR 
indicates that they are successfully coated by MCA, thus insoluble in toluene. The NR 
are washed with toluene to remove the excess MCA and with isopropanol to deprotonate 
the carboxylic acid. The aggregates spontaneously re-disperse in 0.5x tris-borate-EDTA 
buffer (TBE) and are no longer soluble in toluene. Finally, these MCA-NRs are washed 
and resuspended in 10mM Phosphate Buffer. 
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It is necessary to take into account the length of the ligand of the particles during the 
ligand exchange, as it is important for the solubility of each ligand in toluene, and it will 
be an important factor in the DNA conjugation of the NPs.  
Gel electrophoresis of the NPs shows a successful ligand exchange of the particles. Figure 
2-7 shows gel electrophoresis results of the NR in CTAB (lane 1), the NRs-MUDA (lane 
2) and NR-MHDA (lane 3). As previously explained, the CTAB forms a bilayer on the 
NRs surface, but as it is not covalently bound to it, and due to the pH of the TBE 
solution, it can come off the particles, causing them to aggregate [18]. On the other hand, 
MUDA and MHDA are bound to the NRs by a thiol bond. Therefore, the particles are 
still stable while they run in the gel. It is not surprising either that the MUDA particles 
run faster in the gel than the MHDA particles because, even if they have a similar charge 
on their surface, the size of MHDA is bigger than MUDA, thus the overall size of the 
particles is bigger for the MHDA particles than for the MUDA particles.  
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Figure 2-7: Gel electrophoresis of the NRs-CTAB; NRs-MUDA and NRs-MHDA 
 
A PEG binding can be performed after the round trip ligand exchange. In order to do so, 
the MUDA conjugated NPs are conjugated overnight with 1mM PEG of three different 
molecular weights (MW=356; MW=1000 and MW=5000). We are able to successfully 
demonstrate the conjugation by gel electrophoresis. In figure 2-8, we can observe the NRs 
coated with MUDA on the first lane. On the 2nd to 4th lanes, we can see the NRs coated 
with PEG365. PEG365 is smaller in size than MUDA, but also has a lower charge. 
Therefore, it is not surprising that even if the overall charge of the particles is lower, due 
to their smaller size, they end up running faster than the MUDA particles. On the 5th to 
7th lanes, we can see the PEG1000 coated NRs; as their size is bigger than the NRs coated 
with PEG365, they do not run as far in the gel. Finally, in lanes 8th to 10th we can see the 
PEG5000 NRs run in the negative direction, indicating an overall positive charge of the 
particles.  
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Figure 2-8: Gel electrophoresis of PEG-NRs 
 
2.2.2. Salt stability of the gold nanoparticles 
After coating the particles with MCA, and before the DNA conjugation it is important to 
test the salt stability in order to further check that the binding was complete. Also, we 
can see that the particles can hold a critical salt concentration over which they aggregate. 
This threshold concentration can be measured by absorbance of the particles, and it can 
also be approximated by observing their change of color and precipitation at high salt 
concentrations. In the case of the MHA-NRs, it is important not to add more salt than 
the critical salt concentration, as the particles will irreversibly aggregate. One can 
observe that after the DNA conjugation, the particles are stable at higher NaCl 
concentrations, due to an increase of the charge on their surface. 
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2.2.3. DNA conjugation of gold nanoparticles 
In order to use the gold nanorods to control blood clotting, they will need to be 
conjugated with ssDNA. These sequences were purchased from Integrated DNA 
Technologies (IDT) with a thiol group in one of their ends, in order to enable the S-Au 
bond form on the gold surface. Because after the ligand exchange the gold nanoparticles 
have a negative charge on their surface and the DNA is also negatively charged, it will be 
necessary to add salt, to screen the charges and obtain a high coverage of DNA on the 
particles’ surface.   
After the ligand exchange, the MHA-NR can be further conjugated with DNA via thiol 
conjugation through a charge screening method[19, 20]. The thiolated DNA 
oligonucleotides (SH-DNA), are fluorescently labeled at the 3’ ends with either 6-
carboxyfluorescein (FAM) or tetramethylrhodamine (TMR) and purchased from 
Integrated DNA Technologies. The sequences used are 5’-SH-TTTTT TTTTT TTTTT 
GGTTG GTGTG GTTGG-TMR-3’ (SH-T15-TBA); 5’-SH-GGTTG GTGTG GTTGG-
TMR-3’ (SH-TBA), 5’-SH-TTTTT TTTTT TTTTT CCAAC CACAC CAACC-FAM-3’ 
(SH-T15Anti), 5’-SH-CCAAC CACAC CAACC-FAM-3’ (SH-Anti).  
In order to conjugate the MHA-NR with SH-DNA, first the SH-DNA has to be reduced 
by tris[2 -carboxyethyl]phosphine (TCEP) with TCEP/DNA ratio of 100:1. Then, 6nM 
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NR are incubated with the reduced SH-DNA, in 10 mM phosphate buffer with 0.3% SDS 
concentration. SH-DNA to NR ratios are 1000 SH-DNA/NR in order to get a high 
coverage on the NRs and 200 SH-DNA/NR to obtain a low coverage on the NR’s surface. 
After 3 h of incubation, charge screening is performed until the critical salt concentration, 
which depends on the NR synthesis and Ligand Exchange. The charge screening consists 
in adding a volume of salting buffer (typically 0.6M NaCl in 0.3%SDS) every 30 min 
during an hour (a total of three additions) followed by 10s sonication. After this step, the 
samples are incubated at room temperature for 36 hours, during which time the samples 
are sonicated every 12 hours. 
The DNA conjugation on the NR can be confirmed by observing the mobility of the 
DNA-NR with respect to the MHA-NR in gel electrophoresis with 0.5% agarose gels in 
0.5x TBE (Fig 2-9). Glycerol is used to load the samples and ensure that they stay in the 
wells prior to travelling in the gel matrix. Moreover, we are able to quantify the amount 
of SH-DNA per particle by chemically displacing[21, 22] the conjugated SH-DNA with 
1mM mercaptohexanol (MCH). After overnight incubation, the free DNA is separated 
from the NR by centrifugation and quantified via fluorescence spectroscopy of the 
fluorophore labels. We measured 135 T15-TBA/NR on the high coverage conjugation, 62 
T15-TBA/NR on the low coverage conjugation.  
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Figure 2-9: NR-CTAB; NR-MHA and NR-DNA 
 
The loading of oligonucleotides on gold nanoparticles depends on (1) the salt induced 
aging procedures used to decrease electrostatic interactions between neighboring 
oligonucleotides and between oligonucleotides and the NRs, (2) the size and shape of the 
particles, (3) the ligand on their surface and (4) the oligonucleotide sequence. Moreover, 
other parameters such as the sonication of the particles play an important role during the 
DNA conjugation 
The amount of oligonucleotides attached to the surface of the particles increases with the 
NaCl concentration in solution. NaCl is used to screen the charges between neighboring 
oligonucleotides and between the DNA and the surface of the particles, thus enabling the 
Au-S bond and a high coverage of DNA on the surface of the particles. The charge 
screening has to be performed carefully, as the addition of NaCl over the critical NaCl 
concentration causes NRs to aggregate. In order to calculate the critical NaCl 
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concentration at which MHA-NR can be exposed without aggregation, an aliquot of the 
NR is added different concentrations of NaCl, until the particles aggregate. One can see 
the nanoparticles turn blue, or measure the change by absorbance. The critical NaCl 
concentration is the highest concentration at which the particles do not aggregate. This 
critical NaCl concentration depends on the ligand on the particle’s surface –a longer 
ligand will give more protection to the particles against aggregation- and on the size and 
shape of the particles. 
Another key parameter when loading DNA on the surface of gold nanorods is their size 
and shape[23]. The available surface for the S-Au bond to form will differ with the NRs 
measures. 
By calculating the footprint of an oligonucleotide on a gold nanoparticle, Mirkin group 
have mathematically calculated the maximum amount of DNA that can be conjugated on 
a NR surface by using the following formula: 
 
(Eq. 2.1) 
When we apply this formula on the NRs synthesized in Chapter 3 –where TEM imaging 
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maximum loading of oligonucleotides per particle would be 115±25 DNA/NR. Which is 
very close to the previously measured 135 DNA/NR. 
Another key parameter that is very important when conjugating DNA on the surface of 
NRs is their ligand. We have observed that MHDA and MUDA enable lower coverage on 
the particles than MHA. A reason for that is that the MHA is much shorter than the 
MHDA and the MUDA.  
Moreover, the sequence of DNA used for the conjugation will also be a key factor when 
conjugating DNA on the particle’s surface. We can compare the coverage of DNA 
between 5’-SH-TTTTT TTTTT TTTTT GGTTG GTGTG GTTGG-TMR-3’ (SH-T15-
TBA) and 5’-SH-GGTTG GTGTG GTTGG-TMR-3’ (SH-TBA). And we observe an 
average 135 DNA/NR on the case of T15-TBA and an average of 320 DNA/NR for the 
SH-TBA. It is noticeable that the coverage on the second sequence is much higher that 
the monolayer coverage explained above. The explanation for that is that this DNA 
sequence has a secondary structure (G-Quadruplex, figure 2-10) that can lead to the 
formation of intermolecular G-Quadruplexes. Thus, by using the sequence SH-DNA not 
all the DNA is specifically attached on the particles’ surface by a S-Au bond. 
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Figure 2-10: Secondary structure of the thrombin binding aptamer (TBA) 
 
Another case where the importance of the sequence has been tested is when trying the 
conjugation of the following oligonucleotides: 5’-SH-TTTTT TTTTT TTTTT CCAAC 
CACAC CAACC-FAM-3’ and 5’-FAM-CCAAC CACAC CAACC TTTTT TTTTT 
TTTTT-SH-3’. The spacer between the thiol and the first base is a C6 for the first 
sequence and a C3 for the second sequence, and the coverage is 105 DNA/NR and 0 
DNA/NR respectively. Therefore, when the DNA sequence has a longer spacer between 
the thiol and the first base, there will be more loading on the particles. 
2.2.4. Surface modifications on the DNA-conjugated NRs 
After the DNA conjugation of the NRs, it is possible to perform surface modification in 
order to tune the properties of the gold nanoparticles.  
2.2.4.1. HSA block 
Human Serum Albumin (HSA) is a very common protein in blood. It is commonly used 
in a myriad of applications to block surfaces, such as in NP stabilization or microfluidic 
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channels. Because it tends to attach on surfaces, we can use it to block the surface of the 
NR. We add a 0.3% HSA in solution, in order to ensure that the surface of the particles 
is blocked.  
2.2.4.2. PEG backfill 
The DNA-NR can be further exchanged with thiolated PEG (mPEG), that would 
increase their stability and biocompatibility[24-28]. Other studies on bulk and 
nanoparticle surfaces have found that PEG is an ideal molecule for reducing surface 
fouling and non-specific adsorption. In our case, we have been able to successfully backfill 
with mPEG of two different molecular weights (5000 and 1000). The PEG-backfill was 
achieved by incubating the T15-TBA-NR solution with mPEG. The DNA:PEG ratio was 
1:2  for the low PEG-backfill and 1:5 for the High PEG backfill. We confirmed the PEG-
backfill by observing the mobility change of the PEG-DNA-NR in respect to the DNA-
NR in gel electrophoresis with 0.3% agarose gels in 0.5x TBE (Fig. 2-11).  
 
Figure 2-11: Gel of PEG-backfilled NRs 
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In figure 11, one can see in the first lane, the original DNA conjugated NRs. On the 
second and third lanes there are DNA-NRs that have been PEG-backfilled. On the 
second lane, there is double the amount of PEG than the amount of DNA, and in the 
third lane, the concentration of PEG added to the sample is 5 times higher than the 
original concentration of DNA attached. 
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2.3. HS Corona conjugation on NP surfaces 
Loading of ssDNA on gold nanoparticles can also be achieved by taking advantage of 
protein coronas, which weakly and dynamically bind to the NPs. Such protein coronas 
enable for enhanced loading on the NPs[18], and may also reduce toxicity of the NPs, as 
serum proteins are already present in blood. Some proteins have a stronger binding to the 
NPs than others, and interestingly, HSA is not one of the strong binders to NPs[29]. 
Different binding strategies for the formation of the coronas were followed (See Chapter 
5). In a typical experiment, synthesized NPs were spun down after the synthesis, and the 
NP pellet was resuspended in MilliQ water. After, particles were spun at 12000rcf, and 
resuspended in 5mM CTAB, for storage. In order to prepare the NP-coronas, particles 
were spun down for 15 min at 12000rcf, and the pellet was resuspended in a mixture of 
1uM DNA, 5%HS, 5mMPB, followed by incubation at 37ºC overnight. The following 
day, particles were sonicated and centrifuged at 7000rcf for 15min, and washed three 
times in PB, prior to use.  
Carbon nanotube solubilization and characterization 
For some of the experiments, we produced protein coronas on carbon nanotubes (CNT). 
CNTs were purchased from Sigma-Aldrich and were dispersed with CTAB. Highly well-
dispersed CNT-CTAB were obtained after dissolving the CNT in CTAB 5 mM (2 
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mg/mL), sonication (2 h) and centrifugation (16200 xg, 1 h) to isolate from the bundles. 
A set of dispersions (from 2.5 μg/mL to 40 μg/mL) was prepared by diluting the original 
dispersion (CNT-CNT 2 mg/mL) with CTAB 5 mM. These dispersions were 
ultrasonicated for 30 min before UV-Vis analysis. The absorptions at 500 nm were used 
to determine the concentration of the final well-dispersed CNT. Knowing that the 
purchased CNT were 5 μm length, 15 nm diameter and 2.1 g/mL density average, the 
concentration obtained was converted to nM.  
CNT-CTAB conjugates were washed with MilliQ by using centrifuge filters (Amicon 
Ultra-0.5 mL, Merck Millipore). Coronas were prepared on the CNT by following the 
same protocol as for the NPs. 
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2.4. Laser Irradiation of NR 
Laser irradiations were performed using pulsed femtosecond light. For the 800nm 
irradiation, the 532nm output of a Q-switched Nd:YLF laser (Empower, Spectra-Physics) 
was used to pump a Ti:Sapphire regenerative amplifier (Spitfire, Spectra-Physics), which 
amplifies the 82MHz output of a Ti:Sapphire oscillator, producing 50-475μJ light centered 
at 800nm, with a duration of 100fs, a repetition rate of 1kHz, and a spot size of 6mm. 
The 1100nm irradiation was achieved with a two-stage BBO/KNbO3 optical parametric 
amplifier (Femtolasers: 30fs, 1kHz, 800nm), producing 2-6-13.6μJ pulses, with a duration 
of 45fs, and a repetition rate of 1kHz, centered at 1100nm, with a spot size of 1mm. In a 
typical experiment, 100μl of the NR-NB mixture were irradiated in a 3x3mm quartz 
cuvette for 20min. After irradiation, samples were spun at 14000rcf for 15min, and the 
supernatants were collected to quantify the DNA released and for blood clotting tests. 
NR melting was confirmed by observing a decrease in their absorbance spectra.  
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2.5. Blood clotting tests 
Plasma equivalent thrombin time was measured using a Hemochron Signature Elite 
(ITC). It is a standard test to measure the activity of anticoagulants. In order to measure 
blood clotting time, disposable cuvettes are loaded into the Hemochron and clotting time 
is measured by counting the time that it takes for blood to coagulate, with the use of an 
optical sensor. Both thrombin clotting time (TCT) and activated thromboplastin clotting 
time (aPTT) were measured. In a typical TCT experiment, 14.4μl of the sample were 
mixed with 1.8μl of 100nM thrombin and 1.8μl of 1.37M NaCl, and incubated at 37ºC for 
10min. After mixing with 27μl of citrated whole blood, samples were loaded into aPTT 
Citrate cuvettes to measure the blood clotting time.  
Plasma equivalent aPTT clotting time was typically measured by mixing 16.2 μl of the 
sample with 1.8μl of 1.37M NaCl, followed by incubation at 37ºC for 10min. After mixing 
with 27μl of citrated whole blood, samples were loaded into aPTT Citrate cuvettes to 
measure the blood clotting time. Blood was purchased form Research Blood Components 
(RBC), and used within 10 days. 
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3. Characterization of the covalently bound aptamer-NP 
conjugates 
In order to use gold nanoparticles to control blood clotting is important to first 
understand the interactions that thrombin has with the TBA that is bound to NPs, and 
the interaction of TBA bound to particles with the complementary ssDNA (anti). In this 
chapter we are going to introduce thermodynamic and kinetic approaches to quantify the 
interactions of covalently bound biomolecules to gold nanoparticles with biomolecules in 
solution.  
3.1. Introduction 
The behavior of biomolecules that are bound to a surface is difficult to predict and 
control. “Wiring” biomolecules onto surfaces in a way that does not hinder the expected 
or designed behavior is incredibly challenging. DNA and proteins have a strong tendency 
to denature on surfaces due to the numerous non-covalent interactions between the 
biomolecule and the surface and the coating molecules, and denaturation is influenced by 
the surface material, curvature, charge, coating chemistry and crystallinity[1-5]. Due to 
the size of nanomaterials, the surface dominates their behavior. In addition, surfaces are 
not bare and inert, but can have charges or are coated with ligands, and these can also 
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influence denaturation. Finally, adsorption of other species to make a “corona” can 
obscure the desired behavior and function[6]. The interactions responsible for non-specific 
adsorption and denaturation are weak, non-covalent bonds between the side chains of the 
biomolecules and the nanoparticle surface atoms and/or coating ligands and are fluxional 
and numerous. This is a problem even for spherical gold nanoparticles (NPs), which are 
considered to be the most biocompatible nanoscale system due to their highly versatile 
surface chemistry and control in particle quality[7]. Many have shown that the interface 
of NPs with biomolecules significantly affect the structure and function of the attached 
biomolecule, sometimes even resulting in unexpectedly improved situations[8, 9]. What is 
now being established is that biomolecular surface functionality and nanomechanics are 
strongly intertwined. Transformations of biomolecules conjugated to planar or curved 
surfaces come with nanoscale rearrangements of the molecules themselves due to 
intermolecular forces[10]. Such interactions can cumulate and result in deviations from 
bulk solution behavior, introduce effects inherent to interfacial confinement such as 
radical changes in binding affinity, kinetics and yield [2, 3, 8, 11], or result in cooperative 
microscale mechanical work[8, 12, 13]. These issues affect not only nanobiomachines but 
also any sensing application, where molecules must be immobilized on a surface[6, 14]. 
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3.2. Thermodynamic study of the binding of the aptamer-
thrombin on the surface of a NP1 
Biomolecular machines have inspired engineers for their ability to perform mechanical 
work or motion in a way that is rapid, specific error tolerant, and efficiencies that far 
surpasses artificial systems. Many have sought to exploit DNA-protein binding for use as 
biomolecular nanomachines. In particular, the TBA-thrombin interaction has been highly 
attractive due to its high specificity and reversibility[15, 16], enabling creation of 
machines that cycle through thrombin binding and displacement by addition of DNA 
strands. Also, DNA aptamers are simple, easy to handle, and can be made synthetically 
with chemical modifications.  
However, for DNA machines to be eventually useful, they must be interfaced to an 
inorganic surface in order to harness the cumulative molecular-level changes and generate 
macroscopic motion. Typically this involves linking the biomolecules to nanoparticles 
                                         
1  Adapted with permission from de Puig H, Federici S, Baxamusa SH, Bergese P, 
Hamad-Schifferli K. Quantifying the Nanomachinery of the Nanoparticle-Biomolecule 
Interface. Small 2011;7. Copyright 2011 WILEY-VCH Verlag GmbH & Co. KGaA, 
Weinheim. 
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(NPs)[17-19], so that the biomolecules can be signalled to induce assembly and 
disassembly of the nanomaterials[17, 20, 21]. On larger scales, the conformational changes 
of the molecules can induce motion collectively to deflect a cantilever resulting in 
microscale motion[8, 12, 13, 22]. Control and understanding of these unique nano-to-
microscale bridges would disclose unprecedented applications. 
Unfortunately, systematic investigation of interface biomolecular nanomachinery has been 
lacking. In particular, most probes have not been quantitative, but instead 
phenomenological, probing only whether or not biomolecules adsorb, and have been 
explored primarily for biosensing[22]. Few studies on planar surfaces exist [8, 13, 23], but 
to the best of our knowledge, not much has been done for NPs.  
Indeed, empirical observations are not sufficient to enable prediction of the behavior of 
biomolecules under these surface effects. For example, it is known that TBA binding to 
thrombin is influenced by the properties of the surface it is on as well as its molecular 
neighbors, which can give rise to intermolecular repulsions that hinder its ability to fold, 
or the ability of thrombin to get close enough to TBA to bind properly. However, these 
effects have been described only qualitatively, as there are no direct probes. A parameter 
describing these interface interactions would not only yield a deeper understanding of 
surface effects but also enable prediction of molecular behavior. Furthermore, it would 
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allow comparison between systems, which would be beneficial especially for surface 
chemistry modification strategies, which can drastically affect biomolecular behavior and 
are notorious for being difficult to control. Most investigations to date have not been 
quantitative, but instead phenomenological, probing only whether or not biomolecules 
adsorb. Unfortunately, these empirical observations cannot capture quantitative 
information, and therefore are insufficient. Thus, a diagram mapping the TBA binding 
regimes as a function of the relevant surface properties would greatly enhance the ability 
to construct interfaces to biomolecular motors. Therefore, the biological-inorganic 
interface is a critical and open challenge for taking biomolecular machines to a higher 
level. A few such studies on planar surfaces exist[8, 13, 23] but to the best of our 
knowledge, quantitative studies for NPs are few,[24] despite the fact that the surface 
dominates on the nanoscale. 
Here we develop a new thermodynamic treatment for quantifying surface effects and 
apply it to study TBA nanomachinery on gold nanorods (NRs) when it interacts with 
thrombin. This thermodynamic treatment allows for quantitative description of the 
interface effects. We systematically probe how the interaction is influenced by TBA 
coverage, sequence, NR surface chemistry, and blocking proteins. We show that the term 
describing surface work is a relevant parameter for quantifying how the TBA is perturbed 
by interface effects, which is completely missed by phenomenological tests. This 
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treatment sets a promising framework to describe directed self-assembly of 
nanoparticles[17, 25],  and could be useful to advance the state-of-the-art in organizing 
nanoscale ‘building blocks’ into supramolecular assemblies and materials, which to date 
definitively lag behind the advances in the synthesis and characterization of NPs and 
multifunctional macromolecules[26]. 
3.2.1.  Analysis methods 
The binding energetics of the NPs was analysed by using the Langmuir isotherm and the 
Van’t Hoff equation, and the background of those equations is introduced in this chapter. 
In order to use the equations with colloids they were modified. Modifications on the 
equation will be introduced in the corresponding chapters. 
3.2.1.1. Langmuir isotherm 
In 1916, Irwin Langmuir introduced the Langmuir isotherm to describe the sorption of 
gases when in contact with planar surfaces[30]. The theory behind this theoretical 
analysis has been adapted for many conditions. In our case, we will derivate the equation 
for an aqueous system. This model assumes that one reaction is involved in the sorption 
process, and the distribution of the compounds between the two phases is controlled by 
an equilibrium constant. Other assumptions are that the adsorption reaction involves a 
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single reaction with a constant energy of adsorption; and that adsorption does not affect 
the availability (or the energy of adsorption) of the site next to the adsorbate.  
If we consider the following equilibrium reaction: 
𝑆 + 𝐴 → 𝑆𝐴 
Where S represents the solid surface (in our case the colloid with n surface sites) with 
nothing on it, A is the compound in the liquid phase (the adsorbate molecule), and SA is 
the solid phase with the compound A on it. Each A will occupy one surface site. [A] = 
equilibrium concentration of the compound A in the liquid or gaseous phase, and define 
the equilibrium constant k for the above reaction: 
 (Eq. 3.1) 
If we define the total theoretical number of adsorbed A molecules, as n: 
 (Eq. 3.2) 
If we combine the two previous equations: 




[ ] [ ]SSAn +=
[ ] [ ]
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We can solve the equation for [SA] and let Θ = [SA]. This results in the Langmuir 
equation: 
 (Eq. 3.4) 
If K is known, one can predict the amount of the A compound adsorbed (Θ) for any 
concentration of A compound. The Langmuir equation is often rewritten as: 
 (Eq. 3.5) 
Where qe is the coverage of the adsorbate molecule on the particles, n is replaced by Q, 
the maximum number of A molecules that can theoretically be absorbed on the surface, 
and b is designated as the binding efficiency term. One can perform numerical fits of 
adsorption data in order to obtain values for Q and b to allow interpretation of the 
absorption behavior.  
3.2.1.2.  Van’t Hoff equation 
The Van’t Hoff equation will be derived here for ideal solutions. It describes the 
temperature dependence of equilibrium, which is useful to know the enthalpy of the 
reaction. If we picture a two state equilibrium: 
𝐴 → 𝐵 
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Where by increasing the temperature, the NR aggregates disassemble, and we can see 
again the free NR. Then, at constant temperature and pressure, we can see that the 
condition for equilibrium is 𝜇! = 𝜇!. The equilibrium constant is: 
𝐾 = [𝐵][𝐴] (Eq. 3.6) 
The chemical potential of the component A diluted in an ideal solution is of the form: 
𝜇! = 𝜇!! + 𝑅𝑇𝑙𝑛[𝐴] (Eq. 3.7) 
Then, because the equilibrium condition states that: 
𝜇!! + 𝑅𝑇𝑙𝑛 𝐴 = 𝜇!! + 𝑅𝑇𝑙𝑛[𝐵] (Eq. 3.8) 
Rearranging terms, and using the equilibrium constant: 
𝑙𝑛 [𝐵][𝐴] = 𝜇!! − 𝜇!!𝑅𝑇 = −Δ𝜇𝑅𝑇  (Eq. 3.9) 
Knowing that	  Δ𝜇 = ΔH − TΔS	  
By taking into account that both the enthalpy and the entropy are temperature-
independent: 
𝜕𝑙𝑛𝐾𝜕𝑇 = − 𝜕𝜕𝑇 Δ𝜇𝑅𝑇 = − 𝜕𝜕𝑇 Δ𝐻 − 𝑇Δ𝑆𝑅𝑇 = Δ𝐻𝑅𝑇! (Eq. 3.10) 
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Alternatively, we can derivate to 1/T to obtain the Van’t Hoff equation: 
𝜕𝑙𝑛𝐾𝜕 1 𝑇 = − Δ𝐻𝑅  (Eq. 3.11) 
When, as stated above, the enthalpy is independent of temperature, one may integrate 
Van’t Hoff equation in order to obtain: 
𝑙𝑛𝐾 𝑇!𝐾 𝑇! = − Δ𝐻𝑅 1𝑇! − 1𝑇!  (Eq. 3.12) 
Then, we can write this equation about the equilibrium constant calculated at room 
temperature, therefore, using a known factor as the binding constant: 
𝐾 𝑇 = −𝐾!!𝑒𝑥𝑝 Δ𝐻𝑅 1𝑇! − 1𝑇!  (Eq. 3.13) 
We are going to use this approach to calculate the enthalpy of the NR-TBA binding in 
solution. 
3.2.2. Theoretical 
The interaction of thrombin with TBA on NRs results in NR self-assembly, as sketched 
in Figure 1. Because thrombin can bind specifically to TBA at both exosite I (green) and 
exosite II (purple), binding results in the aggregation of TBA decorated NRs (NR-TBA). 
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From a thermodynamic perspective this can be represented as the equilibrium between a 
free and an aggregated state, identified by state I and IV, respectively. 
 
Figure 3-1: Thermodynamic cycle describing the assembly of NR-TBA in the presence of thrombin. Adapted 
with permission from de Puig H, Federici S, Baxamusa SH, Bergese P, Hamad-Schifferli K. Quantifying the 
Nanomachinery of the Nanoparticle-Biomolecule Interface. Small 2011;7. Copyright 2011 WILEY-VCH 
Verlag GmbH & Co. KGaA, Weinheim. 
 
In order to describe this equilibrium system, we introduce the concept of unit block of 
aggregation, defined as an arbitrary fundamental complex from which the entire 
aggregate may be constructed by purely translational additions.  For a three-dimensional 
NR-TBA-thrombin aggregate, several thrombin are bound to each NR-TBA. Thus, it is 
convenient to identify a NR-TBA bound to n thrombins as a unit block. Consequently, 
the equilibrium between state I and state IV can be described as the binding equilibrium 
of n thrombin molecules to a single NR-TBA, where the NR-TBA plays the role of a 
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receptor displaying n binding sites with invariant identical affinities (e.g. a n-valent 
uniform receptor[27]). Within this scheme, state IV represents the particular case of the 
smallest aggregate with n = 1 (Fig. 3-1). 
Therefore, aggregation can be described in terms of the binding efficiency for one TBA, 
q[27] : 
 (Eq.3.14) 
where Θ is the binding efficiency of the NR-TBA receptor as a whole, Kσ  is the 
equilibrium association constant of the TBA-thrombin binding confined at the NR 
surface and [Th] is the equilibrium concentration of thrombin in solution. 
 TBA-thrombin binding is confined on the NR surface, so the overall Gibbs free energy of 
the reaction is comprised of both a chemical and a surface contribution. The chemical 
contribution is related to TBA-thrombin binding, whereas the surface contribution 
describes the work spent in accommodating the thrombin on the surface and for the 
concomitant nanoscale rearrangement of the bound and adjacent TBA molecules[8, 12]. 
The overall surface effect on aggregation can be understood if we construct a 
thermodynamic cycle that goes from the free state (state I) to the aggregated state (state 
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the release of TBA from the NR to the (bulk) solution (from I to II), the second step the 
TBA-thrombin recognition in solution (II to III), and the third the conjugation of the 
TBA-thrombin complexes to the NR (III to IV).  
Each step is characterized by a standard molar Gibbs free energy: ΔrG0rel, ΔrG0bind and 
ΔrG0conj, respectively. It follows that the standard molar Gibbs free energy of aggregation, 
ΔrG0agg, is given by 
ΔrG0agg = ΔrG0rel + ΔrG0bind + ΔrG0conj  (Eq.3.15) 
The surface work, Wσ, can be defined by gathering the non-recognition contributions, or 
Wσ = ΔrG0rel + ΔrG0conj. Thus ΔrG0agg can be written as  
ΔrG0agg = Wσ + ΔrG0bind (Eq.3.16) 
Equation (3.16) elucidates the energy of NR aggregation directed by molecular 
recognition confined on their surface. It is distinct from the energy of molecular 
recognition free in solution, and can be nonzero, as it is usually assumed. The difference 
lies in the surface work component, Wσ. Wσ can be either positive or negative, and 
therefore obscure or promote spontaneous aggregation. For example, a positive Wσ that 
exceeds ΔrG0bind fully inhibits aggregation (ΔrG0agg > 0). The free energy of aggregation 
equals that of binding (ΔrG0agg ≅ ΔrG0bind) only if Wσ ≅ 0, which occurs when the release 
and conjugation energies are similar or very small. These two cases can be described as 
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“mild” surface conditions, possibly resulting from weak or negligible lateral interactions 
between the surface-confined species.  
From the molecular machine standpoint, Wσ is cooperatively triggered by molecule-
surface and molecule-molecule lateral interactions, such as hydration and thermal 
fluctuation forces, originating from nanoscale molecular motions fuelled by the interplay 
of surface molecular recognition, electrolyte surface density variation and “squeezing” 
between the NP surfaces[8, 28] . 
Equation (3.16) can be used to evaluate Wσ from dose-response data for the binding 
variables θ and [Th]. If we express ΔrG0agg as −RTln Kσ and ΔrG0bind as −RTln Kb, where 




where Kdb is the TBA-thrombin dissociation constant in solution. By substituting 
Equation (3.17) into Equation (3.14) we obtain an expression that can quantify Wσ for 
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  (Eq.3.18) 
Equation (3.18) can be seen as a Langmuir equation that specifically describes self-
assembly of NPs directed by molecular interactions. It is related to the Stern equation 
(proposed in 1924 for describing electrolyte adsorption at a charged surface) and the 
modified Langmuir by Fowler and Guggenheim (implemented in 1952 to take into 
account lateral interactions in adsorption of gases on solids)[29]. Here we ascribe a 
physical meaning to the modification via the thermodynamic cycle, i.e. by describing the 
energy of aggregation as a sum of surface and molecular recognition contributions. Note 
that when Wσ = 0, Equation 3.18 reduces to the Langmuir isotherm, which does not 
account for intermolecular interactions. 
3.2.3. Results and discussion 
3.2.3.1. Synthesis and characterization of TBA decorated NRs  
We deployed this thermodynamic framework on NR-TBA with different surface 
treatments (Figure 3-2a).  NRs were monodisperse in size, as confirmed by TEM (Figure 
3-2b), with a length of 35 ± 5 nm and width of 10 ± 1 nm (aspect ratio = 3.6 ± 0.7). The 
TBA surface density on the NRs was varied systematically with the meaning of covering 
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sequence of 15 thymines terminated with a SH moiety (SH-T15-TBA) and straight SH-
modified TBA (SH-TBA). TBA surface density was varied between low and high,   (5.6 ± 
1.1)⋅1012 TBA/cm2 vs. (12.3± 2.5)⋅x1012 TBA/cm2. The NR surface chemistries were also 
varied. NR-TBAs were “backfilled” with ligands of thiolated polyethylene glycol (PEG), 
which are used extensively as a surface coating ligand for NPs to prevent fouling and 
non-specific adsorption[30, 31]. In addition, we probed the effect of “blocking” the surface 
with human serum albumin (HSA, 0.3%), protein which is widely used to prevent 
aggregation and non-specific adsorption for both NP and planar surfaces (For details on 
protocols, see Chapter 2: Materials and Methods).  
Gel electrophoresis was used to probe the effect of the different surface conditions on the 
NRs (Figure 3-2c). Lane 1: NRs conjugated to T15-TBA with high coverage exposed to 
HSA, Lane 2: NRs conjugated to TBA, Lane 3: NRs conjugated to T15-TBA with high 
coverage, Lane 4: NRs conjugated to T15-TBA with low coverage, Lane 5: MHA coated 
NRs before conjugation to DNA. Lane 6: NRs conjugated to T15-TBA with high 
coverage, Lane 7: NRs conjugated to T15-TBA with high coverage and exposed to mPEG 
(MW 5000) at 5:1 mPEG:TBA, Lane 8: NRs conjugated to T15-TBA with high coverage, 
Lane 9: NRs conjugated to T15-TBA with high coverage and exposed to mPEG (MW 
5000) at 0.5:1 mPEG:TBA. 
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Conjugation of the NRs to the SH-T15-TBA and to SH-TBA was confirmed by a shift to 
lower mobility. Increasing the DNA:NR incubation ratio resulted in a higher mobility 
shift, confirming the higher coverage of the DNA on the NR surface, which was further 
confirmed by chemical displacement methods used to quantify the DNA on the NR 
surface (see Chapter 2: Materials and Methods)[32, 33]. Incubation of the NR-TBA (SH-
T15-TBA, high coverage) with thiolated mPEG (MW  = 5000) resulted in further shifts 
to lower mobility, indicating that some of the neutral mPEG was put onto the surface of 
the NR-TBA. Finally, incubating the NR-TBA with HSA resulted in a shift to lower 
mobility. This is due to an increase in NR-TBA size upon adsorption of the HSA and 
confirms successful HSA blocking.  
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Figure 3-2: Samples probed. Adapted with permission from de Puig H, Federici S, Baxamusa SH, Bergese P, 
Hamad-Schifferli K. Quantifying the Nanomachinery of the Nanoparticle-Biomolecule Interface. Small 2011;7. 
Copyright 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. 
 
3.2.3.2. Probing thrombin directed self-assembly  
One of the most popular TBA is a single-stranded DNA 15mer 5’-
GGTTGGTGTGGTTGG-3’ [34]. It folds into a chair structure stabilized by two G-
quartets (Fig. 3-1)[35] .When in this conformation, TBA binds strongly to thrombin at 
either exosite I or exosite II in a highly specific manner. Binding occurs in a way that is 
not only strong, with a binding constant KD that ranges from 1-100’s of nM. Because 
thrombin can bind to two TBAs[35], NR-TBA will self-assemble upon binding to 
thrombin (Fig. 3-1). This results in a red shift and broadening of the surface plasmon 
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resonance (SPR) peak. Figure 3-3 shows the absorption spectrum of NR functionalized 
with SH-T15-TBA incubated with 121 nM concentration of thrombin as a function of 
time. The longitudinal SPR red shifts and broadens with time, suggesting aggregation.  
 
Figure 3-3: Change in absorption spectra of NR-T15-TBA high coverage as a function of time upon 
incubation with 121 nM of thrombin (arrow indicates increasing time). Adapted with permission from de 
Puig H, Federici S, Baxamusa SH, Bergese P, Hamad-Schifferli K. Quantifying the Nanomachinery of the 
Nanoparticle-Biomolecule Interface. Small 2011;7. Copyright 2011 WILEY-VCH Verlag GmbH & Co. KGaA, 
Weinheim. 
 
To quantify aggregation, the ratio of extinctions at 400nm and 800nm (A400/A800) is 
plotted, which increases as a function of time in the presence of thrombin (Figure 3-4). 
A400/A800 time courses are collected for several thrombin concentrations (0-121 nM, Fig. 
3-4).  
time	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Figure 3-4: A400/A800 as a function of time for NR-T15-TBA high coverage for different thrombin 
concentrations. Adapted with permission from de Puig H, Federici S, Baxamusa SH, Bergese P, Hamad-
Schifferli K. Quantifying the Nanomachinery of the Nanoparticle-Biomolecule Interface. Small 2011;7. 
Copyright 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. 
 
The A400/A800 endpoint at t = 1 hr is used to define when equilibrium is attained, and is 
plotted as a function of thrombin concentration (Fig. 3-5) to construct an aggregation 
dose-response curve, or isotherms. The aggregation isotherm exhibits Langmuir-like 
behavior, where after a threshold it increases with increasing thrombin concentration, 
eventually saturating.   
 
Figure 3-5: Aggregation isotherm for NR-T15-TBA high coverage. Adapted with permission from de Puig H, 
Federici S, Baxamusa SH, Bergese P, Hamad-Schifferli K. Quantifying the Nanomachinery of the 
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Nanoparticle-Biomolecule Interface. Small 2011;7. Copyright 2011 WILEY-VCH Verlag GmbH & Co. KGaA, 
Weinheim. 
 
In order to prove that the self-assembly is due to the specific interaction between 
thrombin and the TBA on the NR, we performed a competitive inhibition. Already 
formed NR-TBA-thrombin aggregates were incubated with a DNA strand complementary 
to the TBA. Because TBA must maintain a G-quartet structure to bind to thrombin, 
binding to a complement will not permit it to self-fold and bind to thrombin. Upon 
addition of 10 µl of 1 mM of the complement to the 38.4nM thrombin-aggregated sample 
(Fig. 3-6), A400/A800 decreases and returns to its original value, indicating that the 
aggregate was disrupted and thus confirming that self-assembly is due to the specific 
TBA-thrombin recognition.  
 
Figure 3-6: A400/A800 as a function of time upon incubation with thrombin (t = 0 min) and complementary 
DNA sequence (gray area, 60 min). Adapted with permission from de Puig H, Federici S, Baxamusa SH, 
Bergese P, Hamad-Schifferli K. Quantifying the Nanomachinery of the Nanoparticle-Biomolecule Interface. 
Small 2011;7. Copyright 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. 
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In addition, disruption (melting) of the aggregate by heat was also probed. Already 
formed aggregates with a thrombin concentration of 121 nM were exposed to a heating-
cooling cycle and monitored by tracking A400/A800 (Fig. 3-7). As the temperature 
increased, A400/A800 decreased with a sigmoidal drop centered at ~42 °C, suggesting that 
the aggregate was disrupted by denaturation of the TBA or the thrombin. Decreasing the 
temperature from 75 °C down to 25 °C did not result in a change in A400/A800, suggesting 
that the aggregate could not form again. This could be due to the fact that the thrombin 
was irreversibly denatured [36].  
 
Figure 3-7: A400/A800 of already formed NR-T15-TBA -thrombin aggregates as a function of changing the 
temperature from 25ºC to 80ºC and back down to 25ºC (arrows indicate direction). Adapted with permission 
from de Puig H, Federici S, Baxamusa SH, Bergese P, Hamad-Schifferli K. Quantifying the Nanomachinery 
of the Nanoparticle-Biomolecule Interface. Small 2011;7. Copyright 2011 WILEY-VCH Verlag GmbH & Co. 
KGaA, Weinheim. 
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These experiments further confirm that the aggregation is due to the specific interaction 
of thrombin with the TBA on the NR surface. 
3.2.3.3. Nanomachinery of TBA on NRs  
Aggregation isotherms were analyzed using the modified Langmuir equation (Eq. 3.18). 
assuming that A400/A800 was a measure of the number of aggregated NR-TBA[37], and 
thus of the TBA-thrombin surface binding efficiency θ. Data points from three 
experimental replicates were fitted by a best-fit procedure to obtain θ and Wσ, with the 
associated errors evaluated. 
The first step to exploit Equation (3.18) to fit the experimental curves consists in 
expressing the binding efficiency, θ, in terms of the signal intensity, I. Since θ and I are 
proportional, we can set θ = I ⋅ β-1, in which β is the proportional constant. We obtain 
 (Eq.3.19) 
However, this Langmuir equation fails to fit the experimental data and it needs to be 
further optimized. By using the mathematical principle of translation, we applied a rigid 
shift of the Equation (3.19) with respect to the x and y axes in order to take into account 
the onset of aggregation. These shifts were subtracted from the equilibrium concentration 
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 (Eq.3.20) 
In which IT and ThT refer to the values of signal intensity and equilibrium concentration 
at the threshold. Kdb is the TBA-thrombin dissociation constant in homogeneous solution 
fixed at 3.3 ± 1.1 ×10-7 M[38]. b and Ws are the free parameters of the fitting. 
Data are fitted using Equation (3.20) over three repetitions of the same experiments and 
the errors on the free parameters are assigned as a result of the fitting algorithm (with 
95% confidence bounds). 
Finally, we described the NR aggregation process through a single binding of NR 
confined TBA and thrombin (Equation 3.15). Since aggregation was conducted in excess 
of thrombin with respect to NR concentration (about 6 nM), we may assume in first 
approximation that the concentration of thrombin not involved in that binding event (i.e. 
formally in solution), Th, does not change significantly before and after aggregation ([Th] 
≡ Th). 
Aggregation as a function of thrombin concentration and their fits are all reported (Fig. 
3-8a-3-8e). The fits are also compared in Figure 3-8d. High and low coverage NR-TBA 
display isotherms that differ in two ways (Figure 3-8a, 3-8b, and 3-8f). First, the onset of 
aggregation (ThT) for the high coverage sample is at ~30 nM thrombin, while it occurs at 
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~15 nM thrombin for the low coverage. Also, the rise in the curve is steeper for the high 
coverage NR-T15-TBA. This indicates that changing TBA surface coverage affects the 
binding of thrombin to NR-T15-TBA. Treating the high coverage NR-TBA surface with 
mild PEG conditions also affected the aggregation isotherm, that displays the steepest 
curve rise and highest ThT at ~35 nM thrombin (Fig. 3-8c and 3-8f). On the contrary, no 
isotherm was registered for NR-T15-TBA exposed to stronger PEGylation (Fig 3-8g), 
showing that aggregation varies with surface modification conditions. NRs coated with 
TBA lacking T15 exhibited no aggregation (Figure 3-8e), suggesting that TBA on the NR 
was unable to bind thrombin. TBA coverage was 28.6 ± 5.8 × 1012 TBA cm-2 as 
determined by chemical displacement, which exceeds a monolayer and is likely due to 
formation of intermolecular G-quartets[39] that would disrupt the ability to bind 
thrombin. Incubation of high coverage NR-T15-TBA with HSA prevented thrombin 
binding and thus aggregation, as indicated by negligible change in A400/A800 (Figure 3-
8f). This shows that the HSA was able to block thrombin from the TBA on the NR 
surface. 
Figure 3-8 shows the modified Langmuir aggregation isotherms for a) NR-T15-TBA high 
coverage, b) NR-T15-TBA low coverage, c) NR-T15-TBA mPEG backfill 0.5:1 
mPEG:TBA, d) fits for plots a-c , e) NR-TBA without a poly T spacer (the dashed line 
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is the average value), f) NR-T15-TBA HSA block (the dashed line is the average value), 
g) NR- T15-TBA high coverage mPEG backfill 5:1 mPEG:TBA. 
 
Figure 3-8: Modified Langmuir aggregation isotherms for a) NR-T15-TBA high coverage, b) NR-T15-TBA low 
coverage, c) NR-T15-TBA mPEG backfill 0.5:1 mPEG:TBA, d) fits for plots a-c , e) NR-TBA without poly T 
spacer (the dashed line is the average value), f) NR-T15-TBA HSA block (the dashed line is the average 
value), g) NR- T15-TBA high coverage mPEG backfill 5:1 mPEG:TBA. Reprinted with permission from de 
Puig H, Federici S, Baxamusa SH, Bergese P, Hamad-Schifferli K. Quantifying the Nanomachinery of the 
Nanoparticle-Biomolecule Interface. Small 2011;7. Copyright 2011 WILEY-VCH Verlag GmbH & Co. KGaA, 
Weinheim. 
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The data analysis can also be used to map how Wσ  changes as a function of θ and ThT 
for different TBA coverages and surface chemistry (Fig. 3-9). First, the values for the Wσ 
are all negative and on the order magnitude of −10 kJ/mol, indicating that the surface 
work significantly contributes with TBA-thrombin binding in promoting aggregation. In 
particular, since the binding free energy of thrombin-TBA in solution is ΔrG0bind ~ −37 
kJ/mol[38] , we can calculate by Eq. (3.20) that Wσ nearly comprises 30% of the 
aggregation energy, ΔrG0agg., that results that results ~ −50 kJ mol-1, comes from Wσ.  
This shows that aggregation is not due solely to TBA-thrombin binding, as it is 
predominantly assumed.  
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Figure 3-9: a) θ vs. -Wσ for NR-T15-TBA high coverage (square), NR-T15-TBA low coverage (triangle), and 
NR-T15-TBA -PEG backfill 0.5:1 (circle), b) ThT vs. - Wσ for NR-T15-TBA high coverage (square), NR-T15-
TBA low coverage (triangle), and NR- T15-TBA -mPEG backfill. Adapted with permission from de Puig H, 
Federici S, Baxamusa SH, Bergese P, Hamad-Schifferli K. Quantifying the Nanomachinery of the 
Nanoparticle-Biomolecule Interface. Small 2011;7. Copyright 2011 WILEY-VCH Verlag GmbH & Co. KGaA, 
Weinheim. 
 
From the same calculation we also learn that the ΔrG0agg value is on the order of 50 
kJ/mol, corresponding to about 20 kBT. This confirms that NR-TBA aggregation is long-
lived, on the time scale of hours or days[28]. On the other hand, Wσ values in kBT units 
are (3.2 ± 0.5) kBT, (4.3 ± 0.6) kBT and (5.0 ± 1.1) kBT for low and high coverage NR-TBA 
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and the PEG backfilled NR-TBA, respectively. These values are high enough to say that 
the in-plane intermolecular interactions underpinning Wσ are significantly larger than 
thermal vibrational energy kBT (that on the other hand individuates the order of 
magnitude of the measurement uncertainties). This suggest that the in-plane interaction 
lifetime is < 1 second[28] and in turn that the timescale of TBA motions is well below 
the timescale of NR-TBA aggregation.  
Obtained θ for NR-TBA high and low coverage and PEG-backfill are identical within the 
experimental errors and close to 100% (Fig. 3-9). This means that for all samples 
aggregation was nearly complete. However, Wσ values differ, where low coverage has the 
lowest absolute value (-8.0± 1.3) kJ/mol, higher coverage has a higher value (-10.7 ± 1.5) 
kJ/mol, and the addition of PEG to the surface results in the highest value (-12.4 ± 2.8) kJ/mol. 
Evidently, increasing the surface density of the TBA on the NR increases its absolute Wσ. 
This could be due to the fact that for aggregation to occur, more Wσ needs to be done to 
accommodate the thrombin on crowded surface. Furthermore, introduction of small 
amounts of PEG, which is a cumbersome molecule, increases Wσ.  
This difference in energy is taken from thrombin in solution, which can be shown from 
values of the threshold thrombin concentration for the different samples, ThT (i.e. the 
thrombin chemical potential) (Fig. 3-9). ThT required for the onset of aggregation 
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increases with increasing |Wσ|, showing that samples that require lower |Wσ| and thus 
with smaller interface effects do not need as much thrombin to aggregate. 
These results show that TBA behavior can vary with varying coverage on the NR or NR 
surface chemistry, and in a way that does not affect its aggregation efficiency θ. 
Conversely, this means that simply probing NR aggregation yields incomplete 
information on biomolecular behavior on the NR surface. Surprisingly, in view of Wσ data 
and Equation (3.20) the NR- T15-TBA sample with mild PEGylation has the highest 
energy of aggregation, ΔrG0agg, and thus forms the most stable aggregate. Even though 
the surface treatment does not yield a detectable amount of PEG on the NR by 
electrophoresis, its Wσ is distinct from high coverage NR-T15-TBA. This shows that mild 
surface treatments that are difficult to detect can still result in significant Wσ changes. 
This is in striking contrast with the common understanding that PEG backfilling is inert 
and prevents fouling and non-specific adsorption of other species and highlights the 
variability and complexity of the interface.  
Wσ can be expressed in units of mN/m in order to compare it to Wσ of biomolecular 
transformations confined to planar surfaces and evaluated by microcantilever (MC) 
beams, including DNA hybridization and other molecular recognition interactions[22] as 
well as pH and electrolyte driven conformational changes[8, 13, 23]. To the best of our 
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knowledge, this is the first time analogous studies are reported for NPs. Wσ from the MC 
experiments ranges from 1 to 10’s of mN/m, where one study of aptamer-protein 
interactions reports a Wσ = 9.6 mN/M[40]. By dividing the Wσ we obtained for low and 
high coverage NR-TBA for the respective TBA surface coverage (see [8] for a justification 
of this calculation) we obtain Wσ = (-0.74 ± 0.26) mN/m and Wσ = (-2.18 ± 0.76) mN/m, 
respectively, which are consistent with the reported range of values in the literature. This 
suggests that Wσ involved in transformations of NP conjugated biomolecules is 
comparable to Wσ of biomolecules conjugated to planar surfaces. By some more 
arithmetic, we may note that an average coverage of the NRs of 1013 TBA per cm2 means 
that 1 TBA molecule occupies about 10 nm2, that corresponds to a circle of about 3.5 nm 
diameter. By taking into account that a TBA molecule in the binding chair conformation 
has an average size of 2.5 nm we conclude that the average distance between two TBAs 
is 1 nm, which multiplied to Wσ gives a force in the order of units of pN. Remarkably, 
these data are fairly consistent with unfolding forces from single-molecule 
experiments[41].  
We observed that by heating the NR aggregates solution, the NR aggregates disassemble. 
We can use this data in order to calculate the enthalpy of the TBA-thombin induced 
assembly of the NRs, by using the Van’t Hoff equation[47]. 
Helena de Puig Guixé 
Mechanical Engineering MS Thesis 
MIT 
 
3. Characterization of the covalently bound aptamer-TBA conjugates                                                                                                            130 
𝐾 𝑇 = −𝐾!!𝑒𝑥𝑝 Δ𝐻𝑅 1𝑇! − 1𝑇!  (Eq.3.21) 
By following the approach from literature[47], we can use a thermodynamic analysis to 
study the melting curve of thrombin-TBA-NR aggregates. In order to do that, the 
aggregates were heated and the absorbance of the particles was recorded. In order to 
analyze the behavior of the particles we worked with a model that could take into 
account that more than one particle was binding in the aggregates. In the Mirkin/Schatz 
group[47], they study the assembly of NRs after the addition of DNA strands. In their 
case, it is a short DNA sequence that serves as a binder between two different 
nanoparticles, therefore having the same function as the thrombin(th) has in our project. 
Assuming that there are many particles in every aggregate, and that each pair may be 
linked by more than one thrombin, we may divide the disruption of the aggregates in 
different steps in which: 
𝐴𝑔𝑟! ⇌ 𝐴𝑔𝑟!!! + 𝑡ℎ 𝐴𝑔𝑟!!! ⇌ 𝐴𝑔𝑟!!! + 𝑡ℎ 𝐴𝑔𝑟! ⇌ 𝐴𝑔𝑟 + 𝑡ℎ 𝐴𝑔𝑟 ⇌ 𝑁𝑅 + 𝑡ℎ 
Then, we may as well define the fraction of NRs in an assembled state as: 
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𝑓 = 𝐷!𝐷! = 𝐷!𝐷! = 11 + 1 𝐾 (Eq.3.22) 
Where DT is the total concentration of aggregate, and D0 represents the concentration of 
free nanoparticles after the unbinding process is complete. The overall equilibrium 
constant K is related to the partial equilibrium constants Ki by: 
1𝐾 = 𝑡ℎ𝐾! 1 + 𝑡ℎ𝐾! + 𝑡ℎ!𝐾!𝐾! +⋯+ 𝑡ℎ!!!𝐾!𝐾!𝐾!…𝐾! ∼ 𝑡ℎ!𝐾!𝐾!𝐾!…𝐾! (Eq.3.23) 
The number n represents the total number of thrombin bound per particle, and by using 
the Van’t Hoff formula for Ki: 
𝐾! = 𝑡ℎ   𝑒𝑥𝑝 Δ𝐻!𝑅 1𝑇 − 1𝑇!,!  (Eq.3.24) 
Where Δ𝐻!   is the enthalpy of step i, which is temperature independent; and 𝑇!,!   is the 
melting temperature at i concentration of thrombin. By substituting equation 3.24 into 
3.23 and using 3.22; we obtain a relation for the melting curve: 
𝑓 = 11 + 𝑒𝑥𝑝 Δ𝐻!𝑅 1𝑇 − 1𝑇!  (Eq.3.25) 
By fitting this equation to the obtained melting curve: 
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Figure 3-10: Melting profile of the NR-thrombin conjugates and fitted model 
 
By fitting the obtained data from the experiments following the previous approach, we 
were able to find a ΔH of 547.7 kJ/mol. We can compare this value with other enthalpy 
results[47] and observe that it is in the order of the values that would be expected for NR 
conjugates. Specifically, in Jin et al.’s article which studies the binding of nanoparticles 
by	   the action of complementary DNA strands, the value of ΔH obtained is 1326 kJ/mol; 
one must note that in their model, the number of interaction between particles is much 
higher than in the case of thrombin binding; as DNA is much smaller than thrombin, and 
therefore there is the possibility for a higher number of interactions, and also one must 
note that the DNA-DNA interaction is in general-stronger than the thrombin-TBA 
interaction. 
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3.2.4. Conclusions  
We have introduced a thermodynamic analysis that can quantify the interactions of TBA 
on NR surfaces with thrombin. The model is completely general and relies on the critical 
step of separating TBA-thrombin recognition from surface effects due to confinement of 
the recognition event within NR surfaces. In particular, the model introduces the 
efficiency of aggregation, θ, and the surface work of aggregation, Wσ, this latter 
containing information about the nanoscale motion of how the molecules must 
accommodate each other on the surface or binding to its target. In this way, it enables a 
quantitative understanding of interfacial nanoscale phenomena “fuelled” by thrombin 
directed aggregation. 
Obtained values of Wσ are on order magnitude of −10 kJ/mol. They comprise about 30% 
of the overall aggregation energy and therefore indicate that the surface work 
significantly participates with TBA-thrombin binding to aggregation (that is, they pose a 
strong caveat on the common assumption that aggregation is exclusively directed by the 
molecular recognition event). They also suggest that the in-plane molecular forces that 
trigger Wσ are on the order of magnitude of few pN and have a lifetime well below 1 
second, albeit the TBA-NR aggregation is stable on the day timescale. Wσ can be used to 
compare experiments between flat surfaces (e.g. microcantilevers) and gold nanoparticles; 
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and since it can be quantified, it can also be used to compare results between research 
groups, which would greatly help in understanding the nano-bio interface. 
Wσ is a function of molecular density on the NR surface and surface chemistry and turned 
to be crucial in discriminating molecular directed self-assembly processes that looked 
have similar θ. This would have been missed by phenomenological tests, which probe 
only whether or not aggregation occurs, and de facto giving a qualitative estimation of θ. 
Wσcontains also important information on how the NP-immobilized biomolecule function 
is affected by crowding or the presence of other molecules. Using the model we were able 
to show that while strong PEG treatments result in the expected behavior of no 
aggregation, mild PEG treatments can actually result in a larger value of Wσ and thus 
stronger tendency to aggregate. These PEGylations are mild enough that gel 
electrophoresis cannot detect any difference from non-PEGylated NR-TBA. These results 
show that PEG treatments do not always yield NRs inert, and also highlight the 
complexity and variability of the nano-bio interface. 
In summary, these results indicate that our approach could help a basic understanding of 
surface confined biomolecular transformations, as it extends to nanoparticles quantitative 
information that could previously be determined for only planar surfaces and it is broadly 
applicable to probe the behavior of any receptor-ligand binding event, as well as the 
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effect of other parameters, such as surface curvature and surface material composition. 
Wσ can be used to compare experiments between flat surfaces (microcantilevers) and gold 
nanoparticles; and since it can be quantified, it can also be used to compare results 
between research groups, which would greatly help in understanding the nano-bio 
interface. 
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3.3. Kinetics of biomolecule-induced nanoparticle assembly  
The assembly of gold nanoparticles to form larger structures leads to a change in their 
optical properties[42-44], which can be used in order to detect their target agents. The 
assembly of nanoparticles to form larger structures has interesting applications in many 
physics, chemistry and biology processes. The assembly of DNA functionalized 
nanoparticles to form larger aggregates after the addition of complementary DNA 
sequences has been studied by different authors[45-47]. This approach is important as 
well in sensing applications of proteins, where NPs can be conjugated to aptamers and 
aggregate when the target protein is present in the solution [45, 48, 49].  In such cases, 
the aptamers binds to the target protein; therefore, if the aptamer is interfaced to an 
inorganic surface, it can report a signal that represents the aptamer-target interaction. 
An example of this is the TBA-thrombin recognition. 
Although the thrombin-TBA recognition has been studied in solution, a few studies exist 
on its binding on surfaces, where the interactions between neighbouring DNA sequences 
and between the surface and the DNA play an important role in protein binding at the 
interface.  The distribution of the DNA on the surfaces can vary with the curvature of 
the particles [10, 50, 51]. Nanoparticles have charges or can be coated with ligands that 
affect the interactions between the biomolecules at the interface[1, 4, 7, 9]. Also, the 
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particles’ surface behavior can be modified by the introduction of other species to create 
a corona around the nanoparticle[7]. All these intermolecular forces on the surfaces can 
result in transformations of the attached biomolecule’s structure.  
In order to make nanoparticles useful for biosensing applications, a study on the kinetic 
of the assembly process is necessary. In this chapter we study the mechanism of gold 
nanoparticle assembly and observe the importance that surface chemistry plays in it.  
As we already introduced in the previous chapter, the interaction of thrombin with TBA 
on NRs results in NR self-assembly (Fig. 3-11). Binding results in aggregation of TBA 
decorated NRs, as thrombin is able to bind specifically to TBA at both exosite I (green) 
and exosite II (purple). 
 
Figure 3-11. Nanorod assembly kinetics scheme 
 
In order to describe and understand the mechanism of the NR aggregation, we can divide 
the process into two different reactions that are involved during the aggregation. In the 
first one (Fig. 3-12), we imagine the attachment of thrombin to single NRs in order to 
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form unit blocks of aggregation, that we can define as an arbitrary fundamental complex 
from which the entire aggregate may be constructed by purely translational units, we 
identify a NR-TBA bound to n thrombins as a unit block of aggregation. By assuming 
that the kinetic constants do not change with the number of thrombins attached to the 
unit block of aggregation we can picture the following reaction: 
 
Figure 3-12: Formation of the unit blocks of aggregation scheme 
 
Where ka and kb are the kinetic constants that rule the attachment of thrombin to 
nanorods in order to form unit blocks of aggregation. After the unit blocks of aggregation 
are formed, we can model their attachment in terms of subsequent unit block additions to 
form the aggregate, as sketched in figure 3-13, where kc and kd are the kinetic constants 
that rule the aggregation process of the system. 
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Figure 3-13: Subsequent monomer addition scheme 
 
The first approach we should take into account is that the formation of nanorod-
thrombin unit blocks is very fast compared to the formation of the aggregates (Agr); 
therefore, the rate-determining step would be the formation of the aggregates.  We can 
assume that the concentration of thrombin in solution is high related to the 
concentration of NRs so we can consider it constant. Also, we may assume that after 
every NR addition in the aggregate, the kinetics of the system do not change: 
 
Figure 3-14: Overall kinetic scheme of NR assembly 
 
Helena de Puig Guixé 
Mechanical Engineering MS Thesis 
MIT 
 
3. Characterization of the covalently bound aptamer-TBA conjugates                                                                                                            140 
In figure 3-14, one can observe the scheme studied to solve the assembly of NR 
aggregates. In this case, kon and koff are the overall kinetic constants that rule the system. 
As we previously introduced, this constants will mainly depend on the rate of formation 
of the aggregates; as we consider that the NR-thrombin interaction to form unit blocks of 
aggregation is fast compared to the assembly of the aggregate. We can develop the 
following equation to explain the NR assembly using these considerations: 
 (Eq.3.26) 
 
Where we picture that the rate of formation of the aggregate (Agr), is a function of the 
kinetic constants kon and koff. [NR] is the concentration of free NRs, [th] is the 
concentration of thrombin that we may consider constant, and [Agr] is the concentration 
of the formed aggregate. Knowing that: 
 (Eq.3.27) 
Where m is the number of nanorods present in the aggregate.  







[ ] [ ] [ ]AgrmNRNR t −= 0
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3.3.1. Theoretical 
We may take into consideration that once the aggregates are formed, the concentration 
of the aggregates determines the absorbance difference, and not the size of the 
aggregates[52]. Therefore, after the initial binding, the critical size of the aggregates 
would remain constant, and only their concentration will vary. [NR0] is the initial 
concentration of nanorods and [NR]t is the evolution of the concentration of the nanorods 
in time. We may solve this equation and find the solution that rules the aggregation of 
the particles as a function of time: 
 
(Eq.3.28) 
3.3.2. Results and discussion 
The assembly of NR to form aggregates results in a broadening and red-shift of the SPR 
peak, as can be pictured in figure 3-15, indicating the assembly of the particles.  
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Figure 3-15: Evolution of the extinction of the NRs with time 
 
To quantify the assembly, the ratio of extinctions at 400nm and 800nm (A400/A800) is 
plotted, which increases as a function of time in the presence of thrombin (Fig. 3-16). 
A400/A800 time courses are collected for several thrombin concentrations. 
 
Figure 3-16: Assembly of the NRs at 121nm thrombin 
time	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We can fit equation 3.28 in order to find the kinetic constants of aggregation of the 
particles, as shown in figure 3-16. In order to plot the data points and fit the kinetic 
aquations, we will normalize our data so that the first point in the curve (time=0), will 
give a value of 0 formation of aggregates.  
3.3.2.1. Different surface chemistries 
By changing the surface chemistry of the gold nanoparticles, one can observe a change in 
the kinetics of the assembly process. Curves were fitted using MatLab. The resulting 
binding constants for each fit are: 




Goodness of the fit (r2) 
T15-TBA-High Coverage 0.1049 0.4598 0.7923 
T15-TBA-Low Coverage 0.2249 1 0.8589 
T15-TBA-PEG backfill 0.06768 0.2767 0.9222 
TBA 3.13E-9 0.01151 0.7649 
Table 3-1: Kinetic binding constants for different surface chemistries 
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Figure 3-17: Kinetic fits with different surface chemistries 
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Figure 3-18: Comparison of the fits between different surface chemistries 
 
By comparing the previous plots, one can see that the fastest aggregation occurs with the 
T15-TBA with low coverage, followed by the T15-TBA with high coverage. PEG backfill 
does make the aggregation process slower, and finally almost no aggregation can be 
observed with the TBA without a thymine spacer (Fig. 3-18).  
Knowing that Kdb=3.3 ± 1.1 ×10-7 M[38], it is possible to calculate the surface work and 
equilibrium binding constants of the TBA on the gold nanorod surface, as explained in 
Chapter 3.2. The ratio between koff and kon will be the equilibrium binding constant 
describing aggregate formation. Thrombin is in excess in solution, therefore, its 
concentration is considered constant, and k’1 =kon*[th], thus it is possible to calculate the 
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binding kinetic constants of the binding of thrombin with TBA, when TBA is bound to 
nanoparticles with different surface chemistries.  
The binding equilibrium constant to form the aggregates can be calculated from a 
thermodynamic perspective, as shown in Chapter 3.2. Once the binding constant in 













1.44 x104 6.34x10-5 3.3x10-7 4.39x10-9 -10.7 
T15-TBA-Low 
Coverage 
3.10 x104 4.04x10-4 3.3x10-7 1.30x10-8 -8.0 
T15-TBA-PEG 
backfill 
9.32 x103 2.06 x10-5 3.3x10-7 2.21x10-9 -12.4 
Table 3-2: Assembly kinetic constants of different surface chemistries 
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The values of kon obtained for the formation of complexes of typical heparin-binding 
blood proteins with their aptamers are of the order of 107. For instance, NX-213 binds to 
VEGF with a kon of 1.0x107 when both the protein and the aptamer are free in 
solution[53]. The slower values obtained in our experiments show that the surface plays a 
role, preventing the formation of the complex. Also, the different results enable 
understanding of the molecular structural reorganization required to form the assemblies, 
that is lower in the case of low coverage of T15-TBA on the surface; giving a value for the 
kon of 3.1x104, and increases for both the high coverage (1.44x104) and for the PEG 
backfill (9.32x103). Therefore, the most crowded surface (PEG backfill) requires a major 
reorganization of the molecules to enable the binding of the thrombin; and in the less 
crowded surface (Low Coverage T15-TBA) thrombin can bind more easily, as bound TBA 
is not sterically hindered. During the dissociation process, the results show the slowest 
dissociation values for the low coverage T15-TBA particles, with a koff of 4.04x10-4, 
followed by the PEG backfilled particles, that show a koff of 2.06x10-5. Finally, the fastest 
dissociation is for the High coverage T15-TBA particles, with a koff of 6.34x10-6. We can 
compare the previous values with the koff for a typical heparin-binding protein, such as 
VEGF unbinding from its aptamer, NX-213 is of the order of 1.4x10-3[53].  We can show 
that the dissociation on the surface of a NR is much faster than the one that would be 
obtained with the molecules in solution.  
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3.3.2.2. Different concentrations of biomolecule added 
We have observed that the binding kinetics of nanorods depends on the concentration of 
thrombin added to the system. We can also fit equation (3.28) to different concentrations 
of thrombin added in the solution, in order to compare the binding constants. The kinetic 
constants obtained from fitting equation 3.28 to the T15-TBA with High Coverage 
aggregation data are: 
[thrombin] k’1 kx Goodness of the fit (r2) 
121nM 0.1049 0.4597 0.7923 
61nM 0.05348 0.2595 0.8945 
38nM 0.1427 0.443 0.8299 
26nM 0.9532 0.597 0.9832 
Table 3-3: Kinetic binding constants for High Coverage NR-T15-TBA 
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koff (1/s) Kσ (M) 
W 
(kJ/mol) 
121nM 1.44 x104 6.34x10-5 4.39x10-9 -10.7 
61nM 1.46 x104 6.41x10-5 4.39x10-9 -10.7 
38nM 6.26 x104 2.74 x10-4 4.39x10-9 -10.7 
26nM 6.11 x105 2.68 x10-3 4.39x10-9 -10.7 
Table 3-4: Calculated kinetic binding constants for high coverage T15-TBA  
 
We can observe that the association process is faster with lower concentrations of 
thrombin in solution, and the dissociation process is has a higher rate with higher 
concentrations of thrombin added in solution.  
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In the case of Low Coverage T15-TBA NRs, the fit of equation 3.28 gives the following 
results: 
[thrombin] k’1 kx Goodness of the fit (r2) 
121nM 0.2243 0.9977 0.8589 
61nM 0.2526 1.006 0.8516 
30nM 0.2328 0.6531 0.8483 
Table 3-5: Kinetic binding constants for Low coverage NR-T15-TBA 
 
 
Figure 3-20: T15-TBA low coverage kinetics at different thrombin concentrations 
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koff (1/s) Kσ (M) 
W 
(kJ/mol) 
121nM 3.09 x104 4.03x10-4 1.30x10-8 -8.0 
61nM 6.90 x104 9.00x10-4 1.30x10-8 -8.0 
30nM 1.29 x105 1.69 x10-3 1.30x10-8 -8.0 
Table 3-6: Calculated binding constants for T15-TBA with Low coverage 
 
The aggregation kinetics for the PEG-backfilled samples yields the following results: 
[thrombin] k’1 kx Goodness of the fit (r2) 
121nM 0.06772 0.2728 0.9222 
61nM 0.1102 0.3714 0.7998 
38nM 0.2081 0.5287 0.9331 
Table 3-7: Kinetic binding constants for PEG backfilled NR-T15-TBA 
 
 
Figure 3-21: PEG Backfill kinetics at differetn thrombin concentrations 
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koff (1/s) Kσ (M) 
W 
(kJ/mol) 
121nM 9.33 x103 2.06x10-5 2.21x10-9 -12.4 
61nM 3.01 x104 6.65x10-5 2.21x10-9 -12.4 
38nM 9.13 x104 2.01 x10-4 2.21x10-9 -12.4 
Table 3-8: Calculated kinetic binding constants for PEG-backfilled NR-T15-TBA 
 
3.3.4. Conclusions 
We have been able to find a kinetic model to explain the mechanism of the biomolecule 
induced assembly of nanoparticles, by assuming that the system kinetics do not change 
after every subsequent NR addition to form the aggregate. We have as well assumed that 
the rate-determining step during the assembly is not the thrombin-TBA recognition, but 
the assembly of thrombin molecules to different NRs.  
The kinetic model has been probed as a function of thrombin concentration and different 
surface chemistries of NR, in order to observe mechanism differences between the 
samples. We have seen that the kinetics can be tuned by changing the surface chemistry 
of the particles.  
By using the binding constants calculated in the previous chapter of this thesis, we can 
calculate the constants of formation and dissociation of the aggregates. The assembly 
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process is slower than if the molecules were not bound to NRs, and the disassembly 
shows values of similar orders of magnitude to the binding in solution. Surface chemistry 
plays an important role in the kinetics of NRs assembly, and we have shown that as the 
surface becomes more crowded with molecules, the binding process is slower due to the 
molecular reorganization required. 
Also, different concentrations of thrombin added show that the size of the aggregates 
depends on the available thrombin in solution. Also, the rate constants for different 
concentrations of thrombin added have been calculated. The results indicate that the 
interactions of thrombin with TBA when it is bound to a surface are slower than the 
rates that would be obtained with thrombin and TBA both free in solution. This 
demonstrates that surface effects can significantly impact biomolecular interactions. We 
have observed a 1000 fold difference in the association process, and a 10-1000 fold 
difference during the dissociation. 
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3.4. Reversible nanomachinery at the nanoparticle-biomolecule 
interface 
With the combination of biology and nanotechnology it is possible to develop devices 
smaller and more efficient than the ones currently available. Such nanodevices can be 
used to manipulate atoms and molecules at the cellular level, with huge sensitivity and 
selectivity. Gold nanoparticles conjugated with biomolecules can be used for sensing 
applications to detect proteins in contact with their surface[40, 48, 54, 55]. Also, 
nanodevices that cycle though states of assembly have been explored for a number of 
applications, such as drug delivery[55-57]. 
In particular, the thrombin-TBA interaction has been studied in solution and it is highly 
specific and reversible, and may be viewed as a nanomachine that cycles though assembly 
states after the addition of thrombin and DNA strands. Interfacing this nanomachine to a 
gold nanoparticle surface enables for quantification of the interactions at the 
nanoscale[58]. Thrombin binding aptamer can bind to thrombin at either exosite I or II, 
the interaction of thrombin to TBA-conjugated NRs results in NR self-assembly[59] that 
can be reversed after the addition of the complementary DNA sequence (AntiTBA) of 
the TBA (Fig. 3-22).  
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Figure 3.22: Thrombin-TBA nanomachine 
 
In this reversible nanomachine, TBA binds and releases thrombin after the addition of 
the AntiTBA. However, when interfacing biological nanomachines to nanoparticles, it is 
necessary to understand a number of interactions that can be produced in the surface of 
the particles. 
3.4.1. Theoretical 
From a thermodynamic perspective, the competitive binding of DNA and thrombin on a 
gold nanorod surface conjugated with TBA can be pictured as a disassembly process, in 
which the addition of the complementary DNA sequence of the TBA competes with the 
thrombin to bind to TBA. This can be represented as an equilibrium between an 
aggregated and a disaggregated state, which is states 1 and 5 from figure 3.23.  
Therefore, disaggregation can be described in terms of the binding efficiency for one 
TBA, θ[113] : 
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(Eq.3.31) 
Where Θ is the binding efficiency of the NR-TBA receptor as a whole, Kσ  is the 
equilibrium association constant of the TBA-antidote-thrombin competitive binding 
confined at the NR surface and [anti] is the equilibrium concentration of antidote in 
solution. 
TBA-thrombin and TBA-Antidote binding is confined on the NR surface, so the overall 
Gibbs free energy of the reaction is comprised of both a chemical and a surface 
contribution. The chemical contribution is related to TBA-thrombin and TBA-antidote 
binding, whereas the surface contribution describes the work spent in accommodating the 
thrombin and the DNA on the surface and for the concomitant nanoscale rearrangement 
of the bound and adjacent TBA molecules[8, 12]. The overall surface effect on 
aggregation can be understood if we construct a thermodynamic cycle that goes from the 
free state (state 1) to the aggregated state (state 5) that is broken down into four 
hypothetical steps (Fig. 3.23). The first step describes the release of TBA bound to 
thrombin from the NR to the (bulk) solution (from 1 to 2), the second step the TBA-
thrombin recognition in solution (2 to 3), the third the DNA-DNA interaction (3-4), and 
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Figure 3.23: Thermodynamic cycle of NRs disassembly 
 
 (Eq.3.32) 
Where the Gibbs free energy of the release and binding are the surface work 
contributions, 
 (Eq.3.33) 
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(Eq.3.34) 
We can substitute these equations in eq. 6-33: 
 
(Eq.3.35) 
We may substitute Eq 6.35 in Eq. 6.31, and obtain the modified Langmuir equation that 
can be used to fit our data and obtain the surface contributions on the DNA induced 
disassembly of NR aggregates: 
 (Eq.3.36) 
3.4.2. Results and discussion 
By optical absorbance it is possible to observe the assembly of gold nanorods conjugated 
with TBA after the addition of thrombin, and the disassembly after the addition of Anti-
TBA. 
After the addition of thrombin, one can observe that the aggregation of the particles 
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antiTBA was added in the solution, and one can see that the value of aggregation returns 
to 1, indicating that the assembly of the particles was reversed.  
 
Figure 3-24: Reverisble assembly of NRs after the addition of thrombin and anti-TBA 
 
It is possible to add different amounts of AntiTBA to the solution and observe that as 
the concentration of AntiTBA decreases, the rate of disassembly is slower. 
Addition of AntiTBA 
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Figure 3-25: Disassembly of NRs after antidote addition 
 
3.4.3. Conclusions 
We have seen that the assembly of NR after thrombin addition can be reversed with the 
addition of the AntiTBA. Different concentrations of AntiTBA have been added to the 
particles. As this is a work in progress, more data needs to be obtained in order to have 
concluding results for the disassembly of NRs after the addition of the TBA’s 
complementary DNA sequence. Future work includes a thermodynamic and kinetic study 
of the TBA-thrombin-TBAAnti nanomachines. 
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3.5. Quantifying DNA hybridization at the nanoparticle interface 
 “DNA not only directs the synthesis of proteins and the development of the cell, but it is 
also the substance that is copied to enable a similar development of the progeny of that 
cell”3[60]. The introduction of DNA in cells as new material is a promising tool to treat 
difficult diseases; however, it is necessary to carry the DNA to the cells so that every cell 
suffering from a non-functional group can be cured. Currently, the use of gold 
nanoparticles for gene therapy vectors has received much attention. Therefore, it is 
necessary to understand the interaction that the DNA has with the particles. Some 
studies have already been able to elucidate the interaction of DNA with nanoparticle 
surfaces [10, 45, 47, 61, 62].  
Also, the ssDNA-ssDNA interaction is highly attractive for nanomachines due to its high 
specificity and reversibility. Therefore it is not surprising that since the development of 
nanotechnology, many researchers have started investigating the applications of DNA at 
the interface. 
Although the DNA hybridization has been widely studied in solution, a few studies exist 
on the hybridization of DNA on surfaces, where the interactions between neighbouring 
                                         
3 Kornberg’s Nobel Lecture, in 2006 
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DNA sequences and between the surface and the DNA play an important role in the 
DNA hybridization at the interface[3].  Due to the size of nanomaterials, the surface 
dominates their behavior. The distribution of the DNA on the surfaces can vary with the 
curvature of the particles [10, 50, 51]. Also, DNA can stick on the NR surface, preventing 
it from hybridizing to its target. Nanoparticles have charges or can be coated with 
ligands that affect the interactions between the biomolecules at the interface. Some work 
on the conformation of DNA on gold nanosphere surfaces has already been done in 
Hamad-Schifferli’s group[33, 61]. 
Here, we develop a thermodynamic treatment to quantify the surface effects on the DNA 
hybridization. This thermodynamic treatment allows for quantitative description of the 
interface effects. We probe how the interaction is influenced by the nanoparticle’s 
curvature and surface chemistry and the DNA coverage and spacer length.  
3.5.1. Theoretical 
The hybridization of fluorescently tagged DNA on the NRs’ surface results in fluorescense 
resonance energy transfer (FRET) from one of the fluorophore tags (FAM) to the other 
(TMR), as sketched in figure 3.26.This can be represented as the equilibrium between a 
free and an bound state.  
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Figure 3-26: DNA hybridization on the NRs surface 
 
Where the red DNA sequence would be tagged with TMR (not shown in the drawing for 
simplicity), and the blue DNA sequence would be tagged with FAM. One can observe 
that the fluorescence signal will decrease when the complementary DNA sequence is 
bound to the NPs, due to proximity of the two fluorophore tags. We can subtract the 
signal at 80ºC (complementary DNA sequence is free in solution) from the signal at 25ºC 
(complementary sequence of DNA is bound to the particles) and obtain a plot that shows 
the unbound DNA as a function of antidote concentration added. Instead of measuring 
the DNA fluorescence increase at 80ºC, it would be possible to measure the fluorescence 
in the presence of MHA-NR, where no hybridization could occur. It is necessary to 
compare with NRs in solution as NRs can absorb FAM’s emission.  
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Figure 3-27: FRET curve at 25ºC and 80ºC 
 
One can fit the Langmuir isotherm introduced in Chapter 3.2.1.1: Langmuir Isotherm, in 
order to find the binding constants of the DNA on the surface of the particles. 
 (Eq.3.37) 
Where qe is the coverage of the adsorbate molecule on the particles, Q is the maximum 
number of A molecules that can theoretically be absorbed on the surface, and b is 
designated as the binding efficiency term. One can perform numerical fits of adsorption 
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Also, the melting temperature of the DNA can be measured by slowly heating the NR 
sample with DNA hybridized, and measuring the inflection point of the sigmoidal curve 
fitted to the data points. 
3.5.2. Results and discussion 
We can observe that by using different surface chemistries on the particles, the 
hybridization thermodynamics will be different. We will measure the fluorescence at 
25ºC, when the DNA is hybridized on the surface of the particles, and compare it to the 
fluorescence at 80ºC, when all the DNA is free in solution.  
  
We know that the fluorescence of our fluorophore tags is low compared to the change in 
fluorescence increase after the DNA us unbound.  
For different surface chemistries, we can observe different constants in the Langmuir 
fitting of the curves. This enables us to compare among experiments. Note that the 
following results are preliminary data, and only give an idea of the hybridization with 
different surface chemistries and sizes of the particles. 
freetotalbound DNADNADNA −=
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Figure 3-28: DNA hybridization on high coverage NCs 
 
 
Figure 3-29: DNA hybridization on high coverage NRs 
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Figure 3-30: DNA hybridization on TBA NRs 
 
 
Figure 3-31: DNA hybridization on mid-Coverage NRs 
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Figure 3-32: DNA hybridization on Low-coverage NRs 
 
Sample Q b (1/nM) DNA attached 
DNA/NP 
High Coverage NCs 1.941 5.499x10-3 137 
High Coverage NRs 2.058 9.807x10-3 173 
Mid-Coverage NRs 2.872 6.006x10-3 122 
Low-Coverage NRs 1.182 8.889x10-2 35 
TBA-NR 2.595x102 3.76x10-5 265 
Table 3-9: Compared values of DNA hybridization on different surfaces 
 
We can observe that the binding efficiency of the complementary DNA sequence in long 
capsules is higher than in the shorter NRs, while Q (theoretical maximum amount of 
DNA that can be absorbed) remains constant. The particles conjugated with DNA 
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without a T15 spacer show a higher theoretical amount of DNA absorbed, which could be 
due to a higher coverage on the surface as compared to the particles conjugated with the 
DNA sequence with High Coverage. The three NRs samples with increasing coverage of 
DNA show a higher binding efficiency as the coverage of the attached DNA increases, 
and a lower Q as the coverage decreases.  
We can also measure the melting temperature of the DNA on the surface of the particles 
(Fig. 3-33). The melting temperature of the DNA on the surface of the particles is 39ºC, 
which is lower than the melting temperature that the free 15mer would have in solution 
(which has been calculated to be 49ºC). A possible explanation might be that the 
increase in the melting temperature is due the DNA not being able to completely 
hybridize due to the proximity of the surface.  
 
Figure 3-33: Sigmoidal fit for the DNA hybridization (r2=0.998) 
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3.5.3. Conclusions 
We have been able to find the surface binding efficiency of DNA on the surface of gold 
nanorods, for different surface chemistries of the NRs. and the compare the surface effects 
of the DNA hybridization, as well as being able to see the melting temperature of the 
DNA when hybridized on the surface of a particle. This is work in progress; therefore, 
some experiments need to be performed in order to find reliable results for the 
hybridization of DNA on surfaces.  
So far, we have observed that the surface chemistry, as well as the size of the 
nanomaterials plays an important role in the hybridization of the DNA on them. Note 
that the results are not concluding, and more experiments need to be performed. 
However, it seems that the binding efficiency increases with lower coverage on the 
particles, and it is lower with longer particles. This could be explained as in the longer 
particles there is a higher area of flat surface that would hinder the DNA from 
hybridizing. We have also observed a very high Q (theoretical maximum amount of the 
complementary sequence that can be absorbed) for the particles without a T15 spacer  
that could be explained by the higher coverage of DNA on these samples. 
Further experiments include comparing the DNA hybridization with spherical particles, 
in order to be able to observe the radius of curvature dependence on hybridization, and a 
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new method to obtain more accurate fluorescence readings. Also, the hybridization of 
DNA on particles with a PEG backfill and a HSA block should be performed. 
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3.6. Conclusions 
In this work, we have discussed the effects that biological nanomachines have in the 
interface with NRs surfaces. We have both studied the hybridization of DNA on surfaces, 
and the assembly of NRs induced by the presence of a binding biomolecule –in our case 
thrombin-. We have studied the thermodynamics of the assembly and disassembly of 
NRs.  
We have introduced a model to explain the thermodynamics of NRs assembly in the 
presence of thrombin. This model is completely general and enables for the calculation of 
the surface work that is produced on the NRs surface during the assembly process. By 
using this approach, we have been able to study the interfacial effects on NRs with 
different surface chemistries. Also, the kinetics of the binding process has been 
introduced. We have used a simplified model to explain the kinetics of NRs assembly, 
and we have described the basics to formulate a more accurate method to explain the 
assembly mechanism. Also, a model to explain the NRs disassembly after the addition of 
TBA’s complementary sequence has been introduced.  
DNA hybridization in the interface has been introduced. We have been able to describe it 
by using Langmuir’s approach of surface absorption. We calculated the binding efficiency 
of complementary DNA on the surface of NRs with different surface chemistries, and, 
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although more experimentation needs to be done to obtain more concluding results, we 
have observed a clear difference in the binding efficiency depending on the surface 
properties of the particles.  
All of these results help to quantitatively describe the physical properties of the interface 
of biomolecules with nanomaterials, which can aid applications in which nanomaterials 
are used for biological applications.   
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4. Release of covalently bound aptamers from NPs 
4.1. Introduction 
Phototermal therapy can be used for applications in which the control over the release of 
a biomolecule has to be controlled locally and externally[1, 2]. Selective release of 
multiple covalently bound species (ssDNA) has been demonstrated previously[3]. It has 
been shown that the release of a biomolecule can be accomplished by an external signal, 
such as laser irradiation[4-6]. Laser irradiation of NRs at their SPR leads to increased 
temperatures on the surface of the particles that can lead to melting, if the pulses of the 
laser are short enough[7], whereas continuous laser heating only leads to temperature 
increase on the surface of the particles without inducing melting[8]. By irradiating NRs 
at their SPR through fs laser irradiations, it is possible to release the thiolated DNA 
bound on the surface of the NRs. As it was explained in the introduction of this thesis, 
when the NRs are irradiated by a fs light at their SPR there is an increase of the surface 
temperature of the particles[9] that leads to a change in their shape[10], and also in the 
breakage of the gold-thiol bonds on the NPs[11]. 
We will use this approach in order to release of covalently bound thrombin binding 
aptamer (TBA). By exploring the conjugation and release of the thiolated TBA by fs 
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laser irradiation, it is possible to understand the degradation and activity loss of the 
TBA after it has been released from the NPs. One can expect a decrease in activity of 
the TBA, due to the high surface temperature that the NPs reach during the irradiation, 
which can be as high as 1000K[7, 9, 10, 12-14]. We are able to measure the activity of 
the TBA as a decrease of the expected effect in blood clotting time. We can also observe 
that the concentration of NRs necessary to achieve a high release of thiolated TBA is 
high, therefore, new ssDNA loading methods need to be studied.  
Both NRs and NBs absorb light in the infrared region of light (Fig. 4-1), where tissue 
absorption is minimal. Also, because the SPRs of NRs and NBs do not interact, it is 
possible to excite them selectively when NRs and NBs are mixed. SPR of NRs is at 
800nm, so they can be excited with a laser at 800nm; and the NBs can be excited by 
irradiation with a laser at 1100nm.   
 
Figure 4-1. Absorbance spectra of NRs (red) and NBs (blue). 
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By irradiating the NRs and NBs, we melt them, which can be observed by absorbance as 
a decrease in the SPR peak of the particles. Melting the NPs releases the DNA that is 
bound to the surface of the NPs. In order to quantify the released DNA, we will use 
fluorescently tagged DNA and measure its concentration by fluorescence spectroscopy. 
Therefore, if we start from a mixture of NRs and NBs, it is possible to irradiate the 
mixture at 800nm with a laser, melt the NRs only and release the DNA bound to the 
NRs (Fig. 4-2, red DNA). By irradiating at 1100nm, we can melt the NBs only and 
release DNA from the NBs (Fig. 4-2, blue DNA). 
 
Figure 4-2. Scheme of the selective release of thiolated ssDNA 
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4.2. Melting the NR-CTAB and NB-CTAB 
We first tested if it was possible to melt the NR-CTAB and NBs CTAB, and that it was 
possible to achieve a selective excitation of NRs and NBs with fs laser irradiations. The 
NRs could be selectively excited with a laser centered at 800nm (Fig. 4.3-blue line), 
because it coincides with a maximum of their SPR, and also with minimum in the 
absorption of the NBs. NBs could be selectively excited with a laser centered at 
1100nm(Fig. 4.3-red line), as it coincides with a maximum of the SPR of the NBs and 
with a minimum in the absorption of the NRs.  
 
Figure 4-3. CTAB-NRs and CTAB-NBs 
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4.2.1. Melting NRs and NBs at their SPR 
Next we tested the melting of the NRs at 800nm. Laser irradiation at 800nm of the 
CTAB-NRs (Fig. 4-4, black) for 15min induced a shape transformation of the NRs to 
spheres[10], which could be confirmed by a decrease of their absorption at 800nm, that 
could be observed the absorbance spectroscopy(Fig. 4-4, red). The NR concentration was 
1nM. 
 
Figure 4-4. Melting CTAB-NRs at 800nm 
 
Similarly, NBs (Fig. 4-5, black) were irradiated at 1100nm with a fs laser. Again, 
because the NRs had a SPR maximum at 1100nm, it was possible to melt them with the 
laser irradiation, as could be seen by a decrease of their SPR at 1100nm (Fig. 4-5, red). 
The NB concentration was 0.35nM. 
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Figure 4-5. Melting CTAB-NBs at 1100nm 
 
4.2.2. Control experiments with single NRs and NBs 
We then tested that the NRs would not melt at 1100nm. In order to do that, CTAB-
NRs (Fig. 4-6, black line) were irradiated at 1100nm, and the absorbance spectra of the 
NRs, was measured. We could observe that minimal melting of the NRs did happen 
(Figure 4-6, red), as the outcoming light from the laser had a linewidth of 400 nm. 
Nevertheless, melting was minimal, as the maximum SPR of the NRs was still visible, 
and only a small decrease in absorbance could be observed. 
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Figure 4-6. Minimal melting of the CTAB-NRs at 1100nm 
 
We performed a similar experiment with NBs-CTAB (Fig. 4-7, black) and irradiated 
them at 800nm. We could not observe melting of the NBs after the irradiation (Fig. 4-7, 
red), indicating that the 800nm laser beam was extremely monodisperse.   
 
Figure 4-7. No melting of the CTAB-NBs at 800nm 
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Because the 800nm laser is more selective than the 1100nm laser, we decided to use the 
800nm laser to release the TBA, and the 1100nm laser to release the antidote. Therefore, 
TBA will be bound to the NRs and anti to the NBs. 
4.2.3. Selective melting of a mixture of NRs and NBs 
Once we observed that selective melting of NRs and NBs by fs laser irradiations was 
possible, we confirmed that melting of the NRs and NBs could be selectively achieved 
from a mixture of NR-NBs. We introduced a mixture of NBs-NRs and irradiated them 
both at 800nm and at 1100nm.  
First, we prepared a mixture of CTAB-NBs and CTAB-NRs (Figure 4-8, black, before 
irradiation) and irradiated it at 800nm for 15min and observed the decrease of the 
800nm peak, the SPR of the NRs, indicating that only the NRs melted after laser 
irradiation at 800nm, and showing that the NBs did not melt after the irradiation 
(Figure 4-8, red, after irradiation). 
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Figure 4-8. Selective melting of CTAB-NR-NB at 800nm 
 
We then tested a mixture of NRs-CTAB and NB-CTAB (Figure 4-9, black, before 
irradiation) and irradiated it at 1100nm. We observed a decrease of the SPR of the NBs, 
showing that the NBs melted after the 1100nm irradiation, and the 800nm peak stayed, 
showing that the NRs did not melt after the irradiation (Figure 4-9, red). 
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Figure 4-9. Selective melting of CTAB-NR-NB at 1100nm 
 
Therefore, we have been able to observe melting of the CTAB-NRs and CTAB-NBs. We 
have seen that melting is selective and occurs only when we irradiate the NRs or NBs at 
their SPR. We have as well observed that selective melting is possible in a mixture of 
NRs and NBs. 
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4.3. Release of thiolated ssDNA from NRs 
4.3.1. Increasing the loading of thiolated TBA with intramolecular G-
quadruplexes 
As we observed previously, the 800nm laser is more selective than the 1100nm laser, so 
we decided to link the TBA to the NRs, and the antidote to the NBs. First, we tested if 
higher loadings of TBA on the NRs could be achieved by taking advantage of the fact 
that TBA can form intermolecular G-quadruplexes. By preparing covalent DNA 
conjugation with increasing concentrations of the TBA with and without the T15 spacer, 
we observed that TBA without the T15 spacer (Fig. 4-10, red) could form intermolecular 
G-quadruplexes that resulted in an increased loading of TBA on the nanoparticles. On 
the other hand, TBA that included the T15 spacer (Fig. 4-10, black) did not allow for the 
formation of the intermolecular G-quadruplexes and resulted in a lower binding to the 
particles, approaching a monolayer coverage -92 ssDNA/NR [15]-.  
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Figure 4-10. Loading of thiolated TBA with and without PolyT spacer 
 
Because the antidote does not have a sequence that could enhance its loading by 
intramolecular binding, it was not necessary to test if enhanced loading could be 
achieved. Therefore, we conjugated 5’-SH-GGTTGGTGTGGTTGG-3’ (SH-TBA) and 
5’-SH-T15-CCAACCACACCAACC-3’ (SH-anti) to MHA-NRs and MHA-NBs 
respectively.  
4.3.2. Aptamers and antidotes effect in blood clotting 
First, we tested that the thiolated TBA and the thiolated antidote could be used to 
control blood clotting (Fig. 4-11). In order to do so, we added increasing amounts of 
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thiolated TBA [0-2500nM], and measured tclot. Blood with no TBA added was 
normalized as tclot =1.0. We observed that as the thiolated TBA concentration increased 
blood clotting time increased as well, showing that the thiolated TBA could bind to 
thrombin (Fig. 4-11, left). We also added increasing amounts of thiolated antidote to a 
500nM solution of thiolated TBA, measured tclot and observed that as the SH-anti/SH-
TBA ratio increased, blood clotting time could be restored, showing that the thiolated 
antidote would form duplexes with the thiolated TBA and therefore inhibiting the 
binding of TBA to thrombin (Fig. 4-11, right).  
 
Figure 4-11. Effect of TBA in blood and effect of antidote on TBA 
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4.3.3. Melting and release of TBA from NRs 
We then tested the release of TBA from NRs by fs irradiation of the NR SPR (Fig. 4-
12). We observed NR melting, as evidenced by the decrease in the NR SPR peak, which 
increased with increasing laser irradiation time.  
 
Figure 4-12. ABS spectra of 5nM TBA-NRs at increasing irradiation times 
 
Next, we measured the concentration of TBA that was released at increasing irradiation 
times (Fig. 4-13). We could see that as the NRs were melted (as could be seen by a 
decrease of their SPR), the release of TBA increased until reaching a plateau at 20 min 
irradiation, suggesting that longer irradiation times were not necessary in order to obtain 
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an enhanced release of TBA. Obviously, irradiation times depended on the concentration 
of nanoparticles from where the release should be done. Higher concentrations of NRs 
required irradiation for longer times than lower concentrations of NRs.  
 
Figure 4-13. TBA release as a function of irradiation time 
 
We then tested the effect of released TBA through from the gold nanorods. In order to 
do that, we covalently conjugated thiolated TBA to NRs, and irradiated a 11.22nM 
solution blocked with HSA (see Chapter 2: Materials and Methods). As observed in the 
absorbance spectra (Fig. 4-14), after the 30 min under the 800nm irradiation, the NRs 
melted.  
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Figure 4-14. ABS spectra of TBA-NRs irradiated for 30 min 
 
After irradiation the supernatant was collected, and the fluorescence of the supernatant 
was measured. We could release 1460nM TBA from the 11.22nM NR-SH-TBA solution 
coated with HSA, which corresponds to 130.4 TBA released per NR. (Fig. 4-15)   
 
Figure 4-15. TBA release as a function of irradiation time 
Helena de Puig Guixé 
Mechanical Engineering MS Thesis 
MIT 
 
4. Release of covalently bound aptamers from NRs                                                                                                             
 
199
In order to test the functionality of the TBA after the laser irradiation, we introduced 
the released DNA in blood and tested the blood clotting time, and compared to 
undamaged SH-TBA. We indeed observed that there was a loss of functionality on the 
TBA, and that the TBA had a 64% activity, as compared to the theoretical value of the 
clotting time. Released TBA from NRs yielded an increase in clotting time of 1.18, which 
was equivalent to 959nM undamaged TBA (Fig. 4.16). 
 
Figure 4-16. Functionality of the released TBA 
 
4.3.4. Effect of NPs in blood clotting time 
We also tested the effect of the presence of NPs directly in blood. 12nM NRs with 
different surface chemistries were introduced to blood, and clotting time was monitored. 
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We could observe that the presence of NPs increased normal blood clotting time (Fig. 4-
17, dashed line). NRs without DNA payloads  (NR-MHA) increased clotting time by 
23%, while NRs that were coated with thiolated T15-TBA, caused an increase in tclot of 
27%, and thiolated TBA caused an increase of 30% in tclot. We can observe that the 
increase in clotting time due to the presence of TBA was only a 5-7%. If particles were 
blocked with HSA before the addition into blood, the increases in clotting time resulted 
13% and 17% for thiolated T15-TBA and thiolated TBA respectively (Fig. 4-17). 
 
Figure 4-17. Effect of thiolated TBA-NRs in blood 
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4.4. Release of dsDNA from NRs 
It has been observed that by continuous laser irradiation (CW laser), it is possible to 
heat the NRs without melting them[6, 16], but still release species on the surface that are 
not covalently linked. We decided to test the dehybridization of dsDNA on the surface of 
NRs though heating the NRs by CW laser irradiation. Dehybridization of DNA on NP 
surfaces has been previously studied[17]. Also, in Chapter 3.4, on the hybridization of the 
DNA on the NPs, we measured the melting temperatures of the DNA bound on the 
surface of NPs. We see that by CW laser irradiation, the surface temperature of the NRs 
will need to reach at least 39ºC for the dehybridization to occur (Chapter 3, Fig. 3-33).  
We hybridized TBA (Fig. 4-18, red ssDNA) with thiolated T15-antidote (Fig. 4-18, bue 
ssDNA), and bound the dsDNA to the NRs by thiol conjugation. By heating the NRs 
with a CW laser centered at 800nm, we were able to dehybridize the TBA from the 
NRs- thiolated T15-antidote (Fig. 4-18). Loading on the NRs was lower than monolayer 
coverage of ssDNA, due to the larger size of dsDNA[15]. 
 
Figure 4-18. Scheme of CW irradiation 
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We irradiated a 0.8nM solution of the NRs with a CW laser, and measured the release 
after 1min and 5min irradiation. We confirmed that the NRs did not melt by observing 
that their absorbance spectra was the same before and after irradiation (Fig. 4-19).  
 
Figure 4-19. Absorbance of CW irradiated NRs 
 
We could measure 12nM thiolated T15-antidote and 63.4nM TBA released from the NRs 
after 1 min irradiation, reaching 22% and 40% payload release, respectively; and 10nM 
thiolated T15-antidote and 60nM TBA after 5 min irradiation, showing that irradiation 
times longer than 1 min were not necessary to achieve release. The percentage of DNA 
released was approximately double for the TBA than the thiolated T15-antidote, 
indicating that TBA was preferentially released (Fig. 4-20). Thus, at these laser powers 
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and irradiation times, dehybridization of the DNA was favored over breakage of the thiol 
bond. 
 
Figure 4-20. Released TBA and thiolated T15-antidote after 800nm CW laser irradiation 
 
Although CW laser irradiation can be used to release species on the NRs, the selectivity 
of the release is not as good as for ssDNA conjugated NRs excited by the fs laser.  
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4.5. Conclusions  
It is possible to selectively melt NRs and NBs, both separately and in mixtures. We 
observed a small melting of the NRs after the 1100nm irradiation due to the linewidth of 
the output of the 1100nm laser. Therefore, we decided to bind the TBA to the gold 
nanorods, to obtain a very specific on switch to control blood clotting, and bind the 
antidote on the NBs, that will be excited with the 1100nm laser. We can increase the 
loading of TBA on gold nanorods, by taking advantage of the intramolecular G-
quadruplex structure of TBA. Nevertheless, we have observed that the concentration of 
NPs in order to release the amount of TBA necessary to control blood clotting is very 
high, and this leads to several disadvantages. First, a 12nM solution of NRs is very dark 
and viscous. It absorbs light very strongly, and does not enable for a high yield of release 
of the bound TBA. Second, we were able to observe that the functionality of the TBA 
after the laser irradiation was only 64%. In order to overcome these two limitations, we 
decided to further enhance the amount of TBA bound on the particles, and consequently 
enable the use of nanoparticles at a lower concentration. We decided to use protein 
coronas to enhance the loading on the NRs and NBs.  
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5. Increasing loading capacity: NR coronas 
5.1. Introduction 
When NPs are introduced to biological fluids such as media, serum, and blood, coronas 
made of proteins and other small biomolecules form on the NP surfaces. Since the 
protein corona is the last layer on the NP surface, it gives the particles a biological 
identity[1, 2], as it is the layer that will ultimately interact with the biological system. 
The protein corona is multi-layered, and formed by non-covalent interactions, with a 
gradient of binding energies [3]. The properties and composition of the protein corona 
change with time[4], therefore, it is difficult to characterize and predict[5]. The protein 
corona masks the surface of the NPs, and therefore can prevent the interaction of 
antibodies, ligands or aptamers attached to the NPs[6, 7]. Many have tried to modify the 
surfaces of the NPs, to give them non-fouling properties, however, so far the corona 
formation is inevitable.  
Important advances in understanding corona composition and behavior have been 
made[5, 8]. While the particles have varied in different studies, the key finding is that 
certain classes of proteins bind strongly to the NPs making up the “hard corona,” while 
others have a weaker interaction with the surface, forming the “soft corona”[3, 9]. Serum 
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albumin does not form the bulk of the corona surrounding a NP in serum despite being 
the most abundant species. Because the corona completely masks the surface of the gold 
nanoparticles, there is no need for CTAB exchange, as the corona covers it[10]. These 
advances in understanding protein corona enable us to manipulate its properties and 
optimize it for a particular biological application.  
Because protein coronas are large and multi-layered, they have a high capacity for 
loading payloads that interact with the proteins in the corona[10]. In the case of gold 
NRs, the protein corona can have a capacity 6x higher than would be accomplished by 
covalent binding. Thus, NR-coronas are unique carriers with enhanced physical and 
biological properties for improving delivery. However, different modes of payload release 
are desired depending on the delivery application; in this study we aim to have no 
release of the payloads until there is an excitation by a laser source. However, in some 
applications it is interesting to achieve a specific passive release profile of the payload. In 
this chapter, we will map the passive release rates of ssDNA from protein coronas, as 
well as understanding and minimizing leakage until the laser irradiation triggers the 
release of the ssDNA.  
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5.2. Characterization methods for NR-coronas 
We formed and loaded coronas around three types of NPs: CTAB coated gold NRs, NBs 
and CNTs, using serum proteins. The payload was a 20 base long DNA oligo tagged with 
a fluorophore (sequence 5’ CAG CGT GCG CCA TCC TTC CC -TMR), as it does not 
have a secondary structure, as compared to TBA. Coronas were formed around the NRs 
using a previously published approach [10]. In summary, we achieved loading of ssDNA 
on the NR-coronas by incubating the payload either with the NPs and serum proteins 
simultaneously (combined assembly) or after the NP-coronas were formed (sequential 
assembly) (Fig. 5-1). 
 
Figure 5-1. Scheme of combined and sequential assembly 
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NR-coronas were characterized by a number of techniques, namely, TEM, DLS, Zeta 
potential and absorbance spectroscopy. Loadings were calculated by either (1) heat 
displacement of the ssDNA from the NR-coronas or (2) by measurement of the unbound 
ssDNA (supernatant loss), and measured by fluorescence spectroscopy of the fluorophore 
tags on the ssDNA. 
Optical characterization of both NR-HS-DNA (Fig. 5-2, top) and NB-HS-DNA (Fig. 5-2, 
middle) showed that the longitudinal surface plasmon resonance (SPR) of the NRs was 
still visible, with a minor red shift and slight broadening over the CTAB-NRs (Fig. 5-2, 
top). Red shifts and broadening of the SPR indicates that the NRs and NBs are 
clustering close to one another as the corona is formed. Both CNT-HS-DNA and CTAB-
CNTs, however, showed absorption spectrum typical of Mie scatterers due to the lack of 
SPR in CNTs (Fig. 5-2, bottom).  
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Figure 5-2. Absorbance spectra of the protein coronas 
 
TEM images of all three types of NP-HS-DNA show a large, diffuse agglomerate 
containing many NPs, confirming that there is not one but many NP in a corona (Fig. 5-
3).  
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Figure 5-3. TEM images of NR, NB, CNT and CoNR, CoNB, CoCNT 
 
Zeta-potential measurements of all three positively charged NPs show that as the NP-
corona are formed; they adopt a negative charge (Fig. 5-4, bottom) due to the negative 
species that compose HS. DLS showed that when coronas are formed of HS, a larger 
species results. NRs have a DH = 32 ± 15 nm which increases to DH = 553 ± 33 nm 
with HS corona formation. The increase in DH is also observed for NBs and CNTs (Fig. 
5-4, top). These size increases suggest that HS can form large coronas around a cluster of 
multiple NPs.  
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5.3. Optimizing the protein corona 
5.3.1. Different binding strategies and proteins 
We first tested the formation of protein coronas using human serum (HS), human serum 
albumin (HSA) and equine serum (ES). The composition of the protein corona around 
nanoparticles of polymers, silica, gold, and other materials has been characterized by 
mass spectrometry and other techniques. It has been found that opsonins and 
apolipoproteins (ApoA1, etc.) bind strongly to the NP to constitute the “hard corona” 
[11] and are difficult to be removed. Surprisingly, the corona surrounding NPs does not 
have a high abundance of albumin, despite albumin making up nearly half of human 
serum. Instead, some studies have observed that human serum albumin (HSA) binds 
weakly to the NPs[12-14], making up the “soft corona.” Corona composition varies with 
particle type, size, and surface chemistry[15], but in general, these two classes of corona 
proteins are generally observed. 
We prepared protein coronas using the combined approach (CoNR) and the sequential 
approach (SeNR). We could observe that the particles behave differently depending on 
the type of protein added and the preparation method. In figure 5-5 we can observe the 
CoNR prepared with HS, ES and HSA (from left to right).  
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Figure 5-5. Variation of the corona components 
 
For each of the corona formation strategies and proteins we measured both the 
absorbance of the particles and the DNA loading per NR. The combined loading strategy 
consisted in preparing 1mL of 1nM NRs, and after centrifugation, resuspending the 
remaining 20µl of concentrated NRs into 1ml of 1µM ssDNA, 5%HS and 5mM PB. 
 
Figure 5-6. Absorbance of NR-coronas 
 
In the combined approach, we can observe that the CTAB-NR (Fig. 5-6, black), are not 
aggregated, and after the addition of proteins + ssDNA, there is aggregation of the 
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particles (seen as a decrease in the absorbance ratio ABS800/ABS400). Initially, the NR-
CTAB had an absorbance ratio of 4.4±0.17 and a SPR peak at 796±5.7nm (Fig. 5-6, 
black). We could observe that HSA was the protein that caused the lowest aggregation 
on the particles showing an absorbance ratio of 3.08±0.28, and SPR max at 783±5.2 
(Fig. 5-6, red), while HS is responsible for the highest aggregation with an absorbance 
ratio of 1.77±0.32, and SPR max at 808±9.5 (Fig. 5-6, green). As for equine serum, the 
absorbance ratio was 2.48±0.79, and SPR max at 796±10 (Fig. 5-6, blue). With all three 
loading coronas, the SPR is still visible, which indicates that it is still possible to excite 
the NPs with a laser. 
We also prepared the protein coronas by using the sequential approach. In order to do 
that, 1ml of 1nM NRs, were centrifuged and resuspended in 5% serum proteins, 5mM PB 
and incubated for 4h at 37ºC. After, NR-Coronas were washed twice in 5mM phosphate 
buffer, and resuspended in 1uM ssDNA, followed by overnight incubation at 37ºC. 
Helena de Puig Guixé 
Mechanical Engineering MS Thesis 
MIT 
 




Figure 5-7. Absorbance of SeNR 
 
By sequential loading, all the NRs had similar absorbance ratios. HSA-NRs had an 
absorbance ratio of 2.41±0.18, and a SPR peak at 777.5±6.36nm (Fig. 5-7, red). HS-NR 
had an absorbance ratio of 2.17±0.05 and the SPR peak was at 805±5.66nm (Fig. 5-7, 
green). Finally, the ES-NR had an absorbance ratio of 2.36±0.03 and an SPR peak at 
805±18.4nm (Fig. 5-7, blue). 
We then measured the loading on the NPs by supernatant loss -centrifuging the particles 
and measuring the amount of DNA that was not bound in order to calculate an 
approximate loading on the particles-. DNA concentration was measured by fluorescence 
spectroscopy of the fluorophore tag bound to the ssDNA. Measuring ssDNA loadings by 
supernatant loss showed similar results for all kinds of coronas (Fig. 5-8), but 
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overestimates the loading on the NRs, as ssDNA could be potentially released during the 
subsequent washes of the NPs. 
 
Figure 5-8. Loading from coronas as measured by supernatant loss 
 
In order to confirm these results, we also heated the conjugated NRs at 90ºC for half 
hour and measured the fluorescence of the tagged ssDNA that could be released by heat 
displacement. While high temperature is able to disassemble the corona to release both 
HS and DNA, we note that heating does not displace the entire payload in the corona as 
was found previously[10]. Also, the amount of serum and payload released by heat 
displacement changes with time and underestimates the DNA loading. A more accurate 
quantification would require combining several techniques including chemically dissolving 
the NPs, displacing the proteins in the corona by detergents, etc.  However, we have 
found thermal displacement to give consistent readings if the conditions are kept the 
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same, hence all measurements were done consistently to allow comparison. While HS, ES 
and HSA can form a corona around NPs, their ability to carry a DNA payload are very 
different. We note that the error bars are large compared to covalent attachment 
strategies, due to the complex nature of corona formation, as it involves non-covalent 
interactions between multiple species and it can undergo a constant dynamic exchange 
with its surrounding media. 
 
Figure 5-9. Loading of NR-coronas measured by heat displacement 
 
We observe that both the ES and HS can yield high loading of payload on the NPs 
(>400 DNA/NP, Fig. 5-9), as they are comprised of mixtures of proteins, some of which 
are strong binders to the NPs. In contrast, we can observe that the HSA does not yield 
high loadings of ssDNA on the NPs (~0 DNA/NP), showing that even if HSA is in high 
concentration in serum, it is not a strong binder to the NRs, and confirms that HSA 
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does not bind strongly to the NRs, and it forms the weak corona. Even though a corona 
still forms, as evidenced by the increase in size by DLS (Fig. 5-10), the corona formed 
from HSA is clearly not suitable for loading DNA. Based on these results, it appears that 
other components in the HS, rather than HSA, are responsible for holding the corona 
and DNA payload together.  
 
Figure 5-10. DLS of coronas formed with HS, ES and HSA 
 
Initially, NR-CTAB have a DH of 32nm, which increases after proteins start to form the 
corona around the NRs. NR-HS have a DH of 865nm, and NR-HSA have a larger DH 
(1138nm). In both cases, when the ssDNA is loaded with the HS, DH decreases yielding 
553nm and 1033nm for the NR-HS-ssDNA and NR-HSA-ssDNA, respectively (Fig. 5-10), 
indicating that the ssDNA and the proteins could be competing for the positively 
charged surface of the NPs.  
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5.3.2. 5/5/5 Optimal Conditions 
We can further optimize the loading of ssDNA on the HS-loaded coronas by tuning the 
phosphate buffer (PB) concentration, CTAB concentration and HS concentration in the 
preparation solution. Tests were performed using the combined approach, as it gives 
more consistent loadings on the coronas, and with Human Serum (HS) as human serum 
proteins are already present in blood, and it enables for enhanced loading, as compared 
to HSA and ES. 
5.3.2.1. Effect of phosphate buffer 
We explored the effect of environmental factors on the loadings of NR-coronas. It has 
previously been shown that ssDNA loading varies with [PB], so charge screening of the 
electrostatic interactions between the DNA, corona proteins, and NRs can impact how 
much DNA is loaded. We prepared protein coronas with increasing concentrations of PB, 
and observed that 5mM PB is the optimal concentration in order to achieve a high 
loading of ssDNA on the protein coronas (Fig. 5-11). 
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Figure 5-11. Loading of CoNRs, as a function of [PB] 
 
We could also observe that the aggregation of the particles was dependent on the PB 
concentration. Increasing the PB concentration led to more stable particles, while 
decreased PB concentrations led to larger aggregates, as increased salt concentration 
leads to a diminished Debye length. We can observe in figure 5-12, in which the 
concentration of PB varies (from left to right) from 10mM PB, 20mM PB and PBS. 
However, large aggregates could be resuspended by sonication of the particles for 3min. 
 
Figure 5-12. Stability of NR-coronas in different buffer strengths and buffers. 
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5.3.2.2. Effect of CTAB concentration 
Since the positively charged CTAB is weakly bound to the NR/NB/CNT and can exist 
freely in dynamic flux with the CTAB on the NP’s surface, the free CTAB can interact 
and form complexes with both DNA and the negatively charged corona proteins and be 
intimately involved either in facilitating corona formation on the NP surface or even 
avoiding it due to the possible formation of these new stable micelles. The concentration 
of CTAB on the NR solution was varied as well. NRs were prepared in increasing 
concentrations of CTAB, and then centrifuged. The pellet was resuspended in 1ml of 
5%HS, 5mM PB; and the loadings of the particles were measured (Fig. 5-13). Initially, 
NRs were suspended in 0.5mM CTAB, 1mM CTAB, 5mM CTAB and 10mM CTAB, 
and the final CTAB concentrations in solution were approximately 0.01mM, 0.02mM, 
0.1mM and 0.2mM CTAB after the dilutions, therefore, in all cases, the final CTAB 
concentrations were lower than the critical micelle concentration (cmc) of CTAB 
(cmcCTAB=1.2mM[16, 17]), which indicates that no micelles of CTAB are present in the 
coronas. Thus, the only parameter that was varied is the concentration of free CTAB, 
and CTAB bound to the NPs. NRs are poorly passivated below the cmc, and well 
passivated above the cmc [10, 18]. Free CTAB plays a role in corona formation, at 
[CTAB] = 0.5 mM, which is below the cmcCTAB, there was poor loading arising from 
poor corona formation (Fig. 5-13). At 1 mM of CTAB, which is approximately the 
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cmcCTAB, loading of DNA was higher, and it continued to increase until a peak at 
[CTAB] = 5 mM. This shows that the concentration of CTAB can also be used to tune 
the loading of ssDNA on NR-HS-DNA.  
 
Figure 5-13. Loading of the NRs as a function of CTAB concentrations 
 
5.3.2.3. Effect of HS concentration 
The concentration of HS used in the corona formation and loading of DNA on the NR 
also appeared to affect the loading of payload. We varied the [HS] from 1 to 20% during 
corona formation and found that the loading was low at 1% HS and peaked at for 5% 
HS. At higher concentrations of HS, the loading decreased for 10%HS coronas, until it 
became negligible at 20% HS (Fig. 5-14), showing that it is possible to find an optimum 
for loading of ssDNA on the NR-coronas. At 1% HS, there is not enough serum to 
stabilize the coronas, and therefore loading is not achieved, and at 20%HS there may be 
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protein coronas (mostly negatively charged) that may be competing with the ssDNA to 
bind to the surface of the NRs. 
 
Figure 5-14. Loading of the NRs as a function of HS concentrations 
 
5.3.3  Effect of particle material on loading 
We tested different types of NPs and tested the loading that could be achieved by using 
the “5/5/5” (PB concentration (mM)/ CTAB concentration (mM) /HS%) optimal 
conditions, with the combined assembly approach. We chose NPs relevant for biological 
applications: gold nanorods (NRs), gold nanobones (NBs) and carbon nanotubes (CNTs).  
We could observe an increase in DH that indicated that the coronas were formed with 
the three types of particles (Fig. 5-4). Loadings per nanoparticle were measured as well. 
NB-HS-DNA had 710 ± 130 DNA/NB. This loading, as well as the loading density per 
surface area (give a 0.2 DNA/nm2) is lower compared to NR (777 ± 64 DNA/NR, 1 
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DNA/nm2) given the larger surface area per NB. CNT-HS-DNA had 17·105 ± 7·105 
DNA/CNT (Fig. 5-15). Even with normalization to the estimated larger surface area of 
the CNTs, this loading density (7 DNA/nm2) is much higher than what was achieved for 
the NRs and NBs. These results show that coronas can be formed and loaded with DNA 
on different NPs, though their actual surface area-normalized loading density differed. 
 
Figure 5-15. Loading of the NRs, NBs and CNTs 
 
All these results with different NPs show that the surface effects e.g. surface area and 
surface coating ligand play a dominant role in influencing corona formation and loading, 
as opposed to the identity of the NP material. We note that because the concentration of 
free CTAB in each of the NPs is difficult to control, the NRs, NBs and CNTs may have 
different concentration of free CTAB, which would explain the slight differences in 
loadings in each of the three types of NPs.  
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5.4. Kinetics of formation of the protein coronas 
By monitoring the kinetics of formation of protein coronas we were able to see a decrease 
in their AR, indicating that particles were interacting and coming within proximity of 
one another (Fig. 5-16). We also observed the appearance of an isosbestic point ~740nm 
during the corona formation, which indicated that throughout the reaction there was 
equilibrium between the particles in and out of the corona.  
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5.5. Leakage from the NR-coronas 
Because protein coronas are made of a number of non-covalent interactions, we tested 
the leakage from protein coronas after their formation. In order to do that, we measured 
the amount of ssDNA in the supernatant -released from the coronas- during a period of 
two weeks. Previously we found that by tuning the formation of the protein coronas it 
was possible to tune the loading on them. We found that it is also possible to tune the 
leakage from the protein coronas by changing the environmental conditions of the NPs.  
The first factor we examined to tune the passive release is the effect of free CTAB 
concentration around the NRs before the coronas were formed. As it has been previously 
commented, the CTAB exists in a state of dynamic flux between being free in solution or 
passivating the NP surface. The critical micelle concentration of CTAB is cmcCTAB = 1.2 
mM [16, 17]. We have observed that the NRs are poorly passivated below the cmc, and 
well passivated above the cmc [10, 18] suggesting that the free CTAB plays a role in 
corona formation (Chapter 5.3.2.2) and hence the passive release profile. At [CTAB] = 
0.5 mM, which is below the cmcCTAB, there was minimal passive release of DNA 
observed, due to poor loading on the coronas (Fig. 5-13). At 1 mM of CTAB, which is 
approximately the cmcCTAB, passive release of DNA was higher, and the release 
continued to increase until a peak at [CTAB] = 5 mM. This shows that the 
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concentration of CTAB can also be used to tune the passive release of DNA from NR-
HS-DNA (Fig. 5-17, top). Nevertheless, CTAB did not change the low release profile 
during the first 4 days. 
The concentration of HS used in the corona formation and loading of DNA on the NR 
also affected the passive release of payload. We varied the [HS] from 1 to 20% and found 
that the passive release after 15 days was low at 1% HS (300 ± 70 DNA/NR), before 
peaking at 700 ± 90 DNA/NR for 5% HS. At higher concentrations of HS, the passive 
released amount decreased (200 ± 140 DNA/NR for 10%HS coronas), where it became 
negligible at 20% HS (Fig. 5-17, middle). This non-monotonic passive release profile for 
[HS] is also similar to the loading profile from our earlier study (Chapter 5.3.2.3), where 
the loading also peaked at 5% HS and decreased with higher [HS]. This shows that the 
concentration of HS used to form the corona and load DNA can also be used to tune the 
passive release of payloads from corona. 
Previously we found that charge screening of the electrostatic interactions between the 
DNA, corona proteins, and NRs can impact how much DNA is loaded [10]. We thus 
expect that tuning [PB] and therefore charge screening will also affect passive release 
amounts. The non-monotonic passive release profile (Fig. 5-17, bottom) is similar to the 
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loading profile in our previous study, with peak passive release occurring at 5 mM PB, 
showing that charge screening influences the integrity of the protein corona. 
 
Figure 5-17. Leakage from NP-coronas, by tuning corona formation 
 
The coronas around NPs are known to change when the NPs are placed in different 
environmental conditions. We explored the effect of making the NR-HS-DNA coronas in 
one phosphate buffer condition, before placing them in a new condition with different 
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ionic concentration. NR-HS-DNA were formed in [PB] = 5mM and then release profiles 
were measured in [PB] = 1mM, 5mM, 10mM, and 1X PBS. The release profile in 1 mM 
and 10 mM PB (Figure 5-18, black and green respectively) showed the same initial 3 day 
lag for coronas made and released in 5 mM (Fig. 5-18, red). For example, coronas made 
in 5 mM and then released in 1mM have release profiles in between those exposed only 
to 1 mM (Fig. 5-17, bottom, black) and those exposed only to 5 mM (Fig. 5-18, red). 
This shows that when the coronas are formed in one PB concentration and then used for 
release in another, the release profile retains some of its original release properties. Thus, 
the corona has some resilience and can be maintained in different buffer solutions. The 
release profile in 1X PBS showed that the lag was gone (Fig. 5-18, blue), indicating that 
the increase in charge screening affected the corona integrity. 
 
Figure 5-18. Changing the PB after formation of coronas 
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We next tested the ability of hard and soft corona proteins to block and minimize 
passive release of DNA from the NR-coronas. As we have previously commented, HSA 
could be a good blocking agent, as it forms coronas on the NPs but is not able to hold 
payload. We formed NR-HS-DNA by combined assembly and attempted to “block” their 
surface with either HS or HSA. We compared passive release of the DNA from NR-HS-
DNA that were blocked by HS or HSA to NR-HS-DNA that were not blocked. Blocking 
was achieved by incubating NR-HS-DNA with additional HS or HSA, and then 
subsequent removal of free protein. Release from the blocked coronas was quantified by 
measuring the DNA in the supernatant as a function of time.  
In the absence of blocking, NR-HS-DNA show little release of DNA in the first 4 days 
(Fig. 5.19, a, black), but released increased afterwards, with a large release at Day 7. 
The initial 3 – 4 day lag was observed previously for NRs coated with coronas of equine 
serum[10]. This could be due to the gradual hardening of the corona with time after its 
initial formation [4], which tends to hold the payload and thus slow the release rate. This 
initial lag is beneficial for laser triggered release experiments, where the corona can be 
used to hold the payload within the first three days without significant passive release. 
The kinetics of the release changed with the use of different blocking agents on NR-HS-
DNA. If the NR-coronas were blocked with soft corona proteins HSA, the amount of 
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payload released was lower (Fig. 5-19, a, green) compared to release from corona in the 
absence of blocking. This indicates that there was little protein exchange between HSA 
and proteins in the HS corona, and that the HSA was able to block and thus minimize 
the passive release from the corona. However, if blocking was attempted using HS, 
significant protein exchange would occur between the free HS proteins and those in the 
corona, resulting in ineffective blocking and significantly higher release of payloads in the 
first 4 days (Fig. 5-19, a, red). In fact, around 20 % (264 ± 83 DNA/NR) of payload was 
passively released at day 1. This confirms our earlier postulation that there are other 
protein components in HS apart from HSA that are perturbing the corona to release 
more payload. These protein components are most likely the “hard corona” proteins in 
HS that are able to exchange with the “hard corona” proteins on the NR because of 
similar binding affinity to the NRs. We have thus demonstrated that the selection of 
proteins can provide us with a handle to control the payload release rate.  
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Figure 5-19. Formation of the protein coronas 
 
The unblocked NB-HS-DNA passively released DNA with a profile similar to the NRs, 
starting with negligible release in the first 3 days and then increasing with time (Fig. 5-
19, b, black). However, the use of HSA seemed to increase the amount of DNA released 
passively on the first days (350 ± 220 DNA/NB or 20 ± 9% of loaded DNA at Day 1) 
(Fig. 5-19, b, green). This amount is even higher (850 ± 280 DNA/NB or 50 ± 30% of 
loaded DNA) when HS was used (Fig. 5-19, b, red). While the release profile of NBs was 
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similar to that of NRs, the amount of released DNA from NBs is generally higher 
(reaching 70 ± 15% after 15 days with HSA block vs. 30 ± 15% with HSA block on 
NRs). This shows that the corona formed on larger NBs are apparently more prone to 
leakage and blocking by HSA is less effective for a leakier corona. As was previously 
reported, NP size can also influence corona formation[19-21]. 
CNT-HS-DNA also exhibited similar passive release profiles to NRs and NBs, with 
generally a higher amount of DNA being passively released with time. The same initial 
3-day lag in the passive release was observed for all 3 cases (no blocking, blocking with 
HSA and blocking with HS), after which the release increased significantly (Fig. 5-19, c). 
After 3 days, the release amount was least with HSA blocking (Fig. 5-19, c, green), and 
increased significantly after corona exchange with HS (Fig. 5-19, c, red), similar to 
observations for NRs.  
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These results show that protein coronas can be used for enhanced loading on gold 
nanoparticles for both triggered release applications (where leaking needs to be 
minimized until there is an external signal), or for passive release applications. We can 
strategically tune the properties of NPs in order to enhance the loading by using 
different concentrations of human serum, CTAB or PB when preparing the coronas.  
Exchange of corona proteins can help optimize the carrier properties of coronas 
surrounding NPs. Hard corona proteins exchange more and result in higher release, while 
soft corona proteins exchange less and can be used to decrease release. This strategy can 
be employed different types of nanoparticles, as the ligand on the NP seems to influence 
the release profiles more than the material identity of the NP. We can use these results 
to strategically design corona properties for a particular biological application.  
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6. Switching on and off blood clotting with light 
6.1. Introduction 
Nature has engineered the blood clotting cascade to form clots with temporal and spatial 
precision. Current control of blood clotting is achieved predominantly by anticoagulants 
and thus inherently one-sided. Here we use a pair of nanorods (NRs) to provide two-way 
control of the blood clotting cascade by utilizing their ability to selectively release species 
on their surface under two different laser excitations. We selectively trigger release of a 
thrombin binding aptamer from one NR, inhibiting blood clotting and resulting in 
increased clotting time. We then release the complementary DNA as an antidote from 
the other NR, reversing the effect of the aptamer and restoring blood clotting.  Thus, the 
NR pair acts as an on/off switch. One challenge for nanobiotechnology is the bio-nano 
interface[1-3], where coronas of weakly adsorbed proteins can obscure biomolecular 
function. We exploit these adsorbed proteins to increase aptamer and antidote loading 
on the NRs[4].  
Nanotechnology has great potential as an enabling technology for biology because 
nanoparticles can be designed to interface directly with biomolecules. In particular, 
external laser excitation of nanoparticles can trigger payload release[5, 6], so 
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nanoparticles can act as handles for controlling biological processes. Gold nanorods 
(NRs) have gained considerable interest for therapeutic applications because they can be 
selectively excited at wavelengths where tissue does not absorb to release multiple 
species that can impact complex processes, such as gene expression[5, 7-9] so extension to 
control blood clotting is promising. 
Thrombin inhibitors are of great interest as candidates for anticoagulants because 
thrombin, which cleaves fibrinogen into fibrin to form the clot, is at the apex of the 
clotting cascade[10, 11]. We used ssDNA thrombin binding aptamers (TBA) to bind and 
inhibit thrombin and blood coagulation. We then used complementary DNA as an 
antidote because it can reverse TBA’s effect by base-pairing with it (Fig. 6-1). Selective 
excitation of two different NRs to release TBA and its antidote enables the pair to act as 
an on/off switch for coagulation. Coronas made from human serum (HS) loaded with 
NRs and TBA (NR-HS-TBA) + coronas loaded with NBs and antidote (NB-HS-anti) 
can be irradiated at 800nm, in order to melt the NRs, and release the TBA in order to 
increase blood clotting time. Following that, 1100nm irradiation can trigger the release of 
the ssDNA antidote. The antidote and the TBA can form a hybrid, and therefore blood 
clotting would be restored (Fig. 6-1). 
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Figure 6-1. Scheme of the selective release approach 
 
One critical challenge for nanobiotechnology is the difficulty of controlling the bio-nano 
interface. Proteins adsorb on nanoparticles to form coronas[1, 3, 12] that can obscure the 
function of biomolecules on the nanoparticle surface or result in unpredictable behavior. 
However, protein coronas can possess beneficial properties, so we used them here to 
increase DNA loading on the NRs[4]. 
Here we build upon Chapters 2-5 in order to better engineer NRs as carriers for TBA 
and antidote. We have observed that coronas can be engineered to load high 
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concentrations of payload, and that they can be designed to avoid leakage during the 
first 4 days after preparation (Chapter 5). Moreover, we have observed that thiolated 
TBA released from NRs retains only 64% functionality (Chapter 4). We aim to take 
advantage of protein coronas in order to enhance the concentration and functionality of 
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6.2. Effect of TBA and antidote in thrombin clotting tests 
TBA has been identified by SELEX to bind and inhibit thrombin, the protein at the 
apex of the blood clotting cascade, which cleaves fibrinogen into fibrin, which forms the 
clot[13, 14]. TBA folds into a double G-quartet and binds to exosite I, so it inhibits 
activity by preventing fibrinogen binding[15-19]. Thrombin inhibition results in an 
increase in blood clotting time, tplasma. We verified TBA’s ability to inhibit clotting by 
measuring its effect on tplasma in a thrombin test, with 10nM thrombin[20]. Fluorecently 
labelled TBA (5’ GGTTGGTGTGGTTGG-TMR 3’) was added into blood at increasing 
amounts. Blood with no TBA was normalized as tplasma = 1.0. Increasing TBA 
concentration increased tplasma (Fig. 6-2, top), indicating that TBA inhibited thrombin 
and consequently the blood coagulation cascade. 
We verified that antidote could reverse TBA’s effect. Fluorecently labelled antidote had 
a sequence of 5’ CCAACCACACCAACC-FAM 3’. As antidote:TBA was increased from 
0:1 to 2:1, tplasma started at 4.4 and decreased (Fig. 6-2, bottom). Thus, antidote could 
successfully inhibit TBA by forming a double strand with it and preventing it from 
folding into the G-quartet structure necessary for thrombin binding (Fig. 1)[20]. ΔGbinding 
(TBA-thrombin) = -35.6 kJ/mol, where ΔGbinding (TBA-antidote) = -67 kJ/mol[17, 21], 
so TBA’s affinity for antidote is stronger than for thrombin. Blood clotting time was 
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restored to its original value at 1:1 TBA:antidote, indicating excess antidote was not 
needed to reverse TBA’s function[22, 23]. 
 
Figure 6-2. Calibration of TBA (top) and antidote:TBA, with [TBA]=500nM(bottom) 
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6.3. Preparation and characterization of NR-coronas 
Cetyltrimethylammonium bromide (CTAB)-coated gold particles that absorbed at two 
distinct wavelengths were synthesized (see Chapter 2: Materials and Methods)[24-26]. 
Rod-shaped nanorods (NRs) with an aspect ratio (AR) = 3.7 and DH = 45 nm had a 
longitudinal surface plasmon resonance (SPR) at 763 nm (Fig. 6-3, 6-5). Bone-shaped 
“nanobones” (NBs) with AR = 4.8 and DH = 55 nm had a SPR at 1065 nm (Fig. 6-3, 6-
5). Because NRs and NBs exhibited distinct absorption features, selective excitation by 
fs-pulsed lasers was possible. 800 nm irradiation of a NR-NB mixture resulted in melting 
of the NRs only, seen by a decrease of the SPR at 800 nm (Chapter 4, Fig. 4-8). Melting 
induces the NRs to change shape to spheres, which shifts and decreases their SPR[27]. 
The SPR at 1100 nm did not change, indicating that NBs were not melted because 800 
nm coincides with a minimum in their absorption (Fig. 6-3, bottom, blue line). Likewise, 
NRs do not absorb at 1100 nm (Fig. 6-3, top, red line), so 1100 nm irradiation resulted 
in a decrease of the NB SPR but did not affect the NR SPR, indicating selective melting 
of the NBs (Chapter 4, Fig. 4-9)[5]. Melting of the NRs and NBs separately was 
confirmed (Chapter 4, Fig. 4-4 and 4-5 respectively). 
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Figure 6-3. Absorbance spectra of NR, NB, NR-HS-TBA and NB-HS-anti 
 
While DNA conjugation to gold NRs can be achieved by thiol-Au bonding[28], we used 
protein coronas because they exhibit high payload capacity while still enabling triggered 
release via laser excitation of the NR. Coronas of human serum (HS) were formed around 
the particles[4] and  NR-coronas were loaded with TBA (NR-HS-TBA), NB-coronas with 
antidote (NB-HS-antidote). SPR of NR-HS-TBA was at 777nm, and SPR of NB-HS-
antidote was at 1093nm. Loadings were quantified by heating the sample for 30 min and 
90 °C and measuring the fluorescence spectroscopy of the supernatant, yielding 
674TBA/NR and 1307Anti/NB (Fig. 6-4). 
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Figure 6-4. Loading of NR-HS-TBA and NB-HS-anti 
 
The NR-HS-TBA had DH = 662 nm, and NB-HS-antidote DH = 938 nm (Fig. 6-5), as 
compared to initial CTAB-NR, with a DH = 45 nm and CTAB-NBs, with a DH = 55 
nm, indicating that a corona contains multiple particles. Zeta potentials for NR-HS-TBA 
(-9.8mV) and NB-HS-anti (-10.1mV) were negative because HS is predominantly 
composed of negatively charged species (Fig. 6-5)[29]. Likewise, the zeta potentials of 
NR-CTAB (42.2mV) and NB-CTAB (50.2mV) are positive because CTAB is a positive 
surfactant. 
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Figure 6-5. DLS and Zeta potential of NB-CTAB, NB-HS-anti, NRs-CTAB and NR-HS-anti 
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6.4. Single laser irradiations for the release of TBA and antidote 
Laser irradiation of NR-HS-DNA could trigger DNA release. First, NB-HS-TBA (Fig. 6-
6, black) were irradiated at 1100 nm and their SPR decreased, confirming NB melting 
(Fig. 6-6, red). Released antidote quantified by fluorescence was [anti] = 129 nM, or 430 
anti/NB-HS-antidote (Fig. 6-6, inset).  
 
Figure 6-6. 1100nm irradiation of NB-HS-anti. Melting and release (inset) 
 
Similarly, NR-HS-TBA (Fig. 6-7, black) were irradiated at 800 nm and their SPR 
decreased (Fig. 6-7, red), confirming melting, and released [TBA] = 663 nM or 228 TBA 
released/NR-HS-TBA (Fig. 6-7, inset).  
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Figure 6-7. 800nm irradiation of NR-HS-TBA. Melting and release (inset) 
 
We introduced released TBA in blood, in a aPTT clotting test, with 0nM thrombin 
added, and tplasma increased to 1.61 (Fig. 6-8, red), comparable to the effect of free [TBA]  
= 609 nM (Fig. 3-8, red dot for released TBA, and red stars for TBA calibration). As 
compared to the supernatant from the NR-HS-TBA that was not exposed to the laser 
irradiation (tplasma=1.0). Thus, TBA was ~94% functional in coagulation, which could be 
due to slight damage from the laser or steric hindrance by other released corona species. 
These experiments show that laser irradiation can release TBA from coronas on NRs, 
and released TBA is largely functional and can impact coagulation.  
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Figure 6-8. Comparison of HS-TBA-Bock release, thiolated TBA-NRs and calibrations 
 
Using coronas for DNA loading has several advantages over covalent attachment. 
Compared to NRs conjugated to thiolated TBA (thiol-TBA), coronas had higher 
loadings and resulted in greater released DNA/NR. Analogous experiments performed 
with covalently attached thiol-TBA (Chapter 4) released 1.46 µM TBA from 11.2 nM 
NRs (Fig. 6-7, released thiolated TBA is shown by a blue square, and thiolated TBA 
calibration is shown by blue x), approximately half of what could be released from NR-
HS-TBA (130 released TBA/NR-thiol-TBA vs. 223 released TBA/NR-HS-TBA). 
Furthermore, this NR concentration is optically dense, limiting absorption and 
necessitating long irradiation times (~30 min). Also, the functionality of released thiol-
TBA was deteriorated.   
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Released thiol-TBA resulted in tplasma = 1.47 (Fig. 6-8, blue), comparable to the effect of 
free [thiol-TBA] = 959 nM (Fig. 6.7, blue square and dashed line), exhibiting only 64% 
functionality. This is significantly lower compared to TBA from the corona, and could be 
attributed increased laser damage[30] due to it being directly attached to the NR 
combined with the long irradiation times. Thus, using coronas for loading can improve 
both yield and functionality of DNA, while also reducing irradiation time. 
 
Figure 6-9. Comparison of HS-TBA-Bock release and thiolated TBA-NRs 
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6.5. Selective release of TBA and antidote for the control of 
blood clotting 
We selectively released TBA and antidote to inhibit and then restore blood clotting. 
First, a NR-HS-TBA + NB-HS-antidote mixture (Fig. 6-10, black) was exposed to 800 
nm irradiation. The 800 nm SPR decreased but the 1100 nm SPR was unaffected, 
confirming selective melting of the NRs under the 800nm irradiation(Fig. 6-10, red).  
 
Figure 6-10. Comparison of HS-TBA-Bock release and thiolated TBA-NRs 
 
TMR fluorescence in the supernatant due to released TBA increased while FAM 
fluorescence due to the antidote did not increase as much, illustrating that the NRs 
Helena de Puig Guixé 
Mechanical Engineering MS Thesis 
MIT 
 
6. Switching on and off blood clotting with light                                                                                                             
 
258
preferentially released payload (Fig. 6-11, red). Quantifying release showed that 800 nm 
irradiation released 107 nM TBA (252 released TBA/NR), but only 1.3 nM antidote.  
 
Figure 6-11. Comparison of HS-TBA-Bock release and thiolated TBA-NRs 
 
Released species introduced to blood resulted in an increase in tplasma to 1.73 (Fig. 6-12, 
800nm), indicating that released TBA inhibited thrombin and thus blood coagulation. 
Next, the NR-HS-TBA + NR-HS-antidote mixture was irradiated at 1100 nm. The 1100 
nm SPR decreased, confirming NB melting (Fig. 6-10, blue). FAM fluorescence 
increased, indicating that 152 nM antidote was released (692 released antidote/NB) 
(Fig.6-11, blue), while 63 nM TBA was released. The effect on coagulation was tplasma = 
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0.88, demonstrating that released antidote could reverse the effect of TBA and restore 
coagulation to its original tplasma (Fig. 6-12, 1100&800nm).  
 
Figure 6-12. Comparison of HS-TBA-Bock release and thiolated TBA-NRs 
 
To test selectivity of the switch, 1100 nm irradiation alone on NR-HS-TBA + NB-HS-
anti (Fig. 6-12, 1100nm) did not significantly change tplasma (0.98, Fig. 6-11), showing 
that antidote release alone does not affect coagulation. The mixture of NR-HS-TBA and 
NS-HS-anti (Fig. 6-13, blue) was irradiated at 1100nm, and melting of the NBs as a 
decrease on their SPR was observed (Fig. 6-13, a, red), while NR-HS-TBA did not melt. 
216nM antidote and 4nM TBA were released (Fig. 6-13, b, red). 
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Figure 6-13. 1100nm irradiation of the NR-HS-TBA and NB-HS-antidote. Left: Absorbance. Right: 
fluorescence of the released species 
 
To test whether HS release affects coagulation, NR-HS were prepared without TBA and 
mixed with NB-HS-anti. 800 nm irradiation resulted in no significant change in tplasma 
(1.1), (Fig. 6-12, 800nm no TBA) confirming that the presence of TBA was necessary to 
affect coagulation. Finally, we verified that the presence of NR-HS-TBA + NB-HS-anti 
mixture with blood did not affect tplasma (0.86) (Fig. 6-12, No laser). 
Because protein coronas and ssDNA (TBA and antidote) are not covalently bound to the 
NPs, there is the possibility of disruption of the corona around the NRs, by exchange 
with blood proteins and other small biomolecules. This does indeed happen, and can be 
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measured. We introduced NR-HS-TBA directly into blood, and measured tplasma (Fig. 
6.14, NR). This value can be compared to the increase in tplasma from released TBA from 
coronas (Fig. 6.14, 800nm), and we can observe that even though there is an increase in 
tplasma due to the leakage of TBA from the coronas, the increase on tplasma when NRs are 
irradiated at 800nm is still much higher. The increase on tplasma due to leakage from the 
coronas is equivalent to 38nM TBA -or 89 TBA/NR-, which represent a 14% release 
from coronas, as compared to the 42% released achieved by laser irradiation. We also 
introduced NR-HS-TBA and NB-HS-antidote into blood and measured the effect of 
TBA+antidote leaked from coronas into blood (Fig. 6.14, NB+NR), and the effect of 
TBA+antidote released by laser irradiations from NR-coronas (Fig. 6.14, 800&1100). We 
observe that when NRs and NBs leak both TBA and antidote into blood, there is no 
change in tplasma , as the antidote and TBA hybridize. 
 
Figure 6-14. Measurement of the effect of particles in blood.  
Helena de Puig Guixé 
Mechanical Engineering MS Thesis 
MIT 
 




This work demonstrates that external laser excitation can selectively release a thrombin 
inhibitor and its antidote, allowing the NR/NB pair to act as an on/off switch for blood 
clotting. Blood clotting time is increased after 800nm laser irradiation of the mixture due 
to the release of TBA only. After 1100nm irradiation, blood clotting time returns to its 
original value, as antidote is released and base-pair with the TBA, leaving thrombin free 
to form blood clots. 
Protein coronas represent an advantage in the release of ssDNA, as they enable enhanced 
loading on the particles, doubling the ssDNA/NP released. Furthermore, ssDNA released 
from protein coronas is highly functional compared to the TBA released from covalent 
attachment. 
On the other hand, NR-coronas have shown to leak small amounts of TBA in blood. 
However, TBA leaked from the NR-coronas due to protein exchange in blood represents 
a 14% TBA leaked, as compared to the 40% TBA that can be released from NR-coronas 
though laser irradiation. More research can be done in order to further decrease the 
concentration of TBA that leaks from the NR-coronas in blood. 
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7. Conclusions and future directions 
7.1. Summary of the work 
We have been able to utilize gold nanoparticles in order to create a two-way optical 
switch of blood clotting, in a way that enables a localized, selective, specific and 
externally activated control of the clot formation process. Gold nanoparticles with 
different aspect ratios can be selectively excited with lasers in order to release payloads 
on their surface. We use this idea to selectively release thrombin binding aptamers 
(TBA) and their antidotes. Released TBA can bind to thrombin and increase blood 
clotting time; and the antidote can bind to TBA in order to reverse its effects and result 
in normal clotting times. Moreover, protein coronas enable enhanced release and 
functionality of the payloads compared to covalent attachment strategies. Covalent 
attachment techniques are also introduced and used for quantification of the interactions 
between thrombin and TBA, when TBA is bound to the surface of NRs.  
This approach can be extended to any application that requires the creation of an on/off 
switch or the release of multiple biomolecules in a localized and externally controlled 
manner, such as in cancer applications, where great improvements could be made if it 
were possible to release different drugs in a time and space controlled manner, or in 
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controlled gene expression. Below is a summarized list of the main conclusions of the 
thesis, while more extended conclusions can be found in each chapter of the thesis. 
In Chapter 3 of this thesis, we have discussed the interactions of biological nanomachines 
at the NP interface. We have both studied both the hybridization of DNA on surfaces, 
and the assembly of NRs induced by the presence of a binding biomolecule –in our case 
thrombin. First, we have studied the thermodynamics of the assembly and disassembly 
of NRs, and introduced a model to explain the thermodynamics of NR assembly in the 
presence of thrombin. This model is completely general and enables for the calculation of 
the surface work that is produced on the NRs surface during the assembly process. We 
extend this work in order to compare between NRs with different surface chemistries 
(See Chapter 3.2.4, for more conclusions on this work). Also, the kinetics of the binding 
process has been introduced. We have used a simplified model to explain the kinetics of 
TBA decorated-NRs assembly due to the presence of thrombin (See Chapter 3.3.4, for 
more conclusions on this work). DNA hybridization at the interface has been introduced. 
We have been able to describe it by using Langmuir’s approach of surface absorption. 
We calculated the binding efficiency of complementary DNA on the surface of NRs with 
different surface chemistries, and, although more experimentation needs to be done to 
obtain more concluding results, we have observed a clear difference in the binding 
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efficiency depending on the surface properties of the particles (See Chapter 3.4.3, for 
more conclusions on this work). Also, a model to explain the NRs disassembly after the 
addition of TBA’s complementary sequence has been introduced (Chapter 3.5.3, for more 
conclusions on this work). All of these results help to quantitatively describe the physical 
properties of the interface of biomolecules with nanomaterials, which can aid applications 
in which nanomaterials are used for biological applications.  However, many challenges 
remain for the interface, and more experimentation needs to be done in order to be able 
to give details on the thermodynamics of the NRs disassembly process (see Chapter 3.6 
for more conclusions on this work).  
In Chapter 4, we were able to melt NR-NB mixtures selectively and to release covalently 
bound ssDNA from NRs by using a fs laser excitation. However, the concentration of 
NPs that were necessary to be used in the control of blood clotting was prohibitively 
high (12nM), therefore we decided to test new loading strategies on the NRs that could 
enable for enhanced loading of ssDNA on the NPs, and therefore permit a lower 
concentration of NPs (see Chapter 4.5 for further conclusions on this work). 
In Chapter 5, we used coronas of absorbed proteins as “sponges” for high payload 
capacity. Basically, human serum could hold large amounts of ssDNA (~6x monolayer 
ssDNA coverage compared to loading by covalent chemistry0. We found the parameters 
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that played a most important role in the formation of protein coronas, and searched the 
best conditions for an external release application, in which leakage from the protein 
coronas could be minimized until there is an external signal such as laser irradiation. We 
show that 5mM PB, 5mM CTAB and 5% HS enable for an enhanced loading on the 
NPs, while keeping the leakage minimized. Moreover, we observed that by tuning the 
formation process of protein coronas on NPs, it is possible to modify the passive release 
profile, which would enable us to engineer coronas with controlled passive release 
profiles, in order to decide when maximum release would occur and the speed of the 
release from the coronas. Because the formation of protein coronas on nanoparticles is 
inevitable, using them for enhanced loading and controlled release opens up new 
possibilities in nanobiotechnology and nanomedicine, where the current practise is to 
focus on preventing binding of proteins on the nanoparticles (see Chapter 5.6 for more 
conclusions on this work).  
Finally, in Chapter 6, we show that selective and externally controlled release from NR-
coronas is possible and it can be used to control blood clotting. We demonstrate that 
both NRs and NBs can be selectively excited in order to release TBA and antidote 
respectively. Moreover, we show that ssDNA released from NR coronas is higher 
(double) than the amount released from covalently bound TBA on NRs, due to the 
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enhanced loading that coronas permit. Moreover, we could observe that TBA released 
from protein coronas is highly functional (94%) as compared to the thiolated TBA 
released from covalent binding that exhibited a 64% functionality (see Chapter 6.4 for 
further conclusions on this work).  
These results show that nanomaterials can be used for triggered release. While the 
interface of nanomaterials with biological systems presents many challenges, physical 
characterization of the interface properties can be used to yield a deeper insight and 
ultimately better control. In addition, protein coronas present a unique challenge for 
nanomaterials, but can be exploited for enhanced release capabilities of the NRs, and 
also for biocompatibility, as serum proteins are already present in blood.  
7.1.1. Limitations and further studies 
Although the results of this work are very promising, and in vitro tests show that gold 
nanorods can be used to control blood clotting, there are a number of limitations that 
need to be taken into account, especially if we aim to use the selective release of TBAs 
and antidotes in vivo.  
The first of them are the interactions of coronas of NPs with other proteins in blood. 
Due to the fact that protein coronas and ssDNA (TBA and antidote) are not covalently 
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bound to the NPs, there is the chance that the corona around the NRs will exchange 
with blood proteins. This does indeed happen, and can be measured. However, the 
increase in tplasma due to leakage from protein coronas into blood is much lower than the 
increase in tplasma after laser irradiation. Indicating that although there is exchange of 
proteins from the corona, most of the TBA is retained. 
Other limitations include the size of the NP-coronas. By DLS, we have been able to 
measure the particle’s hydrodynamic diameter to be ~600nm. Although this is still small 
enough for transport in the bloodstream without blocking the capillaries (NR-coronas are 
still much smaller than red blood cells), some flow simulations should be done in order to 
ensure that NR-coronas do not incur a risk of obstructing capillaries, especially in the 
brain, kidneys and lungs.  
Also, shear stress measurements by rheology and computer simulations[1] should be 
performed on NR-coronas to measure if disruption of the coronas is possible when they 
are under shear stresses due to blood flow. Some preliminary experiments have been 
performed by pipetting NR-coronas through capillaries, and no release of TBA was 
observed. However, those experiments were very preliminary and done by hand, so it 
was not possible to measure the shear stresses acting on the coronas during pipetting. 
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Therefore, further experiments need to be performed in order to obtain quantitative 
information.  
New limitations may arise when testing the system in vivo. TBA used in this work is 
highly specific and has a poor effect when targeting non-human thrombin. However, in 
order to use TBAs in a clinical environment it is necessary to perform in vivo tests with 
animals on the first place. This limitation has been overcome by sequencing new 
aptamers that can target thrombin from different animal species by using “toogle” 
SELEX[2]. Moreover, these new aptamers and their antidotes have already been tested 
in vivo and it has been shown that blood clotting can be switched on and off by adding 
the modified TBA and modified antidotes[3]. Nevertheless, localized and external control 
of the blood clotting has not yet been achieved, to the best of our knowledge. 
Other limitations are related to the concentration of NRs that can be introduced in 
blood, and the concentration of NRs that can be melted by laser irradiation. These 
concentrations will depend on the toxicity of the particles, and the concentration of NRs 
that can be introduced in the body without causing side effects would need to be known, 
as well as the release yields of TBA and antidotes in vivo. 
The concentration of payloads released in vivo from the coronas may decrease due to 
absorption and scattering of the laser light by the tissue. As we have previously 
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introduced, laser light with wavelengths between 600-1300nm should be mostly tissue 
and blood transparent[4-8]. However, some absorption and scattering effects do exist, 
which leads to a poor penetration of laser light in tissue, reaching only a few mm in 
penetration[7, 9-11]. This issue could be potentially overcome by using optical fiber 
which can be produced with diameters than < 1mm in order to introduce the laser light 
into the desired part of the body.  
7.1.2. Advantages 
Although limitations do exist, we believe that the advantages of creating a localized 
control of blood clotting would be noteworthy, as they would enable much safer surgery 
on patients.  
When performing surgery on patients that are treated with heparin and warfarin, the 
current practice is to wait until the effects of the drug have stopped in order to avoid a 
high risk of bleeding. However, in situations where emergency surgery is necessary and 
waiting for heparin/warfarin clearance cannot be realistically achieved, patients are 
currently given frozen plasma (or prothrombin in rare occasions) to stop the effects of 
the anticoagulants. However, there is little control in blood clotting when giving frozen 
plasma to patients, and consequently it is a dangerous practice. Therefore, the 
introduction of an anticoagulant/antidote pair would be very beneficial.  
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Moreover, the reason most patients are given anticoagulants is because they tend to form 
blood clots when blood is flowing normally and there is a high risk of formation of blood 
clots when the effect of the anticoagulants in the system is stopped -through the use of 
the antidotes-, because the formed blood clots can later travel through the body and 
potentially cause strokes. Therefore, the introduction of a localized and externally 
controlled switch for blood clotting would be beneficial, as it would enable to stop the 
activity of the anticoagulant only in one specific area, while still preventing the 
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7.2. Future prospects and applications 
While the issue of the interface of nanomaterials with biology is still an open challenge, 
where we have much to learn, this work can enable new applications and potentially 
open up many research possibilities.  
7.2.1. Control of blood clotting using gold nanorods in vivo 
The first opportunity that this work introduces is testing the optical switch for blood 
clotting in vivo. Modified aptamers that can target thrombin from mice, pigs and 
humans can be used[3], and their release from NR-coronas could be tested. These 
experiments can be also performed in vivo, to design an optical switch for blood clotting 
with potential clinical applications.   
In order to release TBAs and antidotes in the site of injury, two methods can be 
envisioned. (1) Directing the laser light only in the site of interest, and therefore only the 
NRs in that area would release TBAs and antidotes, (2) biochemically modifying the 
proteins used for the formation of the NR-coronas, in order to enable tumor targeting 
and (3) including the NR-coronas in hydrogels[12, 13], that could be introduced in the 
site of interest, and directing the laser light in that area as well. This last method would 
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enable the externally controlled selective release of the biomolecules, while minimizing 
the concentration of NR-coronas introduced in the body.   
7.2.2. Triggered release for combinational therapy 
Other conditions that require the use of combinational therapy, where more than one 
drug needs to be used in a certain order or simultaneously, would as well benefit from 
the use of optical switches. A prime example of this is cancer.  
Anticancer drugs are generally cytotoxic for both cancerous and normal cells. Moreover, 
drug resistance in cancer appears due to (1) low vascularization of tumors that can 
reduce drug access and protect cancerous cells from cytotoxicity of the drug; and also, 
(2) through biochemical alterations of cancerous cells that can affect the transport of 
drugs into the cells[14, 15].  
By using gold nanoparticles, it would be possible to selectively release multiple 
anticancer drugs in the tumor site; selective release would enable for the possibility of 
externally controlling the release of different drugs that could (1) on the first place 
silence the genes that prevent the transport of cancer drug in the tumor[16] and (2) later 
release anticancer drugs, such as doxorubicin[17].  
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By using selected aptamers that can target cancerous cells, gold nanoparticles could be 
directed to the tumor[18-23]. Tumor cell targeting and drug delivery by light irradiation 
has previously been demonstrated[24], but to the best of our knowledge, selective release 
from multiple NR-coronas to achieve combinational therapy in cancer has yet to be 
tested. Another advantage of using NR-coronas for the release of drugs in cancers is that 
they are good contrast agents for computed tomography (CT)[22], and therefore it would 
be possible to use them as well to monitor of the tumors during the therapy.  
7.2.3. Switchable enhancement of in vitro translation with light 
Previous work from the Hamad-Schifferli group has shown that using gold nanoparticles 
for nonspecific absorption of proteins can enhance in vitro translation[25]. Following this 
approach, and knowing that near-infrared (NIR) CW laser irradiation results in localized 
heating of the NPs, without melting them or releasing the thiol-gold bonds[26], it is 
possible to envision a situation in which in vitro translation of proteins could be 
externally controlled by localized heating of the NRs.  
Translation of the mRNA that encodes a protein involves the ribosomes, mRNA and 
many other species, that can nonspecifically adsorb on NPs and result in enhanced 
translation, when the NPs are covalently linked with ssDNA that binds specifically to 
the mRNA of interest[25]. Therefore, NP-ssDNA conjugates could be introduced in a 
Helena de Puig Guixé 
Mechanical Engineering MS Thesis 
MIT 
 
7. Conclusions and future work                                                                                                    279
cell-free translation system such as retic lysate or wheat germ mix and result in 
enhanced translation. Through CW laser irradiation, it is possible to selectively heat the 
NPs, resulting in disruption of the nonspecific interactions, and therefore the translation 
of the protein. After stopping laser irradiation it would be possible to enhance protein 
translation again, because the CW laser irradiation does not break the covalent bonds 
between the DNA and the NPs.   
7.2.4. Nanobiomachinery and protein-NR / DNA-NR origamis 
Biomolecular nanomachines can be used for collective behaviour of NPs. In Chapter 3, 
we have shown that the addition of proteins (thrombin) and ssDNA (antidote) can be 
used in order to assemble and disrupt nanoparticle assemblies, due to the specific 
interaction of thrombin and TBA, where thrombin can bind to two different TBAs 
bound to different NRs. Also, the introduction of ssDNA complementary to TBA can 
disrupt the aggregates, as it can bind to TBA and therefore release thrombin. Similarly, 
it has also been shown that assemblies of NP-ssDNA can be prepared by using partially 
complementary ssDNA that can bind to two different ssDNA on the NPs[27, 28]. NP 
assemblies have the great advantage that they can be easily characterized, and the 
energies of binding and disrupting the aggregates can be measured by absorbance 
spectroscopy using the thermodynamic approach explained in Chapter 3.2. 
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Inspired in DNA origami[29] which have been used for drug delivery[30]; NR-DNA 
assemblies could be as well used for enhanced loading of payloads, such as intercalating 
species such as doxorubicin or DNA binding proteins, while maintaining its optical 
properties due to the gold nanoparticles. Furthermore, the nanoparticles enable selective 
and localized release by laser irradiation.  
The NP-DNA assemblies could be prepared in order to have different sizes and shapes 
through direct assembly or in a layer-by-layer approach by surface modification of the 
ssDNA-decorated-NPs, or by tuning the concentration of linker ssDNA. It is known that 
anticancer drugs such as mitoxantrone, doxorubicin or elliptisine can intercalate within 
the dsDNA[31, 32], and therefore it would be possible to encapsulate them in the NP 
assemblies. Once these drugs are encapsulated in the NP-DNA carriers, they could be 
released by laser irradiation of the NPs at their SPR. 
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